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Abstract 
 
The purpose of this dissertation was to synthesize and evaluate porous poly(2-
hydroxyethyl methacrylate) (PHEMA) and PHEMA composite hydrogels containing 
various concentrations of titanium dioxide (TiO2) nanoparticles, silicon dioxide (SiO2) 
nanoparticles, and multi-walled carbon nanotubes (CNTs) for tissue engineering 
applications. Eighteen PHEMA nanocomposite hydrogels and five control PHEMA 
hydrogels were prepared in varying concentrations of water (60-90 wt.%) via a free 
radical polymerization process. Four of these hydrogels were modified further with 
an OVICOLL®CLEAR collagen, a mixture of type I and type III collagen, for the 
improvement of cell activities.  
 
Gravimetric analysis and X-ray diffraction analysis, as well as scanning electron 
microscopy (SEM), were used to examine the presence of the nanoadditives 
contained in the hydrogel polymers. The presence of collagen also was confirmed 
using a Fourier transform infrared spectroscope, an ultraviolet-visible 
spectrophotometer and an SEM.  
 
All hydrogels appeared opaque and exhibited various porous structures, which then 
were studied using a SEM. The porous structures were found to be dependent largely 
on the HEMA:water concentrations in the polymerisation mixtures. There was no 
significant difference in the porous structure for PHEMA and PHEMA composite 
hydrogels containing additives. The results from the polymer volume fraction study 
also indicated the porous structures of the resultant hydrogels.  
 
The tensile properties of the hydrogels were examined using a SINTECH 200/M 
material testing workstation. The viscoelastic properties of the hydrogels were 
investigated using a HAAKE MARS III Modular Advanced Rheometer System. The 
mechanical properties of the hydrogels, apparently, were affected by the presence of 
the porous structures. In general, higher tensile and elastic moduli were seen for 
hydrogels with less porous structures. In contrast, lower tensile and elastic moduli 
were seen for more porously structured hydrogels. The addition of TiO2 particulates 
did not show significant influence on tensile and elastic moduli. However, the 
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addition of CNTs increased the viscoelastic moduli of PHEMA hydrogels, which can 
be attributed to their fibre characteristics. The
 
hydrogels produced in this study have 
shown a great range of linear viscoelasticity and a quick recovery characteristic, 
dependent on the macroporous structures and the presence of the TiO2 nanoadditives. 
 
The delivery of a model molecule, methylene blue and three biomolecules, including 
prednisolone 21-hemisuccinate sodium salt, caffeine, and bovine serum albumin 
were carried out under static and dynamic conditions. Rheological stimulations were 
used for the dynamic conditions. The delivery of both single and dual molecules was 
investigated. It was found that increasing the frequency and the shear strain of the 
stimulations accelerated the relative biomolecule release under dynamic conditions. 
However, in comparison to the static conditions, the relative delivery of the 
biomolecules was slowed by the application of rheological stimulations, due to the 
reabsorption of the biomolecule into the hydrogel matrix under the dynamic 
conditions. The release profiles of the biomolecules were affected by the 
concentrations of the biomolecules and their molecular weights, as well as the porous 
structures of the hydrogels. When dual biomolecules were utilised in the system, the 
delivery profile of each of the biomolecules was the same as the single biomolecule 
delivery profile. The relative release also was dependent on the porous structures and 
the molecular weights.  
 
The biomineralisation of the hydrogels was evaluated with a calcification study. The 
infiltration of the calcium phosphate was found to be more vigorous in a more 
porously structured hydrogel, and it was significantly enhanced after TiO2 
nanoparticles were incorporated. An assay indicated that PHEMA and its 
nanocomposite hydrogels were tolerated well by the NIH 3T3 fibroblast cells. 
However, the cell growth on both PHEMA and PHEMA composite hydrogels was 
relatively slow. The presence of collagen significantly increased numbers of viable 
cells on modified hydrogels in comparison to that seen on hydrogels containing no 
collagen molecules. This was true for two other types of cell, including green 
fluorescent protein-transfected 253 human melanoma cells and human mesenchymal 
stem cells. 
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In summary, porous PHEMA composite hydrogels make an excellent family of 
scaffolding materials for soft tissue regeneration. Their porous structures and 
mechanical properties can be tailor-made, simply by adjusting the chemical 
composition in the formulae to meet the requirements of specific applications. The 
bioactivities of the hydrogels also can be improved by tethering natural molecules 
without altering the porous structure or the mechanical properties. Biomolecules can 
be preloaded into the hydrogel matrices by a simple diffusion process at room 
temperature due to the presence of large pores. The preloaded concentrations and the 
subsequent delivery of these biomolecules can easily be adjusted by changing the 
concentrations of the stock solutions. This is highly desirable for an ideal tissue 
scaffold, which not only can provide interconnected pores and dictated mechanical 
properties, but also is capable of delivering essential signalling biomolecues for the 
tissue regeneration process. Therefore, these preliminary investigations of PHEMA 
and PHEMA composite hydrogels have demonstrated their great potential for tissue 
engineering applications.  
 
 
IV 
 
Acknowledgements 
 
I would like to thank my thesis advisor, A/Prof. Xia Lou, for her guidance, support 
and great patience. I am so deeply grateful for the opportunity to join her research 
group and conduct my PhD work under her supervision. Her vision and dedication to 
research have been truly inspirational. I also want to take this opportunity to thank all 
my dissertation committee members, including Prof. Moses Tadé and Prof. Roland 
De Marco.  
 
Thanks also go to Prof. Ming Ang, the Head of Chemical Engineering, for his 
support and help.  
 
I thank Dr Shaoqiong Liu and Ms Yan Li from the Institute of Bioengineering and 
Nanotechnology, Singapore, as well as Ms Bev Kinnear of the Molecular 
Immunology Group, Curtin University, for their kind help in carrying out the cellular 
activity assays of the collagen-modified hydrogels.   
 
I would like to thank Prof. Choo-May Lai for allowing me to use the facilities and 
resources in the Department of Molecular Ophthalmology at the Lions Eye Institute 
(LEI). Assistance from Prof. Choo-May Lai and Ms Marisa De Pinho at LEI is 
appreciated very much.  
 
Many thanks for those who provided great technical help during my laboratory work. 
These included Grant Cope, Kristy Blyth, Dr Peter Sheppard, Peter Chapman and 
Tomoko Radomirovic (Department of Chemistry, Curtin); Karen Hynes, Ann 
Cornell, Zero Zhang, (Department of Chemical Engineering, Curtin); Alain Delhaize 
(Department of Biomedical Sciences, Curtin), Angela Samec (Department of 
Pharmacy, Curtin); Elaine Miller, Dr Rob Hart (Discipline of Applied Physics, 
Curtin); Peter Duncan, Lyn Kirilak  (Centre for Microscopy, Characterization and 
Analysis, The University of Western Australia). 
 
The work of present and past members in the polymer research group is very much 
appreciated. Thanks go to Dr. Ailin Ding, Yenny, Yuli and Shuo for their friendship. 
V 
 
I would also like to thank undergraduate students completing projects within our 
group, including Elance, Yek Chuan, Tristan and Eric. I also appreciate the help I 
received from other PhD students including Monica and Thu Le in the Department of 
Chemical Engineering. 
 
I would like to thank Dr. John Fielder for his great help in reading my thesis. 
 
I would like to take the opportunity to say how much I appreciate my friends, 
including Binghui and Winie, Yun, Xiangpeng, Hongfei and Xiaomei, Yanqiang and 
Dr. Pengchao Si. I also want to thank friends from the Curtin Christian Union and 
Carmel Church. They brought great fun into my life while in Perth.  
 
I want to acknowledge the Australian Research Council for a Discovery Project 
Grant (DP0557148), Curtin for its International Research Tuition Scholarship 
(CIRTS), and the Department of Chemical Engineering for financially supporting 
this project.  
 
Finally, and most importantly, I would like to thank my parents, Guang-nian Li and 
Xue-ling Zhang for their love, support, encouragement and understanding. Thanks to 
my sister (Ya-ping Li), my bother in-law (Sheng-Li Zhang), my brother (Ming Li) 
and sister in-law (Qing Fang). Thanks to my lovely wife, Nina Wang, for her love 
and understanding. I also want to say thanks to many other relatives who have been 
supportive.  
 
 
 
 
 
 
VI 
 
 
 
This thesis is dedicated to my loving parents. 
VII 
 
Publications and Conference Presentations 
 
Journal Publication 
1. Li, C., Zheng, Y.F., Lou, X.. Enhanced calcification capacity of porous PHEMA 
by TiO2 nanoparticulates, Journal of Materials Science: Materials in Medicine, 
20: 2009, 2215–2222. 
Full Conference Paper 
2. Li, C., Lai, C.M., De Pinho, M. and Lou, X.. Effect of TiO2 nanoparticles on the 
calcification capacity of porous PHEMA hydrogels. 8th World Congress of 
Chemical Engineering. August 23-27, 2009. Montréal. Canada. 
Conference Presentations 
3. Li C., Liu, S. Q., Lou, X..  Collagen modified porous PHEMA hydrogels for 
tissue engineering applications. World Biomaterials Congress, 2012. 
4. Li, C., Lai, C.M., De Pinho, M. and Lou, X.. Effect of TiO2 nanoparticles on the 
calcification capacity of porous PHEMA hydrogels. 8th World Congress of 
Chemical Engineering. August 23-27, 2009. Montréal. Canada. 
5. Li, C. and Lou, X.. Dynamic Mechanical Responses of PHEMA and PHEMA-
TiO2 Composite Hydrogels to the Change of Rheological Conditions. 
International Conference on Materials for Advanced Technologies (ICMAT) & 
The 2nd Asian Biomaterials Congress, 25-27 June, 28 June-3 July, 2009, 
Singapore.  
6. Lou, X., Li, C., Wang, S., Zheng, Y.F.. Preparation and Characterization of 
PHEMA-TiO2 Composite Scaffolds for Bone Tissue Regeneration, 1st Asian 
Biomaterials Congress, 6-8 Dec, 2007, Tsukuba, Japan 
Manuscripts in Preparation 
7. Li, C. and Lou, X.. Dynamic Mechanical Responses of PHEMA and PHEMA-
TiO2 Composite Hydrogels to the Change of Rheological Conditions. 
8. Li C., and Wang, S., Lou, X.. Delivery of Biomolecules from Porous Poly (2-
hydroxyethyl methacrylate) Hydrogel under Static and Dynamic Conditions. 
9. Li C., Liu, S. Q., Lou, X.. Cellular Activities of Porous Collagen-modified 
VIII 
 
Poly(2-hydroxyethyl methacrylate) (PHEMA) and PHEMA-TiO2 Hydrogels for 
Tissue Engineering Application. 
 
IX 
 
Contents 
Abstract ......................................................................................................................... I 
Contents ..................................................................................................................... IX 
List of Figures ...........................................................................................................XII 
List of Tables..........................................................................................................XVII 
CHAPTER 1 INTRODUCTION ................................................................................. 1 
1.1. Background ....................................................................................................... 1 
1.2. Tissue Engineering Approach ........................................................................... 2 
1.3. Tissue Scaffolds and Design Parameters .......................................................... 5 
1.4. Materials for Tissue Scaffold Fabrication....................................................... 10 
1.4.1. Metals....................................................................................................... 11 
1.4.2. Bioceramics and Bioglasses................................................................. 11 
1.4.3. Polymers............................................................................................... 12 
1.4.4. Composite Materials ................................................................................ 13 
1.5. Design of Thesis Work.................................................................................... 13 
1.5.1. Hydrogels and PHEMA ........................................................................... 14 
1.5.2. Titanium Dioxide (TiO2).......................................................................... 24 
1.5.3. Carbon Nanotubes (CNTs)....................................................................... 24 
1.5.4. Silicon Dioxide (SiO2) ............................................................................. 26 
1.5.5. Collagen ................................................................................................... 26 
1.5.6. Research Plan and Methodology.............................................................. 27 
CHAPTER 2 MACROPOROUS PHEMA AND PHEMA COMPOSITE 
HYDROGELS: SYNTHESIS AND CHARACTERIZATION................................. 30 
2.1. Introduction ..................................................................................................... 30 
2.2. Experimental ................................................................................................... 33 
2.2.1. Chemicals................................................................................................. 33 
2.2.2. Synthesis of Porous PHEMA Composite Hydrogels............................... 34 
2.2.3. Quantification of Additives...................................................................... 36 
2.2.4. Morphology Exmination .......................................................................... 37 
2.2.5. Polymer Volume Fraction Measurement ................................................. 37 
2.2.6. Calcification Study................................................................................... 39 
2.2.7. MTT Assay .............................................................................................. 41 
2.3. Results and Discussion.................................................................................... 42 
X 
 
2.3.1. Synthesis of Porous PHEMA Composite Hydrogels............................... 42 
2.3.2. Contents of Nanoadditives ....................................................................... 45 
2.3.3. Polymer Volume Fraction........................................................................ 47 
2.3.4. Morphological Examination .................................................................... 47 
2.3.5. Calcification Capacity of Hydrogels........................................................ 53 
2.3.6. Cell Viability............................................................................................ 63 
CHAPTER 3 TENSILE AND RHEOLOGICAL RESPONSES OF PHEMA AND 
PHEMA-TiO2 COMPOSITE HYDROGELS............................................................ 67 
3.1. Introduction ..................................................................................................... 67 
3.2. Experimental ................................................................................................... 70 
3.2.1. Hydrogel Selection................................................................................... 70 
3.2.2. Tensile Tests ............................................................................................ 71 
3.2.3. Rheological Characterizations ................................................................. 72 
3.2.4. Method Validation and Data Corrections ................................................ 74 
3.3. Results and Discussion.................................................................................... 75 
3.3.1. Tensile Properties..................................................................................... 75 
3.3.2. Viscoelastic Properties ............................................................................. 77 
3.3.3. Creep-Recovery Properties ...................................................................... 85 
3.3.4. Comparison of Mechanical Properties of Hydrogel Materials ................ 90 
3.4. Conclusions ..................................................................................................... 94 
CHAPTER 4 DELIVERY OF BIOMOLECULES FROM POROUS HYDROGEL 
POLYMERS UNDER STATIC AND DYNAMIC CONDITIONS ......................... 95 
4.1. Introduction ..................................................................................................... 95 
4.2. Experimental ................................................................................................... 97 
4.2.1. Drug Selections and Hydrogel Specimens............................................... 97 
4.2.2. Drug Loading and Drug Loading Level................................................... 98 
4.2.3. Drug Delivery Set-ups ............................................................................. 99 
4.2.4. Drug Quantification ............................................................................... 100 
4.3. Results and Discussion.................................................................................. 107 
4.3.1. Drug Loading Level ............................................................................... 107 
4.3.2. Dynamic MB Release ............................................................................ 110 
4.3.3. Release Profiles of Various Biomolecules............................................. 117 
4.3.4. Release mechanism studies.................................................................... 121 
4.4. Conclusions ................................................................................................... 124 
XI 
 
CHAPTER 5 CELL ACTIVITIES IN PHEMA AND PHEMA-TiO2 COMPOSITE 
HYDROGEL SCAFFOLDS .................................................................................... 126 
5.1. Introduction ................................................................................................... 126 
5.2. Experimental ................................................................................................. 129 
5.2.1. Chemicals............................................................................................... 129 
5.2.2. Modification of Hydrogels with Collagen ............................................. 129 
5.2.3. Characterization of the Modified Hydrogels ......................................... 130 
5.2.4. Cellular Activities .................................................................................. 130 
5.3. Results and Discussion.................................................................................. 132 
5.3.1. Confirmation of Collagen in Hydrogels................................................. 132 
5.3.2. Morphological Analysis ......................................................................... 134 
5.3.3. Cell Activities in the Porous Hydrogel Surfaces ................................... 136 
5.4. Conclusions ................................................................................................... 143 
CHAPTER 6 CONCLUSIONS................................................................................ 144 
REFERENCES......................................................................................................... 147 
XII 
 
List of Figures 
Figure 1-1 A general tissue engineering procedure (George 2009)............................. 3 
Figure 1-2 Schematic representation of the occurrence of a phase separation .......... 16 
Figure 1-3 Schematic representation of macrosyneresis and microsyneresis during 
crosslinking polymerization ....................................................................................... 17 
Figure 1-4 The mechanism of radical generation in the APS initiator system and the 
formation of oligmors of PHEMA ............................................................................. 20 
Figure 1-5 Synthetic scheme of PHEMA hydrogel using DVG as a crosslinking 
agent ........................................................................................................................... 21 
Figure 2-1 DYNAVAC freeze drier for treatment of hydrogel specimens................ 35 
Figure 2-2 (a) A mould for casting hydrogel sheets and (b) a tissue culture plate 
consisting of 24 wells, for casting hydrogel buttons.................................................. 36 
Figure 2-3 A set-up using an analytical balance for measuring weights of hydrogels 
in both air and water................................................................................................... 39 
Figure 2-4 TGA curve of 30HEMA-7.5TiO2 composite hydrogel ............................ 46 
Figure 2-5 SEM micrographs of (a) 10HEMA, (b) 10HEMA-7.5TiO2..................... 48 
Figure 2-6 SEM micrographs of (a) 20HEMA, (b) 20HEMA-5TiO2, (c) 20HEMA-
7.5TiO2, (d) 20HEMA-5SiO2, and (e) 20HEMA-0.5CNT ........................................ 49 
Figure 2-7 SEM micrographs (a) 25HEMA, (b) 25HEM-3TiO2, (c) 25HEMA-
7.5TiO2, (d) 25HEMA-12TiO2, (e) 25HEMA-0.5CNT,  and (f) 25HEMA-2CNT... 50 
Figure 2-8 SEM micrographs of (a) 30HEMA, and (b) 30HEMA-7.5TiO2 .............. 51 
Figure 2-9 SEM micrographs of (a) 40HEMA, and (b) 40HEMA-7.5TiO2 .............. 51 
Figure 2-10 SEM micrographs of the 40HEMA-7.5TiO2 hydrogel with different 
magnifications; the arrow in (a) indicates the top surface of the hydrogel ................ 52 
Figure 2-11 XRD spectra showing the presence of TiO2 particles in composite 
hydrogels .................................................................................................................... 53 
Figure 2-12 XRD spectra showing the formation of CaP on selected hydrogels after 
21 days incubation in SBF solution ........................................................................... 54 
Figure 2-13 FTIR spectra of 10HEMA-7.5TiO2 composite hydrogels (a) before and 
(b) after 10 days incubation in SBF ........................................................................... 56 
Figure 2-14 XRD spectra showing the formation of CaP on selected hydrogels after 
(a) 14 and (b) 28 days incubation in SBF .................................................................. 57 
XIII 
 
Figure 2-15 XRD spectra of (a) 20HEMA hydrogel after 14 days and 28 days 
incubation in SBF (b) 20HEMA-7.5TiO2 hydrogel after 14 and 28 days incubation in 
SBF............................................................................................................................. 59 
Figure 2-16 SEM micrographs of 20HEMA-7.5TiO2 sponge after (a) 3, (b) 14, and (c) 
28 days incubation in SBF ......................................................................................... 60 
Figure 2-17 SEM micrographs showing the cross-sectional view of (a) 10HEMA-
7.5TiO2, (b) 20HEMA, and (c) 40HEMA-7.5TiO2 composite hydrogels after 28 days 
incubation in SBF....................................................................................................... 62 
Figure 2-18  Light micrographs of (a) 20HEMA, (b) 10HEMA-7.5TiO2, (c) 
20HEMA- 7.5TiO2, and (d) 40HEMA-7.5TiO2  hydrogels after incubation in SBF 
for 28 days. The arrows indicate the top surface of the hydrogels where the CaP 
formation and infiltration started. The orange-red coloured areas represent the 
thickness of the formed CaP in each hydrogel........................................................... 63 
Figure 2-19 In vitro cell viability measured by MTT assay. The optical density 
values are proportional to the numbers of the living cells. (*) indicates there is no 
significant difference for Day 1, (**) indicates results at Day 3, where 30HEMA-
10SiO2 and 30HEMA-10CNT are significantly different from the Control at the same 
period of time, but not significantly different from the rest of the hydrogels, (***) 
shows that, at Day 5, 30HEMA-10CNT  is significantly different as compared to the 
Control at Day 5 and the rest of the hydrogel samples, (****) shows that, at Day 5, 
30HEMA-10 SiO2  is significantly different as compared to the hydrogels including 
30HEMA and 30HEMA-10TiO2 ............................................................................... 64 
Figure 2-20 In vitro cell viability measured by MTT assay. The optical density 
values are proportional to the numbers of the cells. (*) indicates there is no 
significant difference for Day 1, (**) indicates, at Day 3, 30HEMA-TiO2 is 
significantly different from the rest of the hydrogels, (***) shows that, at Day 3, the 
control sample is significantly different in cytotoxicity as compared to the hydrogel 
samples....................................................................................................................... 65 
Figure 3-1 Schematic illustration of a loaded hydrogel button in the parallel-plate 
configuration; h is the thickness of the hydrogel, a is radius of the hydrogels, γ is the 
shear strain, θ is angular displacement, H is the gap size and R is the radius of the 
plate ............................................................................................................................ 69 
XIV 
 
Figure 3-2 (a) SINTECH 200/M material testing workstation and (b) a dumb-bell 
shaped specimen and the sample cutter ..................................................................... 72 
Figure 3-3 (a) HAAKE MARS III Modular Advanced Rheometer System and (b) 
hydrogel buttons for the rheological tests .................................................................. 73 
Figure 3-4 Illustration of the loading Mode A and Mode B applied in the creep-
recovery test ............................................................................................................... 74 
Figure 3-5 (a) Modulus, (b) tensile strength and (c) elongation of PHEMA and 
PHEMA-7.5TiO2;  in Figure (a) and (b):  (*) indicates no significant difference 
among 10HEMA, 20HEMA and their composite, (**) and (***) indicate significant 
difference for 30HEMA, 40HEMA and their composite hydrogels;  in Figure (c), (*) 
indicates significant difference between PHEMA and its composite hydrogel......... 77 
Figure 3-6 Strain sweep oscillation results of (a) PHEMA and (b) PHEMA-7.5TiO2 
hydrogels .................................................................................................................... 79 
Figure 3-7 (a) Strain sweep oscillation results of PHEMA-CNT composite hydrogels 
and (b) a TEM micrograph of CNTs.......................................................................... 81 
Figure 3-8 (a) Complex modulus G* and (b) tanδ of PHEMA and PHEMA-TiO2 
composite hydrogels under the influence of frequency ............................................. 82 
Figure 3-9 (a) Complex modulus G*  and (b) tanδ of 25HEMA, 25HEMA-7.5TiO2 
and 25HEMA-0.5CNT hydrogels .............................................................................. 83 
Figure 3-10 (a) Complex modulus G* and (b) tanδ of PHEMA and PHEMA-TiO2 
composite hydrogels under the influence of compressive strains (*) indicates the 
significant difference in G* between different compressive strains were applied on 
40HEMA hydrogel..................................................................................................... 84 
Figure 3-11  Creep-recovery of 25HEMA hydrogels with loading Mode A under 
different loading forces .............................................................................................. 85 
Figure 3-12 Creep-recovery of PHEMA-TiO2 composite with loading Mode B under 
a stress of 75 Pa.......................................................................................................... 88 
Figure 3-13 Creep-recovery of PHEMA-TiO2 composite with loading Mode B under 
a stress of 250 Pa........................................................................................................ 89 
Figure 3-14 Creep-recovery of 40HEMA and 40HEMA-TiO2 composite with loading 
Mode B at a stress of 500 Pa...................................................................................... 90 
Figure 4-1 A set-up for static molecule release study................................................ 99 
XV 
 
Figure 4-2 Schematic illustration of the set-up for biomolecule delivery study under 
dynamic stimulations ............................................................................................... 100 
Figure 4-3 An UV-VIS spectrum of BSA solution at a concentration of 600 µg/ml 
pretreated with a BCA kit ........................................................................................ 101 
Figure 4-4 A standard curve of BSA solution at a wavelength of 562 nm .............. 102 
Figure 4-5 An UV-VIS spectrum of MB solution at a concentration of 5 µg/ml .... 103 
Figure 4-6 A standard curve of MB at a wavelength of 665 nm.............................. 103 
Figure 4-7 Standard curves of PSS at both 247 nm and 272 nm wavelengths ........ 104 
Figure 4-8  Standard curves of CAF at both 247 nm and 272 nm wavelengths ...... 105 
Figure 4-9 UV-VIS spectra for a dual-drug and two single drug solutions ............. 105 
Figure 4-10 Relative MB release from PHEMA hydrogels at f=0 Hz; γ=0% ......... 110 
Figure 4-11 Dynamic release of MB from PHEMA hydrogels at f=1 Hz; γ=5%.  The 
figures show (a) relative MB release and (b) released MB amount at various time 
points ........................................................................................................................ 112 
Figure 4-12 Dynamic release of MB from 20HEMA hydrogels at f=1 Hz; γ=5% 
loaded with different concentrations of MB solutions. The figures show (a) relative 
MB release and (b) released MB amount at various time points ............................. 114 
Figure 4-13 Dynamic MB release from 25HEMA hydrogel at f=1 Hz under different 
shear strains. The static release profile was used for comparison............................ 115 
Figure 4-14 Dynamic MB relative from 25HEMA hydrogels at γ=5% under different 
frequencies. The static release profile was used for comparison ............................. 116 
Figure 4-15 Dynamic MB relative from 20HEMA hydrogels at γ=5% under different 
frequencies. The static release profile was included for comparison....................... 116 
Figure 4-16 Relative release of PSS, CAF, and BSA from 20HEMA hydrogels under 
static conditions........................................................................................................ 118 
Figure 4-17 Relative releases of PSS and CAF from 20HEMA hydrogel in a dual 
biomolecule system under static conditions............................................................. 119 
Figure 4-18 Released amounts of PSS and CAF from 20HEMA hydrogel in a dual 
biomolecule system under static conditions............................................................. 119 
Figure 4-19 Relative release of PSS and CAF from 30HEMA hydrogel in a dual 
biomolecule system under static conditions............................................................. 120 
Figure 4-20 Released amounts of PSS and CAF from 30HEMA hydrogel in a dual 
biomolecule system under static conditions............................................................. 121 
XVI 
 
Figure 4-21 Plots of ln(Mt/M∞) against lnt for different drugs release from 20HEMA 
hydrogel.................................................................................................................... 123 
Figure 5-1 FTIR spectra of collagen, 20HEMA, and Col20HEMA........................ 133 
Figure 5-2 UV-VIS spectra of the aqueous extracts from Col20HEMA and 20HEMA 
hydrogels; Spectrum from an OVICOLL®CLEAR collagen solution (20 µg/ml) 
was used for comparison.......................................................................................... 134 
Figure 5-3 SEM micrographs of hydrogels (a) 10HEMA, (b)Col10HEMA, (c) 
10HEMA-7.5TiO2, (d) Col10HEMA-7.5TiO2, (e) 20HEMA, (f) Col20HEMA, (g) 
20HEMA-7.5TiO2, and (h) Col20HEMA-7.5TiO2.................................................. 135 
Figure 5-4 (a) SEM micrograph of Col10HEMA hydrogel, and (b) collagen fibrils 
making up the rat cornea (Han 2006)....................................................................... 136 
Figure 5-5 Fluorescent micrographs showing the growth of GFP-3T3 cells on the 
surface of (a) 20HEMA, (b) Col20HEMA and (c) Col20HEMA-7.5TiO2 hydrogels 
after Day 3................................................................................................................ 138 
Figure 5-6 Fluorescent micrographs showing the growth of GFP-MM253 cells on the 
surface of (a, d) 20HEMA, (b, e) Col20HEMA, and (c, f) Col10HEMA hydrogels 
after Day 1 and Day 4 .............................................................................................. 139 
Figure 5-7 LSCM micrographs showing the growth of hMSCs on the surface of (a, c, 
and e) 20HEMA and (b, d, and f) Col20HEMA after Day 1, 3, and 7 .................... 141 
Figure 5-8 Cross-section analysis of hMSC in Col20HEMA after Day 7 using a 
LSCM (arrow shows the top surface of the hydrogel)............................................. 142 
Figure 5-9 The hMSCs growth measured by the MTT assay. The optical density 
values are proportional to the numbers of the living hMSCs. (*) indicates the 
significant different in optical density in comparison to that from Day 1 Day 3 for 
Col20HEMA ............................................................................................................ 143 
XVII 
 
List of Tables 
Table 1-1 Chemicals and their structures for PHEMA hydrogel preparation............ 19 
Table 1-2 A summary of the methods used for surface modification using collagen 27 
Table 2-1 Chemical composition of PHEMA and PHEMA composite hydrogels .... 43 
Table 2-2 Results from GA of composite hydrogels ................................................. 46 
Table 2-3 Polymer volume fraction of selected hydrogels ........................................ 47 
Table 3-1 Hydrogels for tensile and rheological tests................................................ 71 
Table 3-2 Elastic and viscous moduli of PHEMA hydrogels at a frequency of 1 Hz*
.................................................................................................................................... 80 
Table 3-3 Percentage recovery of PHEMA and PHEMA-TiO2 composite hydrogels
.................................................................................................................................... 87 
Table 3-4 Shear moduli of different tissues and hydrogel materials ......................... 91 
Table 3-5 Comparison of the tensile properties of various PHEMA hydrolgels, soft 
tissues and other hydrogel systems for soft tissue regeneration ................................ 93 
Table 4-1 Chemical structures and wavelengths for UV-VIS measurements............ 98 
Table 4-2 UV-Vis absorbance of PSS, CAF, and combined PSS and CAF solution, 
confirming no interference from each of biomolecule............................................. 107 
Table 4-3 Information for biomolecule loading and delivery study ........................ 109 
Table 4-4 Release exponent (n), rate constant (k), and correlation coefficient (R2) 
following linear regression for static drug delivery experiments ............................ 124 
1  
CHAPTER 1 INTRODUCTION 
 
1.1. Background 
Tissue Engineering is an interdisciplinary field that applies the principles of 
engineering and life sciences to the development of biological substitutes that restore, 
maintain or improve tissue function or, indeed, a whole organ (Langer and Vacanti 
1993). It aims to improve treatments for tissue loss or end-stage organ failure and 
therefore enhances the quality of life of patients.  
 
Tissue loss or end-stage organ failure, resulting from an injury or a disease, is a 
major health care problem. Every day, thousands of people of all ages are admitted to 
hospitals for these treatments. Estimates of the total U.S. health care costs for 
patients with tissue loss or end-stage organ failure exceed $400 billion annually 
(Langer and Vacanti 1993). These damaged or diseased human tissues or organs can 
be treated using donor transplants or with artificial prosthesis devices. Although 
these procedures have saved and improved many lives, both solutions are imperfect. 
There is a declining availability of donor organs and the gap continues to widen 
(Abouna 2001). Prosthetic replacements do not have the capacity to replicate the full 
function of an organ or specific tissues, and sometimes multiple operations are 
needed (Laurencin et al. 1999). 
 
Tissue engineering has developed as an alternative therapy for the treatment of tissue 
loss or end-stage organ failure. Since the emergence of this field in the mid-1980s, 
tissue engineering has experienced a prodigious growth under the impetus of other 
principles such as cell biology and genetic engineering (Bianco and Robey 2001; 
Fuchs and Segre 2000; Muschler, Nakamoto, and Griffith 2004; Phillips, Gersbach, 
and Garcia 2007). So far, a broad range of engineered substitutes have been 
investigated and developed for such tissues as heart valve (Taylor, Cass, and Yacoub 
2006; Simon et al. 2006; Fong et al. 2006), bladder (Pattison et al. 2005), liver 
(Davis and Vacanti 1996; Mayer et al. 2000), skin (Adekogbe and Ghanem 2005; 
Altman et al. 2003), vascular (Sarkar et al. 2006), and bone and cartilage (Hutmacher 
2000, 2006; Kofron et al. 2003; Kose et al. 2003; Müller, Müller, et al. 2006). 
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Engineered skin replacement was one of the earlier breakthroughs of TransCyte®, a 
biosynthetic covering produced by Advanced Tissue Sciences Inc., approved by the 
Food and Drug Administration (FDA) in 1997 (Viola, Lal, and Grad 2003). Apart 
from success in engineering tissues, the first clinical trial of a tissue engineered organ, 
a bladder, was carried out by Atala and his team (Atala et al. 2006). Meanwhile, the 
rapid growth of replacements for such tissues as cartilage, bone, blood vessel and 
pancreas has reached the stage of either clinical use or approval (Place, Evans, and 
Stevens 2009). 
 
Apart from the obvious benefits for human beings, tissue engineering also brings 
substantial financial rewards to those who succeed in translating this new technology 
to the clinic. In 2003, the European Commission estimated that there is a potential 
market range of 4 to 400 billion Euro per year for tissue engineering (Bock, Ibarreta, 
and Rodriguez-Cerezo 2003). According to a new report from Worldwide Markets 
and Emerging Technologies for Tissue Engineering and Regenerative Medicine, 
distributed exclusively by Life Science Intelligence, the largely untapped global 
market potential for tissue engineering and regenerative medicine products will 
exceed $118 billion by 2013 (Lichtenfeld 2010).  
1.2. Tissue Engineering Approach 
A tissue engineering approach involves several major steps in the curing process. 
Figure 1-1 illustrates a general tissue engineering procedure: (1) a small amount of 
cells are removed from patients; (2) the retrieved cells are screened for phenotype 
and their numbers are expanded; (3) cells are seeded onto a porous scaffold together 
with growth factors and cytokines; (4) the cell-seeded scaffold is in intro cultured for 
further increase of the cell numbers; and (5) the regenerated tissue is gained and, 
afterwards, implanted into the human body to replace the damaged tissues (George 
2009). A clinical process in engineering a tissue does not include all these steps at all 
times. Whichever process is taken, cell sources, growth factors and tissue scaffolds 
are considered as the three most critical components in determining the success of 
the tissue engineering procedure (Place, Evans, and Stevens 2009).  
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Figure 1-1 A general tissue engineering procedure (George 2009) 
Cells used in tissue engineering include autologous cells (from the patient), allogenic 
cells (from a human donor) and xenogenic cells (from a non-human donor), named 
according to their sources (Heath 2000). The advantage of using autologous cells is 
that they produce a lower immune response after implantation, but the retrieval of 
these cells can be restricted by the patient’s genetic disease or donor-site morbidity. 
Allogenic cells are relatively easier to obtain and, so far, they have been utilized in 
many commercial products for engineering tissues (Place, Evans, and Stevens 2009). 
The use of xenogenic cells in tissue engineering is controversial due to the potential 
of transmitting unhealthy pathogens to human beings (Griffith and Naughton 2002).  
Stem and progenitor cells can serve as an alternative source of cells from which the 
desired tissue can be derived (Heath 2000; Stappenbeck and Miyoshi 2009; Pittenger 
et al. 1999).  
 
Growth factors are generally required to promote tissue regeneration, as they can 
induce angiogenesis, which supplies oxygen and nutrients to cells transplanted for 
organ substitution to maintain their biological functions (Tabata 2003). This is to say 
that growth factors act as signalling molecules to stimulate cell proliferation, 
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migration, differentiation and local tissue formation (Ma 2004). Growth factors are 
made of polypeptides, exhibiting molecular weights in the range of 15 kDa to 45 kDa 
(Salvay and Shea 2006). They can be found either as matrix bound proteins attached 
to the extracellular matrix (ECM) or as soluble molecules secreted by cells, or 
cleaved from the matrix by certain enzymes or proteases (Tayalia and Mooney 2009). 
 
Various growth factors are available for engineering different sorts of tissue (Chen, 
Zhang, and Wu 2010). It should be noted that different cell types can produce the 
same type of growth factor, which can conversely act on these cell types with the 
same effect (McIntosh, Bellus, and Jab 2000). For example, epidermal growth factor, 
a potent mitogen for epithelial cells, is the most widely used growth factor for skin 
regeneration (Niall, Ryan, and O'Brien 1982). Such a growth factor also has the 
functionality of enhancing proliferation of mesechymal, glial and fibroblast cells 
(Tayalia and Mooney 2009).  
 
The action of growth factors is typically concentration dependent. The concentration 
gradients of growth factors play a major role in tissue regeneration (Tayalia and 
Mooney 2009; Biondi et al. 2008; Gurdon and Bourillot 2001). Normally, growth 
factors can elicit cellular activities at a very low concentration of 10-9~10-11M 
(Gurdon and Bourillot 2001). The concentration gradients of growth factors provide 
a mechanism by which cells can obtain spatial and directional cues. So far, the 
magnitudes of the gradients to elicit the desired cellular activities are unknown 
(Biondi et al. 2008). The presence of growth factors plays a crucial role in the 
process of tissue regeneration, which depends not only on the growth factors 
themselves, but also on many other factors. These factors include concentration, 
spatial/temporal distribution, and a combination of different growth factors. In 
addition, growth factors have short half-lives (of the order of minutes to hours) and 
are rapidly degraded or cleared, thereby minimizing their biological effect (Salvay 
and Shea 2006). Thus, delivery systems using tissue scaffolds have been developed 
for administering the proper amounts of growth factors to enable regeneration. 
Discussion of these delivery systems can be found in Section 1.3. 
 
Tissue scaffolds function as a reservoir to provide support for cells to adhere, migrate, 
proliferate and differentiate, as well as for diffusion of nutrients and growth factors 
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(Ma 2004). Design of a scaffold exhibiting the proper physical properties, 
mechanical properties, surface properties, mass transport properties and biological 
properties plays a prodigious role, as it affects the formation and ultimate function of 
the formed tissues (Drury and Mooney 2003). A few essential requirements must be 
considered when a tissue scaffold is constructed. Firstly, the scaffolding materials 
should be biocompatible, which means they should be non-immunogenic and non-
toxic to the cells. Secondly, the scaffold must contain appropriate pore sizes for cell 
migration and nutrient transport, as well as waste removal (Cheung et al. 2007). 
Thirdly, the scaffold should have proper physical surface properties, including 
surface area, surface topography, roughness and chemical properties, including 
surface charge and suitable biofunctionalities. Fourthly, the scaffold must have the 
required mechanical integrity to maintain the predesigned tissue structure. Lastly, 
construction and the following sterilization procedure should be performed easily 
and economically.  
1.3. Tissue Scaffolds and Design Parameters  
A tissue scaffold should meet certain design parameters to be functional for tissue 
regeneration, regardless of whether the scaffolding material is from natural or 
synthetic resources. These parameters include biocompatibility, pore structures, 
surface properties, mechanical properties and transportation of biomolecules. There 
is detailed discussion of these parameters in the following section. 
 
Biocompatibility 
Biocompatibility is the most important consideration for designing a tissue scaffold. 
Williams (Williams 2008) describes biocompatibility for a tissue scaffold as follows: 
“The biocompatibility of a scaffold or matrix for a tissue engineering product refers 
to the ability to perform as substrate that will support the appropriate cellular activity, 
including the facilitation of molecular and mechanical signalling systems, in order to 
optimise tissue regeneration, without eliciting an undesirable local or systemic 
responses in the eventual host”. That is to say, the scaffold should not have, or have 
very limited, immunological toxicity throughout the healing and cellular regeneration 
process. 
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The toxic response of a polymer scaffold can be caused by the toxic chemicals, 
which are used in the production of the scaffold. These residual chemicals (initiators, 
organic solvents, stabilizers, emulsifiers, and crosslinkers) in the scaffold can be 
toxic to host cells (Gan, Zhang, and Guan 2009). In addition, degradation products 
from biodegradable scaffolds, such as poly(lactic acid) (PLA), poly(glycol acid) 
(PGA) and poly(lactic acid-co-glycol acid) (PLGA), could also cause toxic effects, 
depending on the site of implantation and the rate of degradation (Taylor et al. 1994; 
Ignatius and Claes 1996; Matsusue et al. 1992).  
 
Interconnected pore structure 
A tissue scaffold should have an interconnected pore structure with adequate pore 
sizes for cell accommodation and migration, as well as transportation of nutrients and 
metabolic waste (Jen, Wake, and Mikos 1996). If the pores are too small, cell 
migration will be very limited, resulting in the formation of a cellular capsule around 
the edges of the scaffold. This in turn can limit diffusion of nutrients and removal of 
waste resulting in necrotic regions within the construct. Conversely, if the pores are 
too large, there is a decrease in surface area, limiting cell adhesion (Yannas 1992). 
Therefore, an optimal pore size should be ensured, and this size varies from type to 
type according to the envisioned applications. It is suggested that a pore size of 5 µm 
is required for neovascularisation, 5-15 µm for fibroblast ingrowth, 20 µm for the 
ingrowth of hepatocytes, 20-125 µm for regeneration of adult mammalian skin, 40-
100 µm for osteoid ingrowth, and 100-350 µm for regeneration of bone (Tambralli et 
al. 2009; Coutu, Yousefi, and Galipeau 2009). A recent work by Linnes et al. 
demonstrated that pores of 35 µm in diameter are ideal for soft tissue regeneration 
when compared to 20 and 70 µm pores (Linnes, Ratner, and Giachelli 2007).  
Interconnectivity of pores is also a critical factor influencing transport properties and 
cell transport and migration (Moore et al. 2004; Martys, Torquato, and Bentz 1994). 
 
Mechanical properties 
Controlling the mechanical properties of a scaffold is important in tissue regeneration. 
In general, the mechanical properties of the scaffold are dictated by the tissue into 
which it is implanted. Thus, the mechanical properties of the scaffold must be 
sufficient to withstand the patient’s normal activities without collapse. A stiff 
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scaffold usually is needed for hard tissues, such as bone, whereas a flexible tissue 
scaffold is demanded in engineering elastomeric tissues, such as skin, cartilage and 
blood vessels. However, in designing the proper mechanical properties of the 
scaffold, it is not as simple as matching a single parameter such as modulus or 
strength, because most tissues possess complex viscoelastic, non-linear and 
anisotropic mechanical properties that also vary with age, site and other factors 
(Butler, Goldstein, and Guilak 2000).  
 
The mechanical properties also affect the cellular activities in the scaffold. The 
extent of their influence is similar to that seen for chemical properties (Dado and 
Levenberg 2009; Mitragotri and Lahann 2009; Engler et al. 2006; Ghosh and Ingber 
2007). As such, a tissue scaffold has to be designed with tissue specific mechanical 
properties.  
 
Surface properties  
Physical and chemical properties of a tissue scaffold play an important role in 
determining the cellular response to the scaffold. It is known that protein adhesion is 
the first event occurring on the surface of a foreign body in a biological environment. 
The adsorbed proteins then determine which cells respond to the material surfaces 
(Wilson et al. 2005). Therefore, surface parameters often are identified to relate to 
the protein adhesion. These include surface wettablity, surface topography, surface 
charge and the presence of sell-recognizable ligands. 
 
(a) Surface wettability: The hydrophilic nature of the surface has a strong influence 
on protein adsorption and cell adhesion. In general, cells can effectively adhere onto 
polymer surfaces presenting moderate wettability with water contact angles of 40–
70° (Arima and Iwata 2007). In regard to the scaffolding materials, most metals, 
alloys and bioceramics appear to be more or less hydrophilic (Takebe et al. 2000; 
Ponsonnet et al. 2003; Hallab et al. 2001), while many polymers, particular synthetic 
polymers, are hydrophobic in their natural state (Liu and Ma 2004). 
 
(b) Surface topography: Cells respond to environmental features at all length scales 
from the macro down to the molecular (Stevens and George 2005). This is true for 
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the natural environment, in which ECM provides instructive cues at levels ranging 
from meso- and micro- through to nano-scales to maintain cell phenotype and 
behaviour (Ranella et al. 2010). Although the mechanism of how cells detect and 
respond to these nanofeatures is not yet understood (Curtis 2004), it has been proved 
that increasing the nanoscale roughness of the scaffold pore walls can enhance the 
cellular activities, including cell attachment, proliferation and expression, of matrix 
components (Pattison et al. 2005).  
 
(c) Surface charge: The surface charge of a tissue scaffold has a significant influence 
on cell adhesion, which shows distinct differences for the positively and negatively 
charged surfaces of the scaffold. In general, cells are prone to adhering closely to 
positively charged surfaces, whereas contact occurs only at individual points on near-
neutral and negatively charged surfaces, attributable to the negative charge of cell 
membranes (Dames et al. 1986; Shelton, Rasmussen, and Davies 1988). Thus, 
research has been carried out to modify the surface charge of the scaffolding 
materials in order to improve their interactions with cells (Choi et al. 2008; Tong and 
Wang 2011).  
 
(d) Cell-recognizable ligand: Many biomacromolecules have been used to modify 
the surfaces of tissue scaffolds for the purpose of improving cellular activities. These 
biomacromolecules include collagen, gelatin, heparin, hyaluronic acid, short peptide 
sequences originating from cell adhesive proteins such as the Arg–Gly–Asp (RGD) 
or Tyr-Ile-Gly-Ser-Arg (YIGSR), and sugar moieties such as galactose or lactose 
(Hersel, Dahmen, and Kessler 2003; Lutolf and Hubbell 2005). Among these 
biomolecules, collagen has been one of the key macromolecules because of its 
inherent cell adhesion properties (Heinemann et al. 2008; Ma et al. 2002). More 
details can be found in Section1.5.3.  
 
Transportation of molecules  
The transportation of various molecules is involved in a tissue regeneration process. 
These molecules include growth factors, nutrients, oxygen and waste during the 
tissue formation process (Valentin et al. 2009; Malda et al. 2004; Malafaya et al. 
2002; Biondi et al. 2008; Chen, Zhang, and Wu 2010).  
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There are many ways to control the supply of these molecules. For instance, growth 
factors simply can be added to the culture medium for in vitro tissue formation. 
However, controlling the distribution of the growth factors in the desired sites by 
time and space generally has been unsuccessful, and this has led to an explosion of 
work to develop growth factor delivery strategies (Quaglia 2008; Biondi et al. 2008). 
These strategies can be categorized into three different types: direct loading of 
growth factors into the scaffold matrix, addition of separate release systems to the 
scaffolds, and surface tethering to tissue scaffolds (Tessmar and Göpferich 2007).  
 
The first type of delivery system is the most commonly used. In this type, growth 
factors can be loaded in an interspersed way and released from the scaffold after 
implantation. The delivery of growth factors mainly is controlled by diffusion and 
the physical properties of the scaffold. These parameters include pore structure, 
crosslinking density and the degradation rate of the scaffold. However, this delivery 
system can be detrimental to the stability of the growth factors and sometimes is 
ineffective. For example, significant amounts of growth factor might already have 
been eluted from the scaffold during the manufacturing process. This can happen 
when water is used to remove water-soluble porogens from the scaffolds. In addition, 
the biological activity of the useful molecules cannot always be guaranteed when 
special conditions such as high temperatures are used to generate the scaffolds, as 
seen by the melt-processing method (Tessmar and Göpferich 2007). 
 
The growth factors also can be incorporated into microsphere carriers, which are 
normally developed from polymer materials (Tabata 2000). These microspheres can 
be formed into a tissue engineering scaffold (Nof and Shea 2002) or incorporated 
into a tissue scaffold, forming a composite scaffold (Ennett, Kaigler, and Mooney 
2006).  As such, the polymer carriers can protect the growth factors from proteolysis 
and delay the release process, allowing for a prolonged bioactivity in vivo (Malafaya 
et al. 2002).  In addition, the release rate of the growth factors from these 
microspheres can be adjusted by altering the polymer used, the amount of growth 
factors loaded and the size of the microspheres (Mahoney and Saltzman 1996). 
Meanwhile, these microspheres can be modified to deliver multiple growth factors, 
each with distinct release profiles (Sinha and Trehan 2003).   
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Growth factors also can be attached covalently to the surfaces of tissue scaffolds, 
ideally after the completion of the scaffold construction. This covalent attachment is 
most commonly applied to hydrogel carriers or scaffolds with sufficient spacer 
groups (Tessmar and Göpferich 2007). Results have shown that covalently attached 
growth factors are capable of stimulating cell proliferation and retain their biological 
activity (Mann, Schmedlen, and West 2001; Kuhl and Griffith-Cima 1996) (Eun et al. 
1998). 
 
Several issues should be considered when growth factors are incorporated into the 
scaffolds. These include: (1) the loading capacity; (2) the distribution of growth 
factor; (3) the interactions between the growth factors and the delivery system; (4) 
the release kinetics; (5) the long-term stability; and (6) the economical viability 
(Silva et al. 2009; Zisch, Lutolf, and Hubbell 2003).  
 
Other properties 
Good processability of a tissue scaffold is required because a particular 
configurational shape is of importance in maintaining the functions of the scaffold 
(Yang, Roach, et al. 2001). This preferred configuration should be constructed easily 
when the scaffolding materials are employed. Amongst the various scaffolding 
materials, synthetic polymers have drawn considerable attention due to their 
excellent . Sterilization is another important issue concerning the clinical applications 
of a tissue scaffold (Andrews, Hunt, and Black 2007). An optimal tissue scaffold 
should be able to withstand the normal sterilisation conditions with minimum 
damage to the delicate 3D geometry and the natural characteristics of the materials 
(Holy et al. 2001). 
1.4. Materials for Tissue Scaffold Fabrication   
Various materials have been employed for tissue scaffold fabrication. These include 
metals and alloys, bioceramics, polymers and combinations of these materials. In 
general, metal, ceramics and some strong polymers are used for hard tissue 
regeneration, due to their high mechanical properties. In most cases, polymers are 
used as scaffolding materials for the regeneration of soft tissue, such as skin or 
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cartilage. The advantages and disadvantages of these materials are summarised 
briefly in the following sections. 
1.4.1. Metals  
Metals have been used extensively in orthopaedic tissue replacements. These 
materials include titanium based alloys, cobalt based alloys, stainless steel (316L), 
and magnesium based alloys (Dekker et al. 2005; Frosch et al. 2003; Lopez-Heredia 
et al. 2008; Murugan and Ramakrishna 2005; Witte et al. 2006). Metallic implants 
also are used in non-orthopaedic applications, such as oral and maxillofacial surgery 
(i.e. dental implants, craniofacial plates and screws) and cardiovascular surgery (i.e. 
pacemakers, artificial heart components, catheters, clips, stents and valve 
replacements) (Ratner et al. 2004). 
 
An advantage of metal implants is their excellent mechanical properties, which make 
them the most widely applied implant material for bone grafts. These kinds of 
implant are used mostly in load-bearing sites. However, metal materials have an 
elastic modulus significantly higher than that of bone tissue (Murugan and 
Ramakrishna 2005). This mechanical incompatibility causes implants to be 
structurally stiffer than bones, which may result in stress-shielding, and eventual 
implant loosening and bone resorption (Spoerke et al. 2005).  In addition, metallic 
wear debris and metal ions that are released in vivo from the metal implants have 
been found in many tissues, including the liver, spleen, lung, and even remote bone 
marrow of the iliac crest. The presence of these ions in tissues raises questions of 
biocompatibility and the possible carcinogenic effects of these implants. Moreover, 
the processability of metallic implants is very limited in comparison with other 
materials (Yang, Leong, et al. 2001). 
1.4.2. Bioceramics and Bioglasses 
It was first proposed for ceramics to be used in orthopaedics during the 1960s, due to 
their high compressive strength and hardness properties. Various bioceramics, 
including hydroxyapatite (HA), tricalcium phosphate (TCP), and octacalcium 
phosphate (OCP), have been studied as scaffolding materials for bone regeneration. 
Other kinds of bioinert ceramic, including CaSiO3, and ZrO2, were also investigated 
for tissue regeneration applications (Ni, Chang, and Chou 2006). Among these 
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bioceramics, HA is the most commonly used because its composition is similar to 
bone minerals (Karageorgiou and Kaplan 2005). In addition, HA is able to stimulate 
osteoconduction and further integrate into the bone without provoking an immune 
reaction (Ducheyne and Qiu 1999). Bioglasses are another series of ceramic 
materials, and the most commonly used bioglass is 45S5, consisting of  45% SiO2, 
24.5% Na2O, 25.4% CaO and 5% P2O5 (Chen, Thompson, and Boccaccini 2006). 
Meanwhile, different compositions of bioglass also have been investigated (Jones, 
Ehrenfried, and Hench 2006; Jones et al. 2007). 
 
The overall advantages of using bioceramic and bioglass materials include their 
excellent biocompatibility, osteoconductivity and osteoproductivity (Hench 1997). In 
addition, these materials do not induce local or systemic toxicity, inflammation or a 
foreign body response (Murugan and Ramakrishna 2005). However, scaffolds 
fabricated from these inorganic materials often are difficult to process into highly 
porous structures and are mechanically brittle (Ma 2004).  
1.4.3. Polymers 
Both natural and synthetic polymers have been evaluated for tissue engineering 
applications. Natural polymers, including proteinic polymers (collagen, gelatin, 
fibrin and silk fibroin) and polysaccharides (chitosan-based polymers, cellulose, 
alginate and glycosaminoglycans), demonstrate adequate biocompatibility. Therefore, 
utilization of these materials may avoid the stimulation of chronic inflammation or 
immunological reactions owing to their similarity to the ECM (Mano et al. 2007). 
Another important advantage is that some natural polymers are capable of  enhancing 
cellular activities (Hsu et al. 2004). Mechanically, these polymers can be adjusted to 
be similar to the macromolecular–based tissues (soft tissues) in the human body. 
However, naturally derived materials provide limited versatility in designing specific 
properties, such as mechanical strength and degradation time. In addition, batch 
variations and sterilization methods are major limitations for naturally derived 
materials (Lee and Mooney 2001).  
 
Synthetic polymers are a series of manufactured polymers which have been 
extensively used in our daily lives. Commonly used synthetic polymers in tissue 
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engineering include PLA, PGA, PLGA, polypropylene fumarate, poly(ethylene 
glycol), poly(vinylacohol), poly(acrylic acid), poly(2-hydroxyethyl methacrylate), 
and polycaprolactone (Rezwan et al. 2006; Place et al. 2009). The advantages of 
using synthetic polymers in tissue engineering include their ease of chemical 
synthesis on a large scale. Thus, good processability can be ensured. Synthetic 
polymers have better resistance to high temperature and pressure conditions than 
naturally derived polymers. Moreover, many synthetic polymers, such as PLGA, 
have gained approval from the FDA for their applications in tissue engineering, 
which has motivated the application of synthetic polymers in the tissue engineering 
area. However, a scaffold made of synthetic polymers tends to have limited 
bioactivity and to provide minimal biological cues to guide tissue regeneration. As 
such, cells do not necessarily recognize the surface of the synthetic polymers.  
1.4.4. Composite Materials 
For the reason that no materials can meet all essential requirements for tissue 
engineering applications, composite scaffolding materials have been developed, and 
these materials combine the properties of both the matrix materials and the 
reinforcement agents.  The latter are used to improve the performance of the scaffold 
mechanically and/or biologically. The property of a composite material is dependent 
not only on the matrix and reinforcement materials, but also on the type, size and size 
distribution of the reinforcements. The volume percentages, as well as the bioactivity 
of the reinforcement, also are critical to the ultimate performance of the composite. 
Various particulates, including titanium dioxide (TiO2), multi-walled carbon 
nanotubes (CNTs), silicon dioxide (SiO2), HA, TCP and bioglass, are commonly 
used as bioactive reinforcing phases, while metals and polymers have been used as 
the matrix materials, in composite scaffolding materials (Rich et al. 2002; Liu, 
Slamovich, and Webster 2006; Gerhardt, Jell, and Boccaccini 2007; Torres et al. 
2007; Francis et al. 2010; Madhumathi et al. 2009; Kim et al. 2006; Cabañas et al. 
2009; Cao and Kuboyama 2010; Weinand et al. 2006)  
1.5. Design of Thesis Work 
This project aims to synthesize and evaluate porous PHEMA and PHEMA composite 
hydrogels for tissue engineering applications. Porous PHEMA hydrogels will be used 
as a matrix scaffolding material. Various additives will be used to improve the 
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mechanical and biological properties of the hydrogels. These include TiO2, SiO2, 
CNTs and collagen molecules.  
1.5.1. Hydrogels and PHEMA  
1.5.1.1. Hydrogels and the macroporous structure  
Hydrogels are polymeric materials, which are capable of sustaining their three-
dimensional structure after absorbing large quantities of water or biological fluids 
into their structure (Wichterle and Lim 1960). The presence of hydrophilic groups 
such as -OH, -CONH, -CONH2, -COOH and -SO3H3, enable them to absorb plenty 
of water (Peppas and Khare 1993). The three-dimensional (3D) structure of the 
hydrogels is generally crosslinked through junctions or tie points, among which 
strong chemical linkages (covalent and ionic bonds), permanent or temporary 
physical entanglements, microcrystallite and weak interactions (hydrogen bonds) can 
be formed. In addition, due to their thermodynamic compatibility with water, these 
materials are soft and elastic (Brandon et al. 2009). Therefore, under mechanical 
stress, hydrogels can exhibit a range of responses from rapid or elastic recovery to a 
time-dependent recovery, making the physical properties of hydrogels similar to that 
of living tissue.  
 
Hydrogels can be classified into different groups based on numerous factors, such as 
their source (natural or synthetic), their nature of crosslinking (chemical or physical 
gels), the nature of the network (homopolymer, copolymer, interpenetrating or 
double networks), the presence of pores (homogeneous-optically transparent or 
heterogeneous-optically opaque), and their biodegradability (degradable or non-
degradable hydrogels) (Kopeek and Yang 2007).  
 
Due to their unique properties, hydrogel polymers have been considered as a class of 
promising scaffold materials. These properties include: (1) structural similarity to 
ECM of many tissues in human body; (2) capacity to be processed under relatively 
mild conditions; (3) capability of aqueous environment to protect cells and fragile 
drugs (peptides, proteins, oligonuleotides and DNA); (4) advantages of delivering 
biomolecules in tissue engineering; (5)  provision of good transport of nutrients to 
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cells and products from cells; and (6) ease of modification with cell adhesive ligands 
(Drury and Mooney 2003). 
 
Over the past two decades, various methods have been used to produce macroporous 
hydrogels. These include the freeze–thaw procedure (Plieva, Galaev, and Mattiasson 
2007), porogenation (Kroupová et al. 2006), microemulsion formation (Bennett et al. 
1995), fibre bonding (Mikos et al. 1993), gas foaming (Kim and Mooney 1998), and 
electrospinning (Sill and von Recum 2008).  
 
Macroporous structures in hydrogel networks also may form as a result of a free-
radical, crosslinking copolymerization in the presence of an inert diluent, which 
involves the appearance of a phase separation during the polymerization process 
(Seidl et al. 1967; Guyot and Bartholin 1982; Okay 2000). In the progress of 
polymerisation, there is a stage at which polymer chains cannot absorb all the 
available solvent in the reaction mixture. Microspheres of polymer chains then can 
be formed within the separated continuous liquid phase. As the reaction further 
proceeds, new microspheres are generated continuously, due to the successive 
separations of the growing polymers. The agglomeration of the microspheres results 
in the formation of a heterogeneous gel that is surrounded by interconnected 
channels. The channels were occupied, previously, by the diluent. Thus, the reaction 
system consists of two continuous phases: a gel phase and a diluent phase (Figure 1-
2).  
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Figure 1-2 Schematic representation of the occurrence of a phase separation 
(a) A growing polymer chain with free radical at one end, (b) the formation of polymer microsphere, (c) 
agglomeration of polymer microspheres, (d) further agglomeration leading to the separation of 
polymers spheres from the diluent phase    
 
 
This scenario is a simplified description of a much more complex process, which 
involves macrosyneresis and microsyneresis processes, depending on the synthetic 
parameters (Seidl et al. 1967; Dusek 1971). Figure 1-3 schematically represents the 
mechanism of macrosyneresis and microsyneresis. Macrosyneresis relates to the 
deswelling of the growing network when phase separation occurs. The deswelling of 
the network undergoing crosslinking is transformed, progressively, into a suspension 
of polymer spherical particles dispersed in a liquid phase, consisting of unreacted 
monomer and solvent. Finally, two continuous phases co-exist and one of them is 
formed by loosely connected polymer spherical particles and the other by solvent. 
Conversely, microsyneresis relates to the segregation of solvent inside the growing 
network, followed by the formation of dispersed domains within the polymer matrix. 
When a small amount of solvent is used, pores are not interconnected. 
Microsyneresis can yield an interconnected pore structure for moderate amounts of 
solvent contents.  
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Macrosyneresis                                    Microsyneresis 
White-colored area: Liquid phase 
Brown-colored area: Gel phase 
Figure 1-3 Schematic representation of macrosyneresis and microsyneresis during crosslinking 
polymerization 
Therefore, the polymerization of a polymer network in a given solvent yields a pore 
architecture corresponding to macrosyneresis (spherical, interconnected polymer 
particles) or microsyneresis (dispersed or interconnected pores in a continuous 
polymer matrix), depending on the solvent. It is possible to transit from 
microsyneresis to macrosyneresis when solvent content is beyond a certain amount. 
1.5.1.2. Macroporous PHEMA Hydrogels  
PHEMA is an abbreviation of poly(2-hydoxyethyl methacrylates) which is made of 
crosslinked polymers of 2-hydroxyethyl methacrylate (HEMA). PHEMA is well-
known for its applications in vision correction devices including contact lenses and 
intraocular lenses (Chirila et al. 1998; Hicks et al. 2006). It swells in water without 
dissolution, therefore it is also termed hydrogel. Due to its successful applications for 
medical devices, PHEMA hydrogel has been proved to be well-tolerated by human 
tissues. However, these applications involve the utilisation of nonporous PHEMA 
hydrogels (Chirila et al. 1998; Hicks et al. 2002; Hicks et al. 1997; Hicks et al. 2006).  
The focus of this study is on macroporous PHEMA that could be used for other 
tissue engineering applications.  
 
Macroporous PHEMA hydrogels can be manufactured via a series of methods such 
as bulk polymerization/porogen leaching (Stancu et al. 2007; Liu et al. 2000), fibre 
templating (Flynn, Dalton, and Shoichet 2003), a cryogenic technique (Savina et al. 
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2007), and solution polymerization (Chirila, Chen, et al. 1993; Lou, Dalton, and 
Chirila 2000; Lou et al. 1999; Lou et al. 2005; Lou, Wang, and Tan 2007). Among 
these methods, free radical polymerisation of HEMA in the presence of an initiator, a 
crosslinking agent and a diluent, most commonly water, is probably most convenient 
and cost effective. The pores and the pore structure can be altered simply by 
changing the monomer to diluents ratio, or initiator and crosslinking concentrations 
(Chirila, Chen, et al. 1993).  The free radical initiators used in PHEMA 
polymerisation are ammonium persulphate (APS) and N,N,N’,N’-
tetramethylethylene diamine (TEMED). The chemical structures of the monomer and 
additives are shown in Table 1-1. APS, firstly, is decomposed into free radicals and 
this decomposition process is accelerated by TEMED. Thus, the APS molecule is left 
with an unpaired electron that, in turn, activates a HEMA molecule (Figure 1-4). 
This activated HEMA molecule can attach itself onto another HEMA molecule, 
thereby transferring the active unpaired electron. This continuous transferring of 
active unpaired electrons results in the formation of living HEMA oligomers (Figure 
1-4). The chain reaction occurs until the HEMA molecule supply is exhausted 
(Figure 1-4). When a crosslinking agent, DVG, is added to the polymerising reaction, 
it links the PHEMA chains together and forms the insoluble network (Figure 1-5). 
Both ethyleneglycol dimethacrylate (EDMA) and 1,5-hexadiene-3,4-diol (DVG) are 
commonly used crosslinking agents for the preparation of macroporous PHEMA 
hydrogels (Clayton, Chirila, and Lou 1997). 
 
Owing to chemical similarity, growing chains of PHEMA are very soluble within the 
precursor HEMA monomer. The solubility of the PHEMA chains is, however, 
relatively poor in water, which is used as the diluent in the present study. The 
previous studies confirmed that, when the water concentration is below 40-50 wt%, 
non-porous and transparent PHEMA form (Chirila, Constable, et al. 1993). When the 
water concentration is above the critical value, unfavourable thermodynamic 
interactions between water and the polymer network result in phase separation, 
which has been discussed in the previous section. Droplets of the PHEMA material 
effectively precipitate out of the solution, and continue to react with remaining 
monomers and oligomers. The droplets also join together and eventually become 
fixed in an interconnecting network of spherical polymer particles surrounded by 
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continuous channels occupied by water, which is the macroporous PHEMA 
hydrogels (Chirila, Constable, et al. 1993).   
The channels between the droplets form interconnected pores, typically in the size 
range of 2-30 µm. The result is a highly heterogeneous, opaque material, with 
characteristics colloquially described as ‘spongy’. The term ‘phase separation 
sponge’ has been proposed to describe such materials as they adopt spongy 
characteristics exclusively due to phase separation processes (Chirila et al. 1993a). In 
this study, the opaque heterogeneous sponge materials will be referred to simply as 
the macroporous PHEMA hydrogels. 
 
Table 1-1 Chemicals and their structures for PHEMA hydrogel preparation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chemical name Chemical structure 
HEMA 
 
EDMA 
 
 
DVG 
H2C
CH2
OH
OH
 
TEMED 
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Figure 1-4 The mechanism of radical generation in the APS initiator system and the formation 
of oligmors of PHEMA  
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Figure 1-5 Synthetic scheme of PHEMA hydrogel using DVG as a crosslinking agent 
 
Macroporous PHEMA hydrogels are able to encourage cell and tissue integration and 
have demonstrated excellent performance in a few applications such as ophthalmic 
implants (Crawford et al. 2002; Hicks et al. 2006; Chirila et al. 1998). They also have 
shown potential in applications as drug delivery systems (Lou, Munro, and Wang 
2004; Lou, Wang, and Tan 2007; Wang et al. 2010). Detailed discussion on the 
applications of PHEMA hydrogels is undertaken in the following paragraphs. 
1.5.1.3. Applications of Porous PHEMA Hydrogels 
As mentioned above, successful applications of PHEMA hydrogels have been shown 
in contact lens and intraocular lens manufacturing (Hicks et al. 1999; Hicks et al. 
2002). PHEMA hydrogels in these applications are made of nonporous structures. 
The use of porous PHEMA hydrogels has attracted some attention in recent years. 
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The application of porous PHEMA hydrogel is demonstrated in the development of 
an artificial cornea, AlphaCorTM and an ocular socket prosthesis, in which porous 
PHEMA acted as a scaffold component to host the tissue in-growth to the implants 
so as to prevent extrusion of the devices (Chirila et al. 1998; Hicks et al. 2006).  
 
Apart from their applications in vision correction devices, PHEMA hydrogels also 
have been investigated for controlled drug delivery. In general, non-porous PHEMA 
hydrogels are used for the diffusion of low molecular weight solutes in dense 
hydrogels. However, the nonporous nature of this type of hydrogel has limitations for 
applications such as a delivery system for biomolecules with large molecule weights. 
Results from our research group have shown that macroporous PHEMA hydrogels 
represent significant advances over the non-porous PHEMA hydrogels (Wang et al. 
2010). A much higher drug loading capacity easily can be reached for macroporous 
PHEMA hydrogel due to the large pore volume and free space in the scaffold (Lou, 
Munro, and Wang 2004; Lou, Wang, and Tan 2007), whilst the release of 
prednisolone 21 hemisuccinate sodium salt (a small molecular weight anti-
inflammatory drug) from the porous PHEMA is comparable to that from the less 
porous PHEMA hydrogel (Wang et al. 2010). Meanwhile, the loading of drugs can 
be achieved in ambient conditions through very simple means with less concern 
about the drug's stability (Wang et al. 2010). Moreover, macroporous PHEMA 
hydrogels also are suitable for delivering large molecules (proteins and growth 
factors) (Dziubla et al. 2001).  
 
More recent studies have shown that PHEMA hydrogels have some potential for the 
regeneration of articular cartilage (Bavaresco et al. 2008), bone tissue (Song, 
Malathong, and Bertozzi 2005; Song, Saiz, and Bertozzi 2003), and nerve tissue 
(Carone and Hasenwinkel 2006). The PHEMA used in these studies also were 
nonporous hydrogels. In addition, use of porous PHEMA hydrogels in tissue 
engineering has attracted attention. Porous PHEMA hydrogels obtained from a 
polymerization process in the presence of water have been used to provide a stable 
three-dimensional scaffold for axonal regeneration in the damaged central nervous 
system (Plant, Harvey, and Chirila 1995; Plant, Chirila, and Harvey 1998). A 
channelled porously structured PHEMA hydrogel was produced using 
polycarolactone fibres as a template, for neural tissue engineering (Flynn, Dalton, 
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and Shoichet 2003). In a separate study, porous PHEMA hydrogels were prepared by 
a free radical polymerization of monomers in the presence of NaCl particles, for 
spinal cord injury (Hejcl et al. 2008). 
 
However, like other hydrogels, PHEMA hydrogels exhibit relatively poor 
mechanical properties and a bioinert characteristic. Thus, we have proposed to 
incorporate nanoadditives and biomolecules into PHEMA hydrogels in order to 
improve both the mechanical and biological properties of the hydrogels for tissue 
engineering applications.  
 
It is noteworthy that PHEMA is a stable polymer that is considered to be 
nondegradable. Biodegradable scaffolding materials most commonly are investigated 
for tissue engineering applications. Numerous investigations have been based on 
PLA, PGA and their copolymers (Holy et al. 2001; Savaiano and Webster 2004; Ma 
et al. 2005; Pattison et al. 2005; Gerhardt, Jell, and Boccaccini 2007; Torres et al. 
2007). However, these materials exhibit a number of disadvantages. Firstly, the 
oligomers of these polymers are hydrophobic, which affects protein adhesion. 
Therefore, cell activities including cell attachment and proliferation can be much 
affected (Minamiguchi et al. 2008; Oh et al. 2003). Secondly, degradation products 
of these scaffold materials can cause toxic responses when these acidic degradation 
products are released abruptly, affecting cell growth and increasing inflammation in 
the surrounding tissue area (Martin, Winet, and Bao 1996). Last but not least, 
degradation can change the mechanical properties of a tissue scaffold and an 
autocatalyzed break down can lead to a catastrophic loss of the mechanical support 
from the scaffold (Atzet et al. 2008). Non-biodegradable polymers have the 
advantage that their properties, both chemical and mechanical, are less affected by 
the cellular and tissue milieu (Li et al. 2006). In addition, the fundamental 
understanding of the role of the scaffold biomaterial is still rather limited because of 
its multidisciplinary nature. Determining the ultimate success of non-degradable 
scaffolding materials can benefit us for a wider understanding of scaffold materials, 
for which various factors can be dissected (Jansen et al. 2005). Therefore, 
investigations of non-biodegradable materials such as polytetrafluoroethylene, 
polyethylmethacrylate, PHEMA and hydroxyapatite/Dacron composites in tissue 
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engineering also has produced much activity (Francis Suh and Matthew 2000; 
Kubinová et al. 2010; Kubinová, Horák, and Syková 2009).   
 
Effort has been made to convert PHEMA to degradable hydrogel (Atzet et al. 2008; 
Casadio et al. 2010). However, the degradation relies on the utilization of a 
degradable crosslinker, including oligomeric blocks of polycaprolactone (Atzet et al. 
2008), a series of dimethacrylate peptide-based crosslinking agents (Casadio et al. 
2010), poly(ethylene glycol) diacrylate and N,N'-bis(methacryloyl)-L-cystine (Andac 
et al. 2008). Even though the crosslinker can be degraded, the resultant HEMA 
polymer chains remain nondegradable. Thus, our effort is focused on making porous 
PHEMA hydrogel bioactive so as to extend its application as an effective and 
permanent implanted tissue scaffold material. Non-degradable nano-additives are 
used for the production of composite PHEMA hydrogels.  In the following sections, 
the nanoadditives will be introduced.  
1.5.2. Titanium Dioxide (TiO2) 
TiO2 particles (Titania) exist in different crystalline forms, including anatase, rutile 
and brookite. Among these structures, rutile is the most stable form and the other two 
can convert to rutile upon heating (Mor et al. 2006). TiO2 has been found to be useful 
in such applications as photocatalysis, oxygen sensors and antimicrobial coatings 
(Chin, Chiang, and Fane 2006; Chung et al. 2008; Zheng, Xu, and Xu 2000). TiO2 
nanoparticles also have been found to be useful for tissue engineering, such as bone 
regeneration, because TiO2 particles have an excellent capacity for inducing calcium 
deposition and osteoblast functions in polymers containing nano-sized titania 
inclusions (Liu, Slamovich, and Webster 2006; Savaiano and Webster 2004). The 
cytotoxicity of TiO2 in nanoparticles or films has been investigated using different cell 
lines, including mouse mesenchymal stem cells and human dermal fibroblast cells 
(Kommireddy et al. 2005). The results indicate that TiO2 particles are non-toxic 
(Carbone et al. 2006; Kommireddy et al. 2005; Kommireddy et al. 2006). 
1.5.3. Carbon Nanotubes (CNTs) 
Carbon nanotubes can be produced as a single tube structure (commonly called a 
single-walled carbon nanotube) or concentric cylinder of carbon structure 
(commonly referred to as a multi-walled carbon nanotube) (Harrison and Atala 2007). 
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Both are in cylindrical form with a diameter of several nanometres and a length 
greater than 100 nm, resulting in very large aspect ratios. They possess a very broad 
range of electronic, thermal and structural properties defined by diameter, length and 
twist. CNTs have the capacity to be used in cellular imaging, chemical and biological 
sensing, bioactive agent delivery and tissue engineering.  
 
The toxicity (biocompatibility) of CNT has been investigated in vitro and in vivo 
(Firme Iii and Bandaru 2010; Chlopek et al. 2006). The results are controversial due 
to influences from a range of factors, including length, type of functionality, 
concentration, duration of exposure, method of exposure, and even the dispersant 
used to solubilise the nanotubes (Cui et al. 2010). Some results demonstrate that 
CNTs have a cytotoxic effect (Shvedova et al. 2003; Cui et al. 2005; Jia et al. 2005; 
Monteiro-Riviere et al. 2005; Zhang et al. 2007), whereas other results demonstrate 
their biocompatibility (Flahaut et al. 2006; Dumortier et al. 2006; Chen et al. 2006). 
Apart from the controversy about their cytotoxicity, CNTs have been reported to be 
capable of improving cell adhesion in vitro, as well as supporting other cell types, 
such as smooth muscle, fibroblasts and osteoblasts (MacDonald et al. 2005; Correa-
Duarte et al. 2004; Supronowicz et al. 2002).  
 
CNTs have the potential to provide essential structural reinforcement for tissue 
scaffolds due to their superior mechanical properties and fibre characteristics 
(Bhattacharyya et al. 2008; Wang and Chen 2007). It is reported that significant 
improvements (300%) in the dynamic mechanical properties of the composites have 
been observed after a small fraction (2wt%) of carbon nanotubes were incorporated 
into hyaluronic acid hydrogels (Bhattacharyya et al. 2008). MWNTs blended with 
chitosan showed significant improvement in mechanical properties compared with 
those of chitosan alone. Nanocomposites composed of 2% MWNT more than 
doubled the Young's modulus and tensile strength results compared to neat chitosan. 
Therefore, it has been proven that the mechanical properties of composite materials 
containing CNTs can be “fine-tuned” by varying the concentration of CNTs within 
the bulk polymers (Ceballos et al. 1999; Dang and Leong 2006; Yoshii et al. 2002) . 
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1.5.4. Silicon Dioxide (SiO2) 
Silicon dioxide or silica (SiO2) is one of  the most abundant compounds in the earth's 
crust (Park and Park 2009). Various SiO2 nanoparticles have been used in chemical 
and biomedical products, such as cancer therapy, DNA delivery and enzyme 
immobilization (Barik, Sahu, and Swain 2008). It is one of the components of 
bioactive glasses, which have been widely used as additives for bone tissue 
regeneration scaffolds and soft tissue scaffolds (Rich et al. 2002; Francis et al. 2010; 
Boccaccini et al. 2010). The use of silica alone as an additive for tissue scaffolds also 
has been reported, due to its potential capability to induce apatite formation 
(Madhumathi et al. 2009; Hench 1991; Karlsson, Fröberg, and Ringbom 1989; Day 
et al. 2004). 
1.5.5. Collagen 
Collagens are a group of proteins with a characteristic molecular structure, with their 
fibrillar structures contributing to the extracellular matrix (Gelse, Pöschl, and Aigner 
2003). So far, over 27 types of collagen have been identified and described 
(Myllyharju and Kivirikko 2004). The different collagen types can be recognised by 
the considerable complexity and diversity in their structures, their splice variants, the 
presence of additional, non-helical domains, their assembly and their function. The 
majority of collagen existing in the body is type I, which can be found in great 
abundance in tissues including dermis, tendon, ligaments, cornea and bone (Gelse, 
Pöschl, and Aigner 2003). Types II, IX and XI are found almost exclusively in 
cartilage tissues (Myllyharju and Kivirikko 2004). Collagen functions as a major 
structural component in those connective tissues (Lee and Mooney 2001). In addition, 
collagen molecules interact with cells to transduce molecule signals for the 
regulation of cell adhesion, migration, proliferation and differentiation (Malafaya, 
Silva, and Reis 2007). In addition, characteristics such as excellent biocompatibility, 
low antigenicity, the ability to be crosslinked, and tailored mechanical, degradation 
and water-uptake properties have enabled extensive studies of collagen for the 
various biomedical applications, including tissue engineering (Lee, Singla, and Lee 
2001). Collagen has been used widely to modify the chemistry of scaffolds for 
improving cellular adhesive properties. Listed in Table 1-2 are a few examples that 
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have demonstrated improvements in cellular activities after modification with 
collagen. 
Table 1-2 A summary of the methods used for surface modification using collagen 
 
1.5.6. Research Plan and Methodology  
The aim of this project is to synthesize and evaluate macroporous PHEMA and 
PHEMA composite hydrogels for tissue engineering applications.  
 
Scaffold 
material 
Surface treatment Collagen attachment method Cell tested Ref. 
PLLA Ozone oxidation to 
producing peroxide 
groups on surface 
Redox-initiated coupling 
reaction, allowing grafting with 
collagen molecules 
Osteoblasts (Suh et al. 
2001) 
PLA Grafting 
polymerization of 
methacrylic acid on 
PLLA surface to 
introduce -COOH 
groups 
Chemical grafting of collagen 
type I using carbodimmide as 
coupling agent 
Chondrocyte (Ma et al. 
2005) 
Titanium,  
titanium alloy, 
cobalt alloy; 
stainless steel 
Oxide techniques  Covalent coupling of collagen 
via a silane coupling agent and 
linker molecule. Collagen layer 
was cross-linked by 
carbodiimide reaction 
afterwards. 
Human 
osteoblast-like 
cells 
Mysenchymal 
stem cells 
(Müller, 
Abke, et al. 
2006; 
Müller et al. 
2005) 
Poly(ethylene 
terephthalate)  
Plasma treated  
followed by acrylic 
acid graft 
polymerization 
Electrostatic adsorption of 
collagen onto the modified 
surface 
Human 
smooth 
muscle cell 
(Bisson et 
al. 2002) 
PLGA (85/15) Ammonia plasma 
treated 
Collagen was  
anchored onto the modified 
surface  
Mouse 3T3 
fibroblasts 
(Yang et al. 
2003) 
PHEMA NA Collagen was deposited on 
hydrogels by adsorption from 
acid solutions 
Mysenchymal 
stem cells 
(Brynda et 
al. 2009) 
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Porous PHEMA hydrogels have great potential for tissue engineering applications, as 
has been mentioned in the above sections. These advantages include (1) macroporous 
PHEMA hydrogel with varying pore sizes can be formed easily by polymerization in 
the presence of a large amount of water; (2) the polymerization process conditions 
are mild and the properties of resultant hydrogels can be altered through simple 
chemical and/or physical processes; and (3) macroporous PHEMA hydrogels exhibit 
a high loading capacity for biomolecules (Wang et al. 2010; Lou, Wang, and Tan 
2007; Lou, Munro, and Wang 2004) and allow the transportation of large molecules 
such as growth factors and other nutritional molecules. However, like other 
hydrogels, PHEMA hydrogels exhibit relatively poor mechanical properties and are 
biologically inert. Therefore, we have proposed to incorporate nanoadditives and 
biomolecules into PHEMA hydrogels, and to investigate the effect of these additives 
on the mechanical strength and the cellular activities of the composite PHEMA 
hydrogels.   
 
In addition, the transportation of macromolecules is of significant importance, as cell 
or tissue growth requires constant provision and discharge of macromolecules such 
as growth factors, proteins and other nutrimental substances. For the ultimate 
application of any scaffolding material, investigation and understanding of the 
molecule diffusion properties in the porous structure of the scaffold will help in the 
design and fabrication of effective tissue engineering scaffolds. Therefore, evaluation 
of the transportation of macromolecules within the produced porous composite 
scaffolds also is conducted in this study. 
 
A series of porous PHEMA and PHEMA composite hydrogels, including PHEMA-
TiO2, PHEMA-SiO2, PHEMA-CNT, and collagen modified PHEMA and PHEMA 
composite hydrogels, will be fabricated. The design parameters, including pore 
structure and porosity, mechanical behaviour, topographic properties and cellular 
activities, as well as the ability for biomolecule delivery of these hydrogels, will be 
investigated systematically for possible applications as tissue engineering scaffolds.  
 
In brief, porous PHEMA and PHEMA composite hydrogels will be synthesized 
through a free radical polymerization process in the presence of water (Li, Zheng, 
and Lou 2009). Various porous structures of the hydrogels will be generated by 
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altering of the HEMA:water ratios in the polymerization mixtures. TiO2, SiO2 and 
CNT particulates will be used as nanoadditives for composite hydrogels. Collagen 
will be incorporated, through chemical bonding, into selected hydrogels for the 
improvement of cellular activities.  
 
The presence and the concentrations of the nanoadditives and collagen molecules 
will be analysed using various analytical instruments. These include Fourier 
transform infrared spectroscopy (FTIR), UV-Vis absorption spectroscopy (UV-Vis),  
scanning electron microscopy including energy-dispersive X-ray spectroscopy 
(SEM/EDX), X-ray diffraction (XRD), and gravimetric analysis (GA). The porous 
structure of the hydrogels will be examined using SEM. The polymer volume 
fraction also will be determined as a quantitative measure of the porosity.  
 
Mechanical properties of PHEMA and PHEMA composite hydrogels will be studied 
using a SINTECH 200/M Material Testing Workstation and a HAAKE MARS III 
Modular Advanced Rheometer System. The tensile behaviours, as well as the 
viscoelastic moduli, linear viscoelastic range and recovery properties of the 
hydrogels, will be investigated.  
 
The delivery of biomolecules from selected PHEMA hydrogels also will be 
examined. Both single and dual delivery systems will be used in this study. Delivery 
of biomolecules in static and dynamic conditions will be explored. The cytotoxicity 
and cellular activities of the produced hydrogels will be assessed using various cell 
lines. The calcification capacity of the porous hydrogels also will be evaluated. 
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CHAPTER 2 MACROPOROUS PHEMA AND PHEMA 
COMPOSITE HYDROGELS: SYNTHESIS AND 
CHARACTERIZATION 
 
2.1. Introduction 
This chapter focuses on the synthesis and characterization of a series of macroporous 
poly(2-hydroxyethyl methacrylate) (PHEMA) composite hydrogels containing varying 
concentrations of three nanoadditives, including titanium dioxide (TiO2), silicon 
dioxide (SiO2) and multi-walled carbon nanotubes (CNTs).  
 
As mentioned in the previous chapter, a macroporous network is critical for nutrient 
exchange and oxygen delivery, as well as for the long-term survival of tissue cells, 
when engineering various tissues. Several reported methods have increased the 
effective pore sizes of the PHEMA hydrogels to several micrometers (Krauch and 
Sanner 1968; Haldon and Lee 1972; Murphy, Skelly, and Tighe 1992). These include 
the application of a solid matrix that, subsequently, is dissolved or dispersed in water. 
This method was introduced for the production of PHEMA hydrogels (Krauch and 
Sanner 1968). One of the most convenient methods is to polymerize HEMA 
monomer in the presence of water above a critical level (reportedly 40-45 wt%) 
(Rosenberg, Bartl, and Leško 1960; Yasuda, Gochin, and Stone 1966; Hasa and 
Janáček 1967; Gouda et al. 1970; Warren and Prins 1972). During this process, a 
macroporous PHEMA network forms as a result of phase separation, which is caused 
by the presence of excessive water in the monomer mixture that exceeds the 
maximum swelling capacity of the final polymer (Chirila, Chen, et al. 1993). The 
phase separation occurs due to the thermodynamic interaction between water and the 
polymer network, and the formed macro-pores range from several to hundreds of 
micrometers (Chirila, Chen, et al. 1993; Lou, Munro, and Wang 2004).   
In this current study, phase separation polymerisation also was used to create 
PHEMA hydrogels containing various porosities. Five water concentrations were 
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used, including 60, 70, 75, 80 and 90 wt% in the production of PHMEA and its 
composite hydrogels. Nanoparticulate TiO2, multi-walled CNTs, and SiO2 were 
incorporated into the porous structure in order to explore their effects on the 
mechanical behaviour and bioactivity of the hydrogel polymers. The produced 
hydrogels were examined via SEM examination to reveal the macrostructures. 
Gravimetric analysis (GA) and thermal gravimetric analysis (TGA) were carried out 
to quantify the real concentrations of the additives in composite hydrogels. XRD was 
conducted to confirm the presence of additives in the hydrogels. The polymer 
volume fraction also was measured in order to estimate the porosity of the hydrogels.  
Cell viability (cytotoxicity) indicates the functional status of cells in the presence of 
compounds/materials (Ciapetti et al. 1996). The assessment can be accomplished 
either by directly counting the number of healthy cells or by measuring an indicator 
for healthy cells in cell populations (Castro-Concha, Escobedo, and Miranda-Ham 
2006). In general, an increase in cell viability indicates cell growth, while a decrease 
in cell viability can be interpreted as the result of the toxic effects of the exposed 
materials. Several assays have been reported to quantify the cellular viability by 
measuring the indicator of the healthy cells. The assays can be categorized according 
to two characteristic parameters: metabolic activity or cell membrane integrity of 
healthy cells. The first category includes methods such as MTT, XTT and WST-1, 
which use a colorimetric reaction to measure the reducing potential of the cell. The 
second type of assay takes advantage of the ability of healthy cells with 
uncompromised cytoplasmic membrane integrity to exclude dyes such as trypan blue, 
methylene blue and evans blue (Castro-Concha, Escobedo, and Miranda-Ham 2006).  
In this study, an MTT cleavage assay was used to examine the cytotoxicity of the 
selected hydrogel materials. The method originally was described by Mosmann for 
measuring cell survival/proliferation (Mosmann 1983). It is a colorimetric assay that 
measures the reduction of yellow MTT by mitochondrial succinate dehydrogenase. 
The MTT enters the cells and passes into the mitochondria where it is reduced to an 
insoluble, coloured (dark purple) formazan product. The cells then are solubilised 
with an organic solvent (eg. isopropanol) and the released, solubilised formazan 
reagent is measured spectrophotometrically (Peterson, Kimura, and Schubert 1997). 
Since a reduction of MTT can occur only in metabolically active cells, the level of 
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activity is a measure of the viability of the cells. The advantages of using this assay 
include: (a) sensitivity and reproducibility; (b) elimination of the need for radioactive 
compounds; (c) ease with which it can be performed and quantified; and (d) rapidity 
(Ferrari, Fornasiero, and Isetta 1990). 
Calcium is an important element and is the most abundant mineral in the body. It 
interacts with phosphorus to form calcium phosphate (CaP), which is the material for 
bone and teeth tissue formation. The formation of CaP is a process called 
calcification and it occurs in many situations in the human body. The formation of 
CaP may cause failure of some implants (Vijayasekaran et al. 2000). However, its 
formation helps the osteogenesis of implants and prostheses for orthopaedic 
correction (Aimoli, Torres, and Beppu 2006), as well as aiding in the development of 
new bone tissues in their regeneration (Zhao and Chang 2004). In addition, it has 
been well accepted that the deposition of hydroxyapatite-like CaP onto biomaterial 
surfaces can facilitate direct bonding to hard tissue which, in turn, provides a 
favourable procedure to mimic the bone environment through the promotion of 
osteointegration by the osteoblast attachment and osteogenic differentiation 
(Yokogawa et al. 1997). Thus, many investigations have attempted to promote 
calcification of synthetic biomaterials for applications in orthopaedic and dental 
surgery. 
The calcification capacity of the produced hydrogels was investigated using a 
simulated body fluid (SBF) containing ion concentrations similar to those in human 
blood plasma. Hydrogels, including group I (20HEMA-5TiO2, 20HEMA-0.5CNT, 
30HEMA-5TiO2, and 30HEMA-5SiO2) and group II (10HEMA-7.5TiO2, 20HEMA, 
20HEMA-7.5TiO2, and 40HEMA-7.5TiO2), were selected to explore the 
calcification capacity of porous PHEMA hydrogels. The hydrogels were incubated in 
the SBF and the formation of CaP was evaluated using XRD, FTIR, SEM/EDX and 
Alizarin Red S staining.  
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2.2. Experimental 
2.2.1. Chemicals  
Ophthalmic grade 2-hydroxyethyl methacrylate (HEMA) and ethylene 
dimethacrylate (EDMA) were supplied by Bimax USA. Sigma-Aldrich supplied 1,5-
hexadiene-3,4-diol (DVG) and this was used as a crosslinker. Ammonium 
persulphate (APS) and N, N, N’, N’-tetramethylethylenediamine (TEMED) were 
purchased from Sigma-Aldrich and used as initiators for polymerization. TiO2 
nanoparticles were obtained from Degussa AG Germany (AEROXIDE P 25, 99.5 
wt%) and Sigma-Aldrich. The average size of the particles was 21 nm. SiO2 
nanoparticles (~30 nm) were from Sigma-Aldrich. Multi-walled carbon nanotubes 
(CNTs, diameter 10-30 nm, length 5-15 µm) were purchased from Shenzhen 
Nanotech Port Co., Ltd (Shenzhen, China) with a purity of >97%. CNTs were 
purified by an acid solution (H2SO4:HNO3=3:1) for 5 hours at 40oC, followed by 
sedimentation, centrifugation and filtration prior to use. All other chemicals used 
were analytical grade. Alzarin Red S was from Sigma-Aldrich.   
 
The chemicals used for the cell viability assay included 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) from Sigma-Aldrich, and Dulbecco's 
modified Eagle's medium, fetal calf serum and penicillin/streptomycin from Gibco, 
USA. 
 
An SBF solution  was prepared by dissolving the reagent of 11.994g NaCl (BDH 
Chemicals), 0.525g NaHCO3 (Aldrich), 0.336g KCl (Aldrich), 0.342g K2HPO4·3H2O 
(Aldrich), 0.458g MgCl2·6H2O, 60ml HCl (1 kmol/m3, Ajax Chemicals), 0.417g 
CaCl2 (APS Chemicals), 0.107g Na2SO4 (Aldrich), and 9.086g (CH2OH)3CNH2 
(Sigma-Aldrich) into 750ml Mill-Q water (Masami et al. 1994). The final ion 
concentrations were 1.5 times that of those in human blood plasma. The pH value of 
the solution was adjusted to 7.4 using 1M HCl at 37±1°C, and then the solution was 
transferred into a 1000ml glass volumetric flask. The beaker used for transfer was 
washed using Mill-Q water. The solution was added into the flask and the total 
volume of the solution was adjusted to 1000 ml using Mill-Q water.  
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2.2.2. Synthesis of Porous PHEMA Composite Hydrogels 
PHEMA-TiO2 composite hydrogels 
Outlined below is the general procedure to prepare a PHEMA hydrogel containing 
7.5 wt% TiO2 using 20:80 (HEMA: water) ratio. The hydrogel is coded as 20HEMA-
7.5TiO2. TiO2 nanoparticles (0.15 g) were dispersed in Mill-Q water (8 g) using an 
ultrasonic water bath for 1 hour and mechanically stirred for 30 min. HEMA 
monomer (2 g), crosslinking agent EDMA (20 µl), and 10 wt% APS solution and 
TEMED (initiators; 40 µl) were subsequently added. The mixture was injected into 
the space between two glass plates, separated with a silicon rubber gasket, within 5 
min. The polymerization process was started at room temperature, maintained for 3 
hours, followed by a thermal curing at 60oC for 24 hours. Upon completion of the 
polymerization, the hydrogel materials were removed from the glass plates, extracted 
via water exchange, with sufficient deionised (DI) water, and then replaced, twice a 
day for at least two weeks, in order to remove residual chemicals and monomers. The 
effective removal of the impurities with this method has been verified from the 
previous reports (Chirila, Chen, et al. 1993; Brynda et al. 1985; Kwok et al. 2001).  
 
Other PHEMA-TiO2 composite hydrogels were prepared in the same manner as 
above, but with a different chemical composition in accordance with Table 2-1.    
 
Freeze drying was applied to hydrogel samples prior to some measurements, 
including morphological and thermal analysis. This was conducted using a 
DYNAVAC freeze drier (Model FD3), shown in Figure 2-1. The hydrated hydrogel 
specimens were put into a Petri dish and afterwards kept in a freezer at -40°C 
overnight. The frozen hydrogel specimens were moved into a vacuum chamber, 
followed by sublimation. The vacuum chamber was connected to a condenser, and 
cooled to -55ºC.  The process lasted for a minimum of 24 hours, ensuring a complete 
drying of the samples.  
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Figure 2-1 DYNAVAC freeze drier for treatment of hydrogel specimens  
 
PHEMA-SiO2 and PHEMA-CNT composite hydrogels 
Composite hydrogels containing SiO2 nanoparticles and multi-walled CNTs were 
prepared using the same procedure as that for the PHEMA-TiO2 composite hydrogels. 
The chemical composition of these hydrogels is summarised in Table 2-1.  
 
For the convenience of this investigation, hydrogels were fabricated in two forms 
including sheet and button samples. The sheet samples were polymerized in the 
space between two glass plates, separated with a silicon rubber gasket. The mould for 
casting sheet hydrogel samples is displayed in Figure 2-2 a. The button-shaped 
hydrogels were produced in wells of tissue culture plates consisting of 24 wells (TPP, 
Trasadingen, Switzerland), as displayed in Figure 2-2 b.   
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Figure 2-2 (a) A mould for casting hydrogel sheets and (b) a tissue culture plate consisting of 24 
wells, for casting hydrogel buttons  
 
2.2.3. Quantification of Additives  
Gravimetric analysis was used to quantify the amounts of TiO2 contained in the 
hydrogel polymers. The freeze-dried samples were crushed into fine powder and 
approximately 5 g of the hydrogel polymers were placed in a furnace at 450°C for 
four hours, ensuring complete decomposition. Pure PHEMA and the nanoparticles 
were used as controls. The residual polymers were weighed. The weights of the 
samples, before and after decomposition, were taken as W1 and W2 respectively. The 
weight loss percentage of the composite hydrogels was calculated as 100 × W2/(W1-
W2). Three measurements were carried out for each formulation and an average 
weight percentage of the additive was computed. The error was presented using the 
STDEV. 
 
a 
b 
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A METTLER TOLEDO TGA/DSC instrument was used to confirm the above results 
using 30HEMA-7.5TiO2 composite hydrogel. Approximately 3-5 mg of the crushed 
fine powder was used for the TGA analysis under nitrogen atmosphere at normal 
pressure. The samples were heated in alumina crucibles (70 µl) from 35 to 750oC at a 
heating rate of 10oC/min. A plain crucible containing no sample was conducted 
before any test in order to obtain consistent results.  
2.2.4. Morphology Exmination 
Morphological examination of the produced hydrogel polymers was conducted using 
an SEM (Zeiss 1555 VP FE-SEM, Philips XL30 SEM and Zeiss EVO 40XVP). The 
hydrogel specimens were freeze dried using a DYNAVAC freeze drier (Model FD3) 
and coated with a thin layer of carbon prior to SEM imaging. The bottom surface 
during the fabrication was the one that was prepared for all of these observations, to 
keep the results comparable.  
2.2.5. Polymer Volume Fraction Measurement 
The method for determining the pore size and the size distribution of a material is 
strongly dependant on its natural state (wet or dry). The characterization of these 
properties within a dry sample is relatively easy to achieve (Savina et al. 2011). 
Mercury intrusion porosimetry has been used most commonly, as a direct method 
(Sayil and Okay 2001). Another indirect method, inverse size exclusion 
chromatography, has been reported for the estimation of the pore size and pore size 
distribution of porous sorbents (DePhillips and Lenhoff 2000). However, there is no 
general technique to measure the pore size and size distribution of porous gels in 
their intact wet state (Yao and Lenhoff 2004). The direct methods for visualization of 
pore structure, like scanning electron microscopy (SEM), suffer from the problem of 
variations to pore structure being introduced during sample preparation and thus 
could result in erroneous estimations (Park and Hoffman 1994). Shrinkage of 
PHEMA has been noted commonly in previous reports (Horák, Lednick, and Bleha 
1996). Environmental scanning electron microscopy (ESEM) allows the examination 
of the hydrated samples in their natural state and, normally, extreme care should be 
taken when ESEM is used for this purpose. In addition, quantitative estimation of 
pore size and size distribution from ESEM images also suffers from subjectivity and 
errors (Spiller et al. 2008). 
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Indirect methods commonly have been used for examining and/or quantifying the 
pore size of wet samples (Chalal et al. 2009; Savina et al. 2011). Calculation of the 
overall apparent density has been used to evaluate the porosity of various tissue 
scaffolds (Liu and Ma 2009; Ma and Zhang 1999; Torres et al. 2007). Solution 
(water or organic solutions) uptake is one of the most convenient methods to estimate 
the pore volume in hydrogel materials and it has been reported by many other 
researchers (Horák, Lednick, and Bleha 1996; Plieva et al. 2005; Yin et al. 2007). 
Therefore, this study uses the polymer volume fraction to estimate the porosity of 
PHEMA and its composite hydrogels. SEM images are used for visual examination 
only.  
 
Polymer volume fraction (Φp) is defined as the ratio of the dry polymer volume to 
the wet volume of the same sample at its full hydration. This is a quantitative 
estimate of the porosity of the hydrogel, and can be determined using equations (2-1) 
to (2-3), 
total
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where Vtotal represents the volume of a fully hydrated hydrogel and Vp is the volume 
of polymer after dehydration. Both Vtotal and Vp can be determined using the 
Archimedes’ buoyancy principle, where the density of water (ρw) was taken as 1.0 
mg/cm3 in Equations (2-2) and (2-3), Ww,a and Wd,a represent the weight of a fully 
hydrated hydrogel in air and the weight of the same hydrogel in air after dehydration, 
and Ww,w and Wd,w represent the weight of a fully hydrated hydrogel in water and the 
weight of the same hydrogel in water after dehydration.  
 
Measurement of these four different weights of the hydrogels was conducted using a 
digital balance (Analytical plus, PHAUS, NJ) (Figure 2-3). The samples were cut 
from each fully hydrated polymer. The free water on the specimens was quickly 
blotted using a wet tissue, followed by measuring Ww,a and Ww,w. The specimens 
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then were dried in a convection oven (Venticell 55, MMM, Einrichtungen, Germany) 
for 48 hours at a temperature of 50°C. Wd,a and Wd,w were weighed upon completion 
of the drying process. Full details of the measurements can be found in the 
previously cited publication (Lou, Wang, and Tan 2007). Six specimens were used 
for each test and the average values were presented in the results. The error was 
presented by the STDEV. 
 
 
 
Figure 2-3 A set-up using an analytical balance for measuring weights of hydrogels in both air 
and water 
2.2.6. Calcification Study  
For each of the selected hydrogel polymers, eight specimens of disk geometry (8 mm 
in diameter, 1.5 mm in thickness) were put in 10 ml of 1.5 SBF solution at 37±1°C. 
The bottom surface of the hydrogels during the fabrication process was used for all 
analyses to keep the results comparable. The SBF solution was replaced with a fresh 
solution, weekly. Samples were retrieved at pre-designated time intervals (3, 7, 10, 
14, 21 and 28 days). The formation of CaP was characterized by a series of 
techniques, including FTIR, Alizarin Red S staining, SEM/EDX and XRD analysis. 
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FTIR  
An FTIR examination was carried out using a Bruker IFS 66 with a resolution of 4 
cm-1. The formation of CaP was confirmed using FTIR, and OPUS software was 
used for data analysis. The composite hydrogels were first freeze-dried and crushed 
into fine powders prior to the KBr disc preparation. 
 
Alizarin Red S Staining 
A small piece of calcified hydrogel sample was embedded in Tissue-Tek (O.C.T 
compound, ProsciTech) in a chamber and kept overnight in a freezer (Forma 
Scientific Inc, Marietta, USA) at -80°C. Sectional samples (10µm in thickness) were 
sliced using a Leica CM3050S Cryostat (Leica Microstystems, Milton, UK) at -20°C, 
following this standard procedure: (1) set the temperature of the cryostat at -20°C, at 
least 30 min prior to slicing; (2) move the frozen sample into the cryostat, followed 
by mounting the sample onto a sample holder using Tissue-Tek; (3) load the sample 
holder and make proper adjustments; (4) change the trimming thickness to 10 µm 
and begin trimming the sample; (5)  slice sections; (6) carefully collect the section on 
a room temperature microscope slide; (7) keep the sections at -20°C prior to staining; 
and (8) clean up the chamber using 100% EtOH. 
 
The presence of calcium in the hydrogel specimens was highlighted using a 2 wt% 
Alizarin Red S solution as a stain, prepared in Mill-Q water. The pH value of the 
solution was adjusted to 4.1~4.3 with 10 wt% ammonium hydroxide. The staining 
procedure followed these steps: (1) dip the slides into distilled water to remove OCT; 
(2) put excessive Alizarin Red Solution onto slides for 5 min; (3) shake off excess 
dye with care; (4) dehydrate in acetone, 10 dips; (5) wash in acetone-xylene (1:1) 
solution, 10 dips; and (6) clear in xylene (5 dips) and mount in permount. Eventually, 
the presence of calcium in the deposits was examined using an Olympus BX60 light 
microscopy. 
 
SEM-EDX  
The method for SEM imaging was described in Section 2.2.4. EDX analysis was 
carried out using a Philips XL30 with an Oxford Instruments Si-Li x-ray detector. 
Nickel and copper were used to calibrate the equipment. The sectional hydrogel 
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specimens (~0.5mm) were sliced from the bulk materials. The samples were then 
freeze-dried and coated with a thin layer of gold prior to the SEM imaging. The 
thickness of the CaP in the hydrogel samples was determined from SEM images.   
 
XRD 
XRD measurements were conducted using a Siemens D-500 powder diffractometer 
with Cu Kα radiation. The diffractometer was operated at 40 kV/30mA. The 
scanning was carried out at a step size of 0.02° and a count time of 1.5 s/step.  
2.2.7. MTT Assay 
The NIH 3T3 fibroblast cells were cultured in a Dulbecco's modified Eagle's medium 
(DMEM) containing 10% fetal calf serum (FCS) and 1% penicillin/streptomycin 
(Gibco, USA) at 37 °C in a humidified 5 % CO2 incubator. Hydrogel disks (10 mm 
in diameter, 1.5 mm in thickness) were sterilized (autoclave: 121°C, 15 min) prior to 
the pre-culture with DMEM media in 24-well cell culture plates for 2 hours. Cell 
suspension (150 µl) with a density of 8.5×104  cells/ml was added to each of the 
hydrogels after the pre-culture media was aspirated. 200 ml of fresh media were 
added carefully, after 1 hour. At the desired times (Day 1, Day 3 and Day 5), 30 µl 
fresh MTT solution (5 mg/ml in PBS) were added to each well and the culture plates 
were incubated for 6 hours. The formed purple formazan was dissolved with sodium 
dodecyl sulfate solution (200 µl) in hydrochloric acid (pH 4.7). The culture plates 
were kept in the incubator overnight. The optical density of each well was measured 
after the hydrogels were removed from the culture plate with a spectrophotometer 
(Beckman, USA) at 570 nm, with background subtraction at 650 nm. Readings of a 
minimum of four disks were taken for each formulation. The readings from the cell 
culture plate (TPP, Transadingen, Switzerland) were used as a control and the 
reading values were normalized according to the surface area of each hydrogel. Mean 
± standard deviation and the P value were calculated using one-way ANOVA with 
OriginPro (Version 7.5) software and the Turkey test. P values <0.05 were 
considered statistically significant. It should be noted that cell culture was performed 
on the bottom side of the hydrogels in order to obtain comparable results.   
42  
2.3. Results and Discussion 
2.3.1. Synthesis of Porous PHEMA Composite Hydrogels 
Eighteen composite hydrogels containing TiO2, multi-wall CNT and SiO2 were 
prepared. The hydrogels were named as follows: 10HEMA-7.5TiO2, 20HEMA-
5TiO2, 20HEMA-7.5TiO2, 20HEMA-10TiO2, 25HEMA-3TiO2, 25HEMA-7.5TiO2, 
20HEMA-12TiO2, 30HEMA-5TiO2, 30HEMA-7.5TiO2, 30HEMA-10TiO2, 
40HEMA-7.5TiO2, 20HEMA-0.5CNT, 25HEMA-0.5CNT, 20HEMA-2CNT, 
30HEMA-0.5CNT, 20HEMA-5SiO2, 30HEMA-5SiO2, and 30HEMA-5SiO2. Five 
control PHEMA hydrogels, including 10HEMA, 20HEMA, 25HEMA, 30HEMA 
and 40HEMA, also were synthesized. The sample codes and the chemical 
compositions of these hydrogel polymers are listed in Table 2-1. Numbers, including 
10, 20, 25, 30 and 40, in front of HEMA, denote the percentage concentrations of 
HEMA monomer in relation to the total quantity of HEMA and water used in the 
monomer mixture. The numerical parts, including 0.5, 2, 3, 5, 7.5, 10 and 12, in front 
of an additive, represent the initial percentage concentrations of the additive based on 
the mass of HEMA in composite hydrogels. For example, a 10HEMA-7.5TiO2 
composite hydrogel material was synthesized by a mixture consisting of 10 wt% 
HEMA monomer, 90 wt% water and 7.5 wt% of TiO2 nanoparticles based on HEMA 
content. 
All hydrogels appeared to be opaque in fully-hydrated conditions, indicating a 
porous structure. The occurrence of the porous structure was a result of phase 
separation due to the presence of water during the polymerisation process (Chirila, 
Chen, et al. 1993; Seidl et al. 1967; Guyot and Bartholin 1982; Okay 2000). The pore 
sizes of the hydrogels ranged from some nanometers to micrometers, depending 
mainly on the HEMA:water ratios. The influence of HEMA:water ratios, and the 
addition of the additives, on the resultant porous structures will be displayed and 
discussed later.  
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Table 2-1 Chemical composition of PHEMA and PHEMA composite hydrogels 
Sample ID TiO2 (g) 
HEMA 
(g) 
Water 
(g) EDMA (µL) 
APS  
(10 wt.%)  
(µL) 
TEMED 
(µL) 
10HEMA - 1.0 9.0 10 20 20 
10HEMA-7.5TiO2 0.075 1.0 9.0 10 20 20 
20HEMA - 2.0 8.0 20 40 40 
20HEMA-5TiO2 0.1 2.0 8.0 20 40 40 
20HEMA-7.5TiO2 0.15 2.0 8.0 20 40 40 
20HEMA-10TiO2 0.2 2.0 8.0 20 40 40 
20HEMA-0.5CNT 0.01 2.0 8.0 20 40 40 
20HEMA-5SiO2 0.1 2.0 8.0 20 40 40 
25HEMA - 2.5 7.5 25 50 50 
25HEMA-3TiO2 0.075 2.5 7.5 25 50 50 
25HEMA-7.5TiO2 0.1875 2.5 7.5 25 50 50 
      ... cont. 
Continued      
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Sample ID 
Nanoadditives 
(g) 
HEMA 
(g) 
Water 
(g) EDMA (µL) 
APS (10 
wt.%)  (µL) 
TEMED 
(µL) 
25HEMA-12TiO2 0.3 2.5 7.5 25 50 50 
25HEMA-0.5CNT 0.0125 2.5 7.5 25 50 50 
25HEMA-2CNT 0.05 2.5 7.5 25 50 50 
30HEMA - 3.0 7.0 30 60 60 
30HEMA-5TiO2 0.15 3.0 7.0 30 60 60 
30HEMA-7.5TiO2 0.15 3.0 7.0 30 60 60 
30HEMA-10TiO2 0.3 3.0 7.0 30 60 60 
30HEMA-0.5CNT 0.015 3.0 7.0 30 60 60 
30HEMA-5SiO2 0.15 3.0 7.0 30 60 60 
30HEMA-10SiO2 0.3 3.0 7.0 30 60 60 
40HEMA - 4.0 6.0 40 80 80 
40HEMA-7.5TiO2 0.3 4.0 6.0 40 80 80 
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2.3.2. Contents of Nanoadditives  
It is proposed that the content of the nanoadditive has an effect on the properties of a 
tissue scaffold. The properties include mechanical properties and cell-matrix 
interaction. The bioactivity also will be affected when a bioactive additive is used. 
Thus, it is useful to determine the real concentration of the incorporated nanoadditive. 
Thermal gravimetric analysis has commonly been used for this purpose and it has 
been applied to PHEMA composite materials as well (Huang, Chin, and Yang 2005; 
Nguyen et al. 2011; Silvestri et al. 2009). Table 2-2 displays the gravimetric analysis 
results, representing measured concentrations of the additives in the selected 
composite hydrogels. The results of blank PHEMA hydrogels (no additives) and the 
nanoparticles were used as controls. The measured concentrations of all particles are 
close to the incorporated values. Most of the values were lower than the theoretical 
concentrations of the additives, which is reasonable considering that some small 
particles might have been lost during the curing and extraction processes in the 
presence of large amounts of water. The loss of the additives is more significant in 
20HEMA-10TiO2 and 20HEMA-5SiO2. For 20HEMA-10TiO2, the greater amount of 
TiO2 (10wt%) in the preparation might have affected the phase separation process, 
leading to the formation of a more porous hydrogel matrix and, therefore, a greater 
loss of the nanoparticles. Indeed, the polymer volume fraction of this hydrogel is 
smaller than that of 20HEMA-7.5TiO2, indicating a more porous structure in 
20HEMA-10TiO2 (see Page 46, Section 2.3.3.).  As for 20HEMA-5SiO2, the extra 
weight loss could have been caused by the poor thermal stability of SiO2. Weight 
loss of SiO2 in a control sample was about 5% and more weight loss (7.2%) has been 
reported (Zhang et al. 2012). Therefore, the TA results for SiO2 containing hydrogels 
indicate the minimum contents of the particles.  
 
TGA results also confirmed the real concentration of TiO2 in a composite hydrogel, 
30HEMA-7.5TiO2 (Figure 2-4) and demonstrated that the real concentration of the 
nanoparticles was 6.9 wt%, which was consistent with the results from GA.  
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Table 2-2 Results from GA of composite hydrogels 
Sample ID 
Measured 
concentration of 
the additives (wt%) 
Sample ID 
Measured 
concentration of 
the additives (wt%) 
10HEMA 0 10HEMA-7.5TiO2 7.8±0.1 
20HEMA-7.5TiO2 6.8±0.2 
20HEMA-10TiO2 6.3±0.1 20HEMA 0 
20HEMA-5SiO2 2.1±0.1 
25HEMA 0 25HEMA-7.5TiO2 6.7±1.0 
30HEMA-7.5TiO2 6.7±0.5 
30HEMA 0 
30HEMA-5SiO2 4.5±0.1 
40HEMA 0 40HEMA-7.5TiO2 7.0±0.1 
 The measurements were performed in triplicate 
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Figure 2-4 TGA curve of 30HEMA-7.5TiO2 composite hydrogel  
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2.3.3. Polymer Volume Fraction 
The measured polymer volume fraction (Φp) values of all hydrogels are summarised 
in Table 2-3. The higher value of Φp indicated a less porous structure. The results 
revealed that the higher the HEMA content, the less porous were the hydrogels. The 
incorporation of the additives increased Φp in most composite hydrogels, which was 
probably due to the higher density of the particles present in the hydrogel matrices.  
  
Table 2-3 Polymer volume fraction of selected hydrogels 
Sample ID 
Polymer 
Volume 
Fraction, Φp 
(%) 
Sample ID 
Polymer 
Volume 
Fraction, Φp 
(%) 
10HEMA 10.30±0.8 25HEMA-7.5TiO2 21.4±4.0 
10HEMA-7.5TiO2 14.3±0.3 30HEMA 26.0±0.8 
20HEMA 18.3±0.3 30HEMA-7.5TiO2 27.0±0.0 
20HEMA-5TiO2 19.0±0.8 30HEMA-0.5CNT 27.7±0.5 
20HEMA-7.5TiO2 22.7 ±1.7 30HEMA-5SiO2 26.7±0.3 
20HEMA-10TiO2 20.2±0.8 40HEMA 37.8±0.4 
20HEMA-5SiO2 20.9±0.5 40HEMA-7.5TiO2 39.2±0.4 
25HEMA 21.3±0.5   
        Six repeats were done for each sample 
 
2.3.4. Morphological Examination 
The SEM micrographs displayed in Figures 2-5 to 2-9 provide the visible evidence to 
support the results received from the polymer volume fraction study. Obviously, 
hydrogels containing 10wt% HEMA had the most porous structures (Figure 2-5 a). 
The pore size became smaller once the HEMA content was increased to 20% (Figure 
2-6 a). The pores in 25HEMA hydrogels were smaller (Figure 2-7 a). The pore size 
was dramatically reduced when the HEMA concentration was increased to 30wt% 
(Figure 2-8 a) and a further reduction in pores was observed in 40HEMA (Figure 2-
9a). A measurement of the pore size of 20HEMA hydrogel, prepared using a similar 
method was 10-30 µm. However, it is suggested that the channel-like pores can 
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attain up to 70 µm in this hydrogel material (Chirila et al. 1993). Thus, it is a better 
estimation of the porosity of PHEMA hydrogels when results from polymer volume 
fraction and SEM images are used.  
 
Variations in the morphology of the PHEMA hydrogels can be explained using the 
phase separation theory (Seidl et al. 1967; Guyot and Bartholin 1982; Okay 2000). 
When the polymerization process was carried out in a mixture containing a high 
water content (90 wt% for 10HEMA hydrogel), the monomers reacted to each other 
via the crosslinker until reaching a stage at which the amount of unreacted monomers 
was not sufficient to dissolve the growing polymer chains and the system became 
discontinuous, resulting in a phase separation. Thus the porous structure of the 
hydrogel was formed. In the solution in which less water was involved in the 
polymerization process (60 wt% for 40HEMA hydrogel), the phase separation was 
delayed due to the presence of a large amount of monomer, resulting in the formation 
of less porous hydrogels.    
 
In comparison with the blank PHEMA hydrogels, the addition of the 
nanoparticulates had little influence on the porosity of the resultant composite 
hydrogels and its enhanced effect was observed for PHEMA hydrogels containing 
high HEMA contents, including 30 and 40% (Figure 2-8b and 2-9b).    The presence 
of the nanoparticles was well demonstrated in most composite hydrogels.  
 
  
 
Figure 2-5 SEM micrographs of (a) 10HEMA, (b) 10HEMA-7.5TiO2  
 
 
a b 
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Figure 2-6 SEM micrographs of (a) 20HEMA, (b) 20HEMA-5TiO2, (c) 20HEMA-7.5TiO2, (d) 
20HEMA-5SiO2, and (e) 20HEMA-0.5CNT 
c 
a b 
d 
e 
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Figure 2-7 SEM micrographs (a) 25HEMA, (b) 25HEM-3TiO2, (c) 25HEMA-7.5TiO2, (d) 
25HEMA-12TiO2, (e) 25HEMA-0.5CNT,  and (f) 25HEMA-2CNT  
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Figure 2-8 SEM micrographs of (a) 30HEMA, and (b) 30HEMA-7.5TiO2 
 
 
Figure 2-9 SEM micrographs of (a) 40HEMA, and (b) 40HEMA-7.5TiO2  
 
The distribution of TiO2 nanoparticles in a hydrogel, namely 40HEMA-7.5TiO2, is 
displayed in Figure 2-10. The composition of the nanoparticles was verified using 
EDX when the SEM images were taken (Image not shown due to the melting of the 
hydrogel under the beam). From the image in Figure 2-10 a, it can be seen that the 
aggregated nanoparticles were evenly distributed across the sectional surface of the 
hydrogel, though a decrease of TiO2 towards the top surface of the hydrogel was seen. 
This is due to the gravitational sedimentation of the particles during the 
polymerization process. The presence of TiO2 also was confirmed by XRD and is 
shown in the spectra (Figure 2-11), in which typical peaks at 25.2°, 27.4° and 48° 
  
  
b 
b a 
a 
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represent the presence of TiO2 in the hydrogels. It can be noticed that the peak 
locations were shifted in different PHEMA hydrogels, which was caused by 
experimental error (Kishen, George, and Kumar 2006; Nakano et al. 2002). 
 
 
 
 
 
 
 
Figure 2-10 SEM micrographs of the 40HEMA-7.5TiO2 hydrogel with different magnifications; 
the arrow in (a) indicates the top surface of the hydrogel 
a 
b 
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Figure 2-11 XRD spectra showing the presence of TiO2 particles in composite hydrogels 
2.3.5. Calcification Capacity of Hydrogels 
Influence of nanoadditives  
The CaP formation was first investigated using PHEMA composite hydrogels 
containing all three types of nanoadditives. These included 20HEMA-5TiO2, 
20HEMA-0.5CNT, 30HEMA-5SiO2, and 30HEMA-5TiO2. The formation of CaP 
was determined using XRD, and the deposition of hydroxyapatite-like CaP mineral 
was verified using typical peaks at 26° and 32° (Shi et al. 2006). This method has 
been reported in numerous publications (Torres et al. 2007; Miyazaki et al. 2002). 
The XRD results demonstrated that the formation of hydroxyapatite-like CaP was 
much more apparent in the hydrogels containing TiO2 nanoparticles after 21 days 
incubation (Figure 2-12). A small amount of CaP was found on 20HEMA-0.5CNT 
and no apatite formation was observed on SiO2 containing composite hydrogels. The 
capability of inducing CaP formation by TiO2 has been demonstrated by other 
research groups (Gerhardt, Jell, and Boccaccini 2007; Torres et al. 2007). The fibre-
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shaped structure (5-15 µm in length) of CNTs was attributed to the CaP formation on 
the composite hydrogel containing CNTs (Firkowska et al. 2006). However, other 
researchers also have reported slow growth of apatite using CNTs in the composite 
materials, because of their low concentration (Zhang et al. 2009). The lack of 
calcification in the SiO2-containing hydrogels could be due to the low concentration 
silanol groups in comparison to silica gel (Li et al. 1994; Pereira, Clark, and Hench 
1995). Based on these obtained results, further investigations in the following 
chapters will focus only on TiO2-containing PHEMA hydrogels.   
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Figure 2-12 XRD spectra showing the formation of CaP on selected hydrogels after 21 days 
incubation in SBF solution 
 
CaP formation on HEMA-TiO2 composite hydrogels 
10HEMA-7.5TiO2, 20HEMA, 20HEMA-7.5TiO2 and 40HEMA-7.5TiO2 were 
selected for
 
systematic investigation of the CaP formation. The occurrence of the 
CaP was confirmed by FTIR and the results from FTIR are shown in Figure 2-13. 
The FTIR spectrum of 10HEMA-7.5TiO2 before incubation in SBF solution is 
shown in Figure 2-13a. From the spectrum, a number of peaks at 1726 cm−1 (ν, C=O), 
1454 cm−1 (δ, CH2; δ, CH3), 1390 cm−1 (CH2 twist and rock), 1160 cm−1 (νa, C-O-C), 
1075 cm−1 (ν, C-O-C) and 750 cm−1 (ν, -C-O-) were determined, corresponding to 
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PHEMA structure (Huang, Chin, and Yang 2004, 2005; Ji et al. 2003). In 
comparison to the FTIR spectrum of the same material after incubation in SBF 
(Figure 2-13 b), strong absorbance at 564 and 603 cm-1 and between 1000 and 1200 
cm-1 respectively were seen, attributed to the asymmetric bending and stretching 
modes of the phosphate group (Liu, Tao, and Ding 2002; Radin and Ducheyne 1992). 
Similar results have been reported using other types of PHEMA composite hydrogels 
(Costa et al. 2005).  
 
Figure 2-14 shows the XRD spectra of CaP formed on different hydrogels, including 
a porous 20HEMA-7.5TiO2 and a dense hydrogel 40HEMA-7.5TiO2, after (a) 14 and 
(b) 28 days incubation in SBF respectively. Strong peaks at 32° corresponding to 
CaP can be observed from the spectrum of 20HEMA-7.5TiO2 (Figure 2-14a), which 
indicates that much more CaP has been formed on the 20HEMA-7.5TiO2 hydrogel in 
comparison to that formed on the 40HEMA-7.5TiO2. After 28 days incubation, a 
peak at 32° (corresponding to hydroxyapatite-like CaP) became obvious, presenting 
a continuous growth of CaP on both hydrogels. Also, the continuous growth of CaP 
on 20HEMA-7.5TiO2 was shown by the relatively high intensity of the CaP peak in 
comparison to the peaks corresponding to TiO2 (2θ=25.2°). The relative intensity of 
the CaP on 20HEMA-7.5TiO2 was still much higher than 40HEMA-7.5TiO2 after 28 
days incubation.  
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Figure 2-13 FTIR spectra of 10HEMA-7.5TiO2 composite hydrogels (a) before and (b) after 10 
days incubation in SBF 
a 
b 
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Figure 2-14 XRD spectra showing the formation of CaP on selected hydrogels after (a) 14 and 
(b) 28 days incubation in SBF 
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XRD spectra in Figure 2-15 show the growth of CaP in 20HEMA and 20HEMA-
7.5TiO2 at various time points. As can be noticed, there was no CaP formed on 
20HEMA after 14 days incubation, whereas a small amount of CaP was formed on 
20HEMA after 28 days incubation (Figure 2-15 a). However, strong peaks, attributed 
to CaP on the 20HEMA-7.5TiO2 composite hydrogel, were found after 14 days 
incubation, indicating an enhancement of the calcification capability after the 
addition of TiO2 nanoparticles. Continuously increasing amounts of CaP were 
verified, when the incubation time lasted for 28 days, by comparing the relative 
intensity of CaP peaks with that of TiO2 nanoparticles (Figure 2-15 b). 
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Figure 2-15 XRD spectra of (a) 20HEMA hydrogel after 14 days and 28 days incubation in SBF 
(b) 20HEMA-7.5TiO2 hydrogel after 14 and 28 days incubation in SBF 
SEM examination revealed CaP deposits on the composite hydrogel 20HEMA-
7.5TiO2 at as early as day 3 (Figure 2-16a). With the increase in the SBF incubation 
time to day 14 and 28, increased CaP formation also was observed (Figure 2-16b and 
2-16c). A mixture of both singular spherical and the aggregated form of CaP was 
observed. This formation characteristic of CaP also has been reported on other types 
of PHEMA hydrogel (Zainuddin et al. 2006). On day 28, the surface of the TiO2-
containing hydrogel became fully covered with CaP.  
 
 
b 
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Figure 2-16 SEM micrographs of 20HEMA-7.5TiO2 sponge after (a) 3, (b) 14, and (c) 28 days 
incubation in SBF 
b 
a 
c 
 61 
 
The penetration of CaP during the formation process also was examined by SEM on 
the cross-sections of the specimens, (see Figure 2-17). The images demonstrate that 
most CaP formation occurred on the surface closest to the edge of the hydrogels. 
Based on the micron bar of the images, the thickness of the formed CaP layer 
increased significantly from around 30 µm in the control 20HEMA hydrogel, to 70 
µm in the 40HEMA-7.5TiO2 composite hydrogel, and further increased to 120 µm in 
the most porous hydrogel, 10HEMA-7.5TiO2.  
 
 
 
 
 
a 
 
b 
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Figure 2-17 SEM micrographs showing the cross-sectional view of (a) 10HEMA-7.5TiO2, (b) 
20HEMA, and (c) 40HEMA-7.5TiO2 composite hydrogels after 28 days incubation in SBF 
 
The formed CaP on various hydrogel materials after 28 days incubation was stained 
with Alizarin Red S (Lou et al. 2005). The stained CaP layer formed on different 
hydrogels is shown clearly by the orange-coloured layers seen in Figure 2-18. A 
similar trend was found for the thickness of the CaP layer in comparison to the 
previous findings (Figure 2-17). The results show significant enhancement in 
calcification capacity in all PHEMA-TiO2 hydrogels (Figures 2-18b to 2-18d). A 
limited amount of CaP was found in 20HEMA (Figure 2-18 a). Infiltration of 
calcium up to 800-1000 µm was observed in 10HEMA-7.5TiO2 and 20HEMA-
7.5TiO2 (Figures 2-18b to 2-18c). Diffusion of calcium ions was less than 100 µm in 
40HEMA-7.5TiO2 (Figure 2-18d). The rapid infiltration of calcium ions must be due 
to the porous structure of the hydogels. These findings signify that the formation of 
CaP is strongly dependent on the bioactivity of TiO2 nanoparticles.  
 
The estimated thickness values of CaP layers using the staining method is generally 
greater than those from SEM images. This is understandable since the staining was 
carried out using fully hydrated samples whilst the samples examined by SEM were 
dehydrated.  
c 
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Figure 2-18  Light micrographs of (a) 20HEMA, (b) 10HEMA-7.5TiO2, (c) 20HEMA- 7.5TiO2, 
and (d) 40HEMA-7.5TiO2  hydrogels after incubation in SBF for 28 days. The arrows indicate 
the top surface of the hydrogels where the CaP formation and infiltration started. The orange-
red coloured areas represent the thickness of the formed CaP in each hydrogel 
2.3.6. Cell Viability 
A group of composite hydrogels containing 30 wt% HEMA, but with different 
additives (TiO2, SiO2, CNT) was selected to evaluate the influence of the additives 
on cell viability. The results are displayed in Figure 2-19. Results from 30HEMA 
hydrogel and a cell culture plate (TPP, Transadingen, Switzerland) are shown as the 
control. It was clear that no apparent cell growth had occurred after Day 1, 
particularly for the composite hydrogel containing CNT, whereas significant cell 
growth was seen at Day 3. The NIH 3T3 fibroblast cells continued growing and 
proliferating, and the cell numbers increased greatly for all hydrogels. This 
comparison of cell growth on composite hydrogels containing different additives 
showed that 3T3 fibroblast cells proliferate more rapidly on 30HEMA and 
30HEMA-10TiO2 hydrogel than on 30HEMA-10SiO2 and 30HEMA-0.5CNT.  
b 
c d 
a 
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Figure 2-19 In vitro cell viability measured by MTT assay. The optical density values are 
proportional to the numbers of the living cells. (*) indicates there is no significant difference for 
Day 1, (**) indicates results at Day 3, where 30HEMA-10SiO2 and 30HEMA-10CNT are 
significantly different from the Control at the same period of time, but not significantly different 
from the rest of the hydrogels, (***) shows that, at Day 5, 30HEMA-10CNT  is significantly 
different as compared to the Control at Day 5 and the rest of the hydrogel samples, (****) shows 
that, at Day 5, 30HEMA-10 SiO2  is significantly different as compared to the hydrogels 
including 30HEMA and 30HEMA-10TiO2 
 
Figure 2-20 shows the NIH 3T3 fibroblast cell viability as a function of incubation 
time on PHEMA-7.5TiO2 composite hydrogels containing different concentrations of 
HEMA monomer. 20HEMA hydrogel is an United States of America Food and Drug 
Administration (FDA) approved material for ophthalmic implants (Lou, Munro, and 
Wang 2004; Vijayasekaran et al. 2000) and, therefore, is used as a control material. 
The results from the cell culture plate also are shown as a control. No significant 
difference among the materials was observed after Day 1, attributed to the recovery 
of the cells from the culture conditions. Apparent cell growth was demonstrated in all 
hydrogel materials on Day 3. There was no significant difference between the cell 
viability of the control hydrogels and that of the composite hydrogels, 10HEMA-
7.5TiO2, 20HEMA-7.5TiO2 and 40HEMA-7.5TiO2. A reduction of cell growth on 
40HEMA-7.5TiO2 and a significant reduction on 30HEMA-7.5TiO2 were observed 
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on Day 3, which was probably due to the less porous surface structures of these two 
hydrogels (Figure 2-8 and Figure 2-9). The results from the cell culture plate at Day 
3 showed a significant difference among all hydrogel samples.  
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Figure 2-20 In vitro cell viability measured by MTT assay. The optical density values are 
proportional to the numbers of the cells. (*) indicates there is no significant difference for Day 1, 
(**) indicates, at Day 3, 30HEMA-TiO2 is significantly different from the rest of the hydrogels, 
(***) shows that, at Day 3, the control sample is significantly different in cytotoxicity as 
compared to the hydrogel samples 
 
2.4. Conclusions 
Eighteen porous PHEMA composite hydrogels containing various amounts of 
nanoadditives, together with five control PHEMA hydrogels, were successfully 
prepared through a free radical polymerization process in the presence of water.  
 
SEM examinations indicated the presence of macroporous structure in all hydrogels.  
The porous structure of the resultant hydrogels was largely dependent on the amount 
of water used in the polymerisation process. In general, higher water content was 
beneficial for a more porous structure formation. The addition of the additives had no 
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obvious influence on the porosity of the hydrogels containing the same amount of 
HEMA monomer when their concentrations were less than 30%. Therefore, the 
results demonstrated that the macroporous structure of the hydrogel polymers can be 
tuned simply by adjusting the chemical composition of the formula.  
 
A calcification study demonstrated that the calcification capacity of porous PHEMA 
hydrogels can be enhanced significantly using TiO2 nanoparticles. Changing of 
porosity also can improve the ability to enhance and the infiltration capacity of the 
calcium phosphate deposits.  
 
MTT assay has demonstrated that most hydrogels were well tolerated by 3T3 
fibroblast cells. In comparison of cell activities on composite hydrogels containing 
TiO2 nanoparticles, a reduction of cell growth on 40HEMA-7.5TiO2 and a significant 
reduction on 30HEMA-7.5TiO2 were observed on Day 3, which was probably due to 
reduced porous surface structures of these two hydrogels after the incorporation of 
the nanoadditives.  
 
Based on the above results, the TiO2 nanoadditive has been chosen for further 
investigation, including mechanical responses and drug transport properties, for 
following chapters.  
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CHAPTER 3 TENSILE AND RHEOLOGICAL 
RESPONSES OF PHEMA AND PHEMA-TiO2 
COMPOSITE HYDROGELS 
3.1. Introduction 
The focus of this chapter is to evaluate the tensile and rheological responses of 
porous PHEMA and PHEMA-composite hydrogels. The tensile tests were conducted 
using fully hydrated hydrogel specimens according to a standard-D2116 from 
American Society for Testing and Materials (ASTM D2116). Three different 
modules were used in rheological measurements. These include oscillation strain 
sweep, oscillation amplitude sweep, and controlled creep-recovery tests. The 
mechanical properties of the hydrogels were correlated with the structures and the 
compositions of the hydrogels.  
 
The mechanical properties of a tissue scaffold for engineering tissues are of great 
importance. In general, the scaffold should exhibit sufficient mechanical strength to 
maintain the spaces required for cell in-growth and tissue formation. It must also 
provide sufficient temporary mechanical support, matching the mechanical properties 
of the host tissue in order to bear in vivo stresses/strains. Moreover, mechanical 
forces play an important role in the homeostasis, remodelling, and repair of load-
bearing tissues, such as bone and cartilage (Puppi et al. 2010).  
 
A wide range of methods can be used to characterize the mechanical properties of the 
tissue substrates. These include tensile, compressive, and rheological testing methods 
which are often performed directly on bulk materials. AFM-related techniques are 
also used working on small volumes of tissue scaffolds (Engler et al. 2004). Tensile 
tests have been extensively used to characterize the tissue scaffolds, so properties 
including ultimate tensile stress (strain), tensile modulus, Poisson’s ratio, and 
equilibrium relaxation modulus can be obtained. Properties such as aggregate 
modulus, hydraulic permeability, and young’s modulus can be gained though 
compressive tests (Moutos, Freed, and Guilak 2007).  
 
 68 
Rheological test is a one of the commonly used methods for the characterization of 
the viscoelastic properties of soft materials and/or tissues. Properties including 
equilibrium shear modulus, complex shear modulus, and loss angle can be obtained 
(Moutos, Freed, and Guilak 2007). These parameters determine the capability of 
materials to dissipate mechanical energy, covering a few influencing factors, 
including temperature, frequency and shear amplitude. In addition, most of the living 
tissues in the human body exhibit viscoelastic behaviour and thus comprehensive 
characterizations of these living tissues using rheological tests provide criteria for 
designing suitable tissue scaffolds.  
 
Rheological test can be performed using different modules, such as creep, relaxation 
and oscillatory tests. In a creep test, a shear stress is applied onto the materials 
through different loading modes, resulting in a deformation measured as a function 
of time. A recovery segment is normally linked to the creep test, in which the shear 
stress is set to zero. Thus, the resultant deformation from the creep test can recover at 
zero stress level and the recoverable portion of the deformation can be determined 
based on the stress levels.  
 
Oscillatory rheology is the most commonly used technique for understanding the 
structural and dynamic behaviour of materials (Macosko 1994). Two methods in the 
present study, including oscillation strain sweep and oscillation amplitude sweep, are 
based on the oscillatory mode. The principle of oscillatory rheology is to induce a 
sinusoidal shear deformation (γ) in the sample and measure the resultant stress (σ) 
response. Figure 3-1 illustrates a loaded hydrogel sample parallel-plate configuration 
during a test, in which a specimen is placed between two plates and a sinusoidal 
force is applied on the specimen. The shear deformation can then be created onto the 
hydrogel as the force is applied onto the hydrogel sample for a period (t0→t1). At a 
time point (t), the shear strain can be expressed by )sin(0 tωγγ = , where 0γ is the 
shear amplitude, ω  the oscillation frequency. Simultaneously, a stress response from 
the soft sample can be determined by ( ) ( ) ( ) ( ) ( )tGtGt ωγωωγωσ cos"sin' 00 += , in 
which ( )ω'G  is the elastic modulus and ( )ω"G  the viscous modulus. Both moduli 
represent the viscoelastic properties of the material, from which the complex 
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modulus of the hydrogel can be derived using "' iGGG +=∗ . The magnitude of the 
complex modulus G* can be obtained by 22 "' GGG +=∗ . The ratio of viscous 
and elastic modulus, ( )( ) δω
ω
tan
cos
sin
'
"
==
t
t
G
G
 shows the phase shift between two 
modules, where δ is the phase shift. The same principle is applied for the stress 
controlled test. The value of δ  for a soft material lies between that of solids and 
liquids, 0<δ <pi/2.  
 
 
Figure 3-1 Schematic illustration of a loaded hydrogel button in the parallel-plate configuration; 
h is the thickness of the hydrogel, a is radius of the hydrogels, γ is the shear strain, θ is angular 
displacement, H is the gap size and R is the radius of the plate 
 
The oscillation strain sweep test is employed to determine the limit of linear 
viscoelasticity of a material. The test is conducted at constant frequency with varying 
strain amplitude until a particular value, in which a critical point can be found where 
dynamic properties (G', G") remain steady.  The values of G', G" begin to change 
beyond this range. Thus, this point in strain represents the limit of linear 
viscoelasticity. The material displays non-linear viscoelastic behaviour beyond that 
point.  
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The oscillation amplitude sweep is conducted by applying a small sinusoidal strain 
(within the linear viscoelastic range) at a range of frequency. The levels of G', G" 
and δ  at a particular range of frequency are determined.  
 
The G', G" and δ  values, together with other properties including the strength, 
modulus and recovery, allow for correlating the dynamic mechanical behaviour of 
the materials with physiological requirements for tissue substitutes. Understanding of 
these properties is very important for the ultimate usage of the materials as tissue 
engineering scaffolds.  
 
In order to fully understand the mechanical properties of porous PHEMA and 
PHEMA-TiO2 composite hydrogels, the characterizations of tensile and viscoelastic 
properties of the hydrogels were conducted on a series of materials containing 
different concentrations of HEMA and TiO2 nanoadditives.  
3.2. Experimental 
3.2.1. Hydrogel Selection 
Hydrogel polymers selected for this study are listed in Table 3-1. Tensile tests were 
conducted on four composite hydrogels including 10HEMA-7.5TiO2, 20HEMA-
7.5TiO2, 30HEMA-7.5TiO2 and 40HEMA-7.5TiO2. Rheological tests were 
conducted on five composite hydrogels including 25HEMA-3TiO2, 25HEMA-
7.5TiO2, 25HEMA-12TiO2, 30HEMA-7.5TiO2 and 40HEMA-7.5TiO2. Control 
PHEMA hydrogels were also tested using the same methods to investigate the 
influence of the TiO2 nanoparticles on the mechanical properties.  
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Table 3-1 Hydrogels for tensile and rheological tests 
Rheological test 
Hydrogel 
codes 
Tensile test Oscillation 
strain sweep 
Oscillation 
frequency 
sweep 
Creep 
recovery 
10HEMA √    
10HEMA-7.5TiO2 √    
20HEMA √    
20HEMA-7.5TiO2 √    
25HEMA  √ √ √ 
25HEMA-3TiO2   √ √ 
25HEMA-7.5TiO2  √ √ √ 
25HEMA-12TiO2   √ √ 
30HEMA √ √ √ √ 
30HEMA-7.5TiO2 √ √ √ √ 
40HEMA √ √ √ √ 
40HEMA-7.5TiO2 √ √ √ √ 
 
3.2.2. Tensile Tests  
Tensile testing was carried out using a SINTECH 200/M Material Testing 
Workstation (MTS Systems Corporation, USA) (Figure 3-2 a). Dumb-bell shaped 
specimens were cut from fully hydrated hydrogel samples to the dimensions 
recommended by ASTM D2116 (Figure 3-2 b). The working length of the central 
part was 13 mm and the thicknesses of the hydrogels were measured by a digital 
calliper. The movement of crosshead was controlled at a speed of 0.5 mm/s until the 
hydrogel specimen was broken. The measurements were conducted at room 
temperature. The modulus, tensile strength and percentage elongation at break point 
were recorded and average values were taken from five measurements. Mean ± 
standard deviation and the P value were calculated using one-way ANOVA with 
OriginPro (Version 7.5) software and Turkey test. P values <0.05 were considered 
statistically significant. 
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Figure 3-2 (a) SINTECH 200/M material testing workstation and (b) a dumb-bell shaped 
specimen and the sample cutter 
 
3.2.3. Rheological Characterizations 
The rheological properties of the hydrogel specimens were carried out using a 
HAAKE MARS III Modular Advanced Rheometer System (Thermo Electron, 
Germany) with a stainless steel, parallel-plate geometry (Figure 3-3 a). The diameter 
of the plate geometry is 35 mm. Hydrogel specimens were cut from the hydrogel 
sheets into cylindrical disks with a diameter of 16 mm, followed by immersing in 
deionised (DI) water for over 12 hours for equilibrium prior to conducting the 
measurements (Figure 3-3 b). The thickness of the hydrogels (h) was measured using 
a digital calliper. The specimen was loaded onto the centre of the bottom plate of the 
rheometer. A gap size (H) was reached by lowering down the top plate to 0.9 h, 
which results in a compressive strain on hydrogel samples.  
 
Ten percent compressive strain was used to ensure a complete torque transfer. 
Validation experiments were carried out to confirm that there was no interference to 
the testing result in such conditions (3.3.2.). This set-up was used for all rheological 
measurements, including strain sweep oscillation, oscillation amplitude sweep and 
creep-recovery tests. All tests were conducted at 25oC, which was controlled by a DC 
50 thermocontroller. 
b a 
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Figure 3-3 (a) HAAKE MARS III Modular Advanced Rheometer System and (b) hydrogel 
buttons for the rheological tests 
 
Oscillation strain sweep  
The oscillation strain sweep was conducted at a fixed frequency of 1 Hz under an 
increasing shear strain ( 0γ ), increasing from 0.05% to 50%. Elastic (G') and viscous 
(G″) moduli were recorded. Three measurements were conducted for each hydrogel 
formulation. 
 
Oscillation frequency sweep 
The hydrogels were subjected to fixed sinusoidal strain (0.35%) within the 
viscoelastic linear range. Elastic (G') and viscous moduli (G″) were recorded within a 
wide range of frequency, ranging from 0.02 to 20 Hz. Three measurements were 
carried out for each hydrogel formulation. 
 
Creep-recovery test 
The creep-recovery test was measured using a controlled stress method. Two 
different loading modes, Mode A and Mode B, were employed, shown in Figure 3-4. 
b a 
 74 
In loading Mode A, a simultaneous shear stress (40, 75, 125 or 250 Pa) was applied 
onto a hydrogel specimen for 600 s followed by the recovery of the hydrogel that 
was recorded for 600 s after releasing the stress. The recoverable elastic portions 
were calculated. In Mode B, a stress was gradually applied from 0 to a selected value 
(75 Pa or 500 Pa) within 120 s and afterwards the shear stress was released. The 
recovery profile was recorded by shear strain γ as a function of relaxation time t. 
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Figure 3-4 Illustration of the loading Mode A and Mode B applied in the creep-recovery test 
 
3.2.4. Method Validation and Data Corrections 
It should be noted that the values (shear strain) are based on measurements at the 
outer edge of the samples in the parallel plate configuration, where the strain is 
maximal (Instruction Manual, HAAKE MARS; Version 1.1).  Since the diameter of 
the samples is smaller than the plate diameter R, the measured moduli are 
underestimated by a factor of (R/Rsample)4, where R= 17.5 mm and Rsample=8 mm, 
because the stress scales with R as 1/R3, while the strain is proportional to diameter. 
Therefore, the correction factor was 22.9 for elastic and viscous moduli and 0.46 for 
the strain. 
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3.3. Results and Discussion 
3.3.1. Tensile Properties  
Figure 3-5 shows (a) tensile modulus, (b) tensile strength and (c) elongation (%) of 
PHEMA and the composite PHEMA containing 7.5% TiO2. Tensile modulus and 
strength of the composite hydrogels increased significantly with the increase in 
HEMA content in the monomer mixture. This is due to the decrease of porosity of 
the hydrogel materials (Figure 2-7 to 2-9 in Chapter 2). There was an increase in 
tensile strength in most composite hydrogels after the addition of TiO2 particulates. 
The change became more significant in hydrogels containing higher HEMA content, 
such as 40HEMA-7.5TiO2. A drastic reduction of tensile strength was observed for 
20HEMA-7.5TiO2 when compared with its control polymer 20HEMA (Figure 3-5 b). 
Repeated testing on the same hydrogel and those produced in different batches 
yielded similar results. Reasons are unknown. Change in tensile modulus by TiO2 
was insignificant and without an apparent pattern. This was probably due to the large 
pore sizes of the hydrogels and generally low concentration of TiO2 particulates 
incorporated into the hydrogels. 
 
PHEMA hydrogels containing a low HEMA concentration exhibited a greater 
elongation value. The percentage elongation was reduced when HEMA content was 
increased from 10 wt.% to 30 wt.% and then 40 wt.% (Figure 3-5 c). This is due to 
the increased density of the polymer structure that limits the capability of movement. 
For 10HEMA and 20HEMA, the addition of TiO2 decreased the elongation of 
macroporous hydrogels. This could be due to the weakened conjunction force 
between hydrogel chains in the presence of the TiO2 nanoparticles. An increase of 
elongation was observed for 30HEMA and 40HEMA composite hydrogels, which 
was attributed to their less porous structure, which was influenced after incorporating 
TiO2 nanoparticles.  
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Figure 3-5 (a) Modulus, (b) tensile strength and (c) elongation of PHEMA and PHEMA-
7.5TiO2;  in Figure (a) and (b):  (*) indicates no significant difference among 10HEMA, 
20HEMA and their composite, (**) and (***) indicate significant difference for 30HEMA, 
40HEMA and their composite hydrogels;  in Figure (c), (*) indicates significant difference 
between PHEMA and its composite hydrogel 
3.3.2. Viscoelastic Properties 
Shear Strain Influence 
 
Figure 3-6 displays the elastic modulus G' and viscous modulus G″ from oscillation 
strain sweep on (a) PHEMA and (b) PHEMA-7.5TiO2 composite hydrogels 
containing different HEMA concentrations. Hydrogels containing no TiO2 
nanoparticles (Figure 3-6 a) exhibited a linear viscoelastic dependence of up to 15-
25% shear strain, whilst most composite hydrogels showed a linear dependence 
within a range of 1.7-10% (Figure 3-6 b). Hydrogels containing lower HEMA 
content, such as 25HEMA showed a wider range of linear viscoelastic dependence in 
comparison to that of both 30HEMA and 40HEMA hydrogels. This is true for both 
plain and composite hydrogels.  
 
The increased linear viscoelasticity range observed in the hydrogels containing less 
HEMA was attributed to the more porous structure in these hydrogels, which ensured 
better material mobility and stretchability (Stavrouli, Aubry, and Tsitsilianis 2008). 
c 
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The presence of TiO2 nanoadditives can cause some defects in the hydrogels, which 
can be easily broken under shear forces. As a result, reduction in linear range was 
observed for hydrogels, especially in 30HEMA and 40HEMA.  
 
The results also demonstrated that the moduli of the hydrogels were largely 
dependent on HEMA:water ratios in the hydrogels. In PHEMA hydrogels, the elastic 
and viscous moduli were increased from G': 19900 Pa; G″: 1900 Pa to G': 34000 Pa; 
G″: 3300 Pa, when HEMA content was increased from 25 wt.% to 30 wt.%. The 
moduli were further increased to about G':70000 Pa and G″: 7500 Pa for 40HEMA 
hydrogel, indicating an increasing elastic stiffness of the hydrogels as a result of 
increasing HEMA concentrations. The change of moduli in PHEMA-7.5TiO2 
composite hydrogels followed a similar trend as PHEMA hydrogels and there was no 
significant change of the values after incorporating the nanoparticles into the 
hydrogels. The lack of influence of TiO2 addition on the stiffness of PHEMA 
hydrogels was due to the smaller size of the particles.  
 
 
0.1 1 10 100
103
104
105
G
',
 
G
''
 
(P
a
)
Shear strain (%)
 
 
 
 
 G'  (25HEMA)
 G'' (25HEMA)
 G'  (30HEMA)
 G''  (30HEMA)
 G'  (40HEMA)
 G''  (40HEMA)
a
 
 79 
0.1 1 10 100
103
104
105
 Shear strain (%)
G
',
 
G
''
 
(P
a
)
  
 
 G' (25HEMA-7.5TiO2)
 G" (25HEMA-7.5TiO2)
 G'  (30HEMA-7.5TiO2)
 G" (30HEMA-7.5TiO2)
 G' (40HEMA-7.5TiO2)
 G" (40HEMA-7.5TiO2)
b
 
 
Figure 3-6 Strain sweep oscillation results of (a) PHEMA and (b) PHEMA-7.5TiO2 hydrogels 
 
A similar experiment was carried out on 25HEMA composite hydrogels containing 
CNTs. A more apparent increase in moduli in 25HEMA hydrogels containing CNTs 
was observed in comparison to that of blank 25HEMA (Figure 3-7 a). The values of 
the moduli values of the hydrogels are listed in Table 3-2. A significant increase was 
observed as CNTs were added into the hydrogel, while varying concentration of 
CNTs (0.5 and 2%) did not show a significant increase in the moduli, indicating a 
maximum improvement of moduli via the addition of CNTs. The increase of moduli 
in composite PHEMA containing CNTs was attributed to the long fibre structure (5-
15 µm) of the multi-walled CNTs used in the investigations. Figure 3-7 b shows the 
fibre structure of the CNTs using a TEM micrograph.  
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Table 3-2 Elastic and viscous moduli of PHEMA hydrogels at a frequency of 1 Hz* 
Sample codes Elastic moduli (Pa) Viscous moduli (Pa) 
25HEMA 19700 2000 
25HEMA-7.5TiO2 22000 2600 
25HEMA-0.5CNT 29600 4000 
25HEMA-2CNT 31200 3900 
30HEMA 34000 3900 
30HEMA-7.5TiO2 38000 3600 
40HEMA 69000 9100 
40HEMA-7.5TiO2 68000 7100 
         *The results were summarised from strain sweep oscillation tests in the linear range (Figure 3-6).  
 
It should be noted that for both the blank and composite hydrogels, elastic modulus 
G' maintained a higher level than viscous modulus G″ during the whole measurement 
range. This indicates that PHEMA and its composite hydrogels are highly elastic 
materials. 
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Figure 3-7 (a) Strain sweep oscillation results of PHEMA-CNT composite hydrogels and (b) a 
TEM micrograph of CNTs  
Frequency influence  
 
The complex modulus G*and the phase shift tanδ were used to investigate the 
effect of the oscillatory frequency on the viscoelastic properties of the composite 
hydrogels. As shown in Figure 3-8 a, the complex moduli of all hydrogels were 
frequency-dependent. Within the investigated frequency range (0.05-15 Hz), a 
continuous increase of complex modulus is demonstrated with an increasing 
frequency. This is a typical behaviour of strong gel, as described by Clark and Ross-
Murphy (Clark and Ross-Murphy 1987).  
 
The results also show that the hydrogels containing higher HEMA concentrations 
exhibited higher G*values. There was a increase in complex modulus in the 
composite hydrogels in comparison with the blank hydrogel polymers. However the 
influence of TiO2 nanoparticles on G* was less prominent than that of HEMA 
content. When CNTs were incorporated into hydrogels, a more significant increase in 
the complex modulus was observed (Figure 3-9). This is again due to the size of the 
CNTs, which is about 5-15 µm.  
b 
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The influence of frequency change on phase angle tanδ, representing the ratio of the 
viscous (G') and elastic (G″) portion of the viscoelastic deformation behaviour of the 
hydrogels, is displayed in Figure 3-8 b. It was found that the phase angle was 
increased with increasing frequency, indicating a more rapid increase in viscous 
modulus with the increase in the frequency of oscillation.  
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Figure 3-8 (a) Complex modulus G* and (b) tanδ of PHEMA and PHEMA-TiO2 composite 
hydrogels under the influence of frequency 
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Figure 3-9 (a) Complex modulus G*  and (b) tanδ of 25HEMA, 25HEMA-7.5TiO2 and 
25HEMA-0.5CNT hydrogels  
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Compressive strain influence 
It should be noted that the above results were obtained at a 10% compressive strain.  
When a higher compressive strain (15%) was applied to the samples, similar 
responses were observed for the hydrogels. Figure 3-10 shows (a) the G* and (b) 
tanδ at 1 Hz and 0.35% shear amplitude, when two different shear strains were 
applied on the samples. There was no significant change on G* for majority 
hydrogels except 40HEMA hydrogel when the compressive strain was increased 
from 10% to 15%.  As for tanδ, these was no significant change for all the hydrogels 
as different compressive strains were applied.   
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Figure 3-10 (a) Complex modulus G* and (b) tanδ of PHEMA and PHEMA-TiO2 composite 
hydrogels under the influence of compressive strains (*) indicates the significant difference in 
G* between different compressive strains were applied on 40HEMA hydrogel 
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3.3.3. Creep-Recovery Properties 
The creep-recovery test was conducted using two different loading modes as 
described in 3.2.3. Figure 3-11 represents the creep-recovery of a 25HEMA hydrogel 
via loading Mode A, where the selected hydrogels were tested under two different 
shear stresses (75 Pa and 125 Pa), resulting in different levels of deformations. The 
hydrogel recovered to different levels once the stress was released and the recovery 
ratio was dependent on the permanent damage caused by different stresses. Therefore, 
the recovered portion of the hydrogel after different levels of shear stress can be 
calculated to investigate the nonlinear rheological properties of the hydrogels, which 
is important for understanding the materials behaviour in an environment that 
experiences complex force conditions, such as a tissue scaffold. 
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Figure 3-11  Creep-recovery of 25HEMA hydrogels with loading Mode A under different 
loading forces 
 
Listed in Table 3-3 are the test results from HEMA and HEMA composite hydrogels 
that have been examined by the creep recovery method using the Mode A. Most 
hydrogels can recover fully under a small stress (40 Pa). When the stress was 
increased to 75 Pa, the recovery portion of 25HEMA hydrogel was 83.3%, lower 
than that from 25HEMA-3TiO2 and 25HEMA-7.5TiO2 hydrogels (87%, and 86% 
respectively), indicating the addition of TiO2 nanoadditives increased the recovery  
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capability of the hydrogels. All other hydrogels can fully recover under this shear 
stress (75 Pa).   
 
When the stress was increased to 125 Pa, the recovery portions of 25HEMA and 
25HEMA-3TiO2 hydrogel were reduced 72.9% and 77.1% respectively indicating 
the high nonlinear deformation of the hydrogels, while other hydrogels (25HEMA-
12TiO2, 30HEMA, 30HEMA-7.5TiO2 and 40HEMA) were able to fully recover. A 
dramatic decrease in the recovery portion was seen for 40HEMA-7.5TiO2 hydrogel, 
attributed to the damage of the structure from its nonuniform structure after TiO2 
nanoparticles addition.  
 
A high shear stress, 250 Pa, was applied to 30HEMA, 30HEMA-7.5TiO2, 40HEMA, 
and 40HEMA-7.5TiO2 hydrogels. A complete recovery was only observed from 
40HEMA hydrogel and other hydrogels showed different levels of permanent 
deformations, indicating that the porous structure of the hydrogels can be destroyed. 
A dramatically reduced recovery was found for hydrogels containing TiO2 
nanoparticles, which was due to the formation of defects in the polymer structure 
after the addition of the particles into the porous structure.   
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Table 3-3 Percentage recovery of PHEMA and PHEMA-TiO2 composite hydrogels 
 
 
 
 
 
 
 
 
 
 
                 The test results are based on single measurement. 
 
Figure 3-12 shows the creep-recovery of different composite hydrogels when a stress 
(75 Pa) was applied to the specimens via loading Mode B. Different shear strains 
were induced for different hydrogels under the same stress. The value of induced 
shear strain was 5.4% for 25HEMA-7.5TiO2, 2.6% for 30HEMA-7.5TiO2 and 1.5% 
for 40HEMA-7.5TiO2 respectively. The difference in the reduced shear strain levels 
is due to the different stiffness of hydrogels. 30HEMA-7.5TiO2 and 40HEMA-
7.5TiO2 hydrogels fully recovered after the share stress was removed, consistent with 
the results from oscillation strain sweep (Figure 3-6 b). 96% recovery was found for 
25HEMA-7.5TiO2 hydrogel and the loss of minimal water during the loading process 
was attributed to this non-fully recovery. 
 
Recoverable portion (%) 
Sample codes 
40 Pa 75 Pa 125 Pa 250 Pa 
25HEMA NA 83 73 NA 
25HEMA-3TiO2 100 87 77 NA 
25HEMA-7.5TiO2 100 86 87 NA 
25HEMA-12TiO2 100 100 100 NA 
30HEMA NA 100 100 87 
30HEMA-7.5TiO2 NA 100 100 7 
40HEMA NA 100 100 100 
40HEMA-7.5TiO2 NA 100 54 65 
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Figure 3-12 Creep-recovery of PHEMA-TiO2 composite with loading Mode B under a stress of 
75 Pa 
 
When an increased shear stress, τ=250 Pa, was applied to 30HEMA, 30HEMA-
7.5TiO2, 40HEMA and 40HEMA-7.5TiO2 composite hydrogels, increased shear 
strains were observed (Figure 3-13). About 11% shear strains were found for 
30HEMA, 30HEMA-7.5TiO2. The shear strains were about 5% for 40HEMA and 
40HEMA-7.5TiO2 hydrogels. After the stress was released, 40HEMA and 40HEMA-
7.5TiO2 hydrogels demonstrated an almost complete recovery (95%), which was 
attributed to the high stiffness of hydrogels containing higher HEMA concentrations. 
However, higher permanent deformation, 14% and 22% respectively, was found for 
the 30HEMA, 30HEMA-7.5TiO2 hydrogels. The more permanent deformation that 
occurred on 30HEMA-7.5TiO2 hydrogel was because of some defects caused by the 
addition of TiO2 nanoparticles. These defects in the composite hydrogels can be 
easily damaged under the stress. Similar observations can be made for 40HEMA-
7.5TiO2 under a further increased stress (Figure 3-14). 
 
In comparison with the results from loading Mode A, better recovery behaviours 
were found, particularly for hydrogels from loading Mode B. This observation was 
most noticeable for composite hydrogels including 30HEMA-7.5TiO2 and 40HEMA-
7.5TiO2. In loading mode B, a slow loading was applied from the top surface of the 
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hydrogel and therefore the stress on the hydrogel, can be transferred down to the 
whole hydrogel. Thus it was assumed that the deformation of the hydrogel in Mode 
B was more uniform than that for hydrogel under Mode A. In this case, the defects in 
the hydrogels showed better resistance for the strain within. Large stress levels 
(Mode A) can easily destroy the porous structure of composite hydrogels.  
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Figure 3-13 Creep-recovery of PHEMA-TiO2 composite with loading Mode B under a stress of 
250 Pa  
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Figure 3-14 Creep-recovery of 40HEMA and 40HEMA-TiO2 composite with loading Mode B at 
a stress of 500 Pa 
 
3.3.4. Comparison of Mechanical Properties of Hydrogel Materials 
Table 3-4 shows the shear moduli of a series of soft tissues and of some reported 
hydrogel materials for soft tissue engineering applications. The modulus values of 
the tissues were categorized according to their levels, ranging from very soft brain 
and nerve tissues (102-103 Pa), to liver and relaxed muscle tissues (103-104 Pa) and 
further to connective tissues (105-106 Pa). The shear modulus of cartilage tissue is 
reported by Moutos et al within a range from 5×104 to 2.5×105 Pa (Moutos, Freed, 
and Guilak 2007; Vanderhooft et al. 2009). For some soft tissue engineering 
applications, the desirable shear modulus ranges from 2 to 2.5×105 Pa (Agrawal et al. 
2008).    
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Table 3-4 Shear moduli of different tissues and hydrogel materials  
Tissues and hydrogels Shear modulus (Pa) Reference 
Brian, nerves 102-103 (Engler et al. 2006)   
Liver, fat, relaxed muscle,  
breast gland tissue 
103-104 (Vanderhooft et al. 2009)    
*Porous PHEMA and 
PHEMA composite 
hydrogels 
104~105 
 
Current study 
 
Articular cartilage 5×104-2.5×105      (Moutos, Freed, and 
Guilak 2007) 
Dermis, connective  
tissue, contracted muscle 
105-106 (Vanderhooft et al. 2009)    
Eepidermis, cartilage 107-108 (Vanderhooft et al. 2009)    
HYAFF®11 (HA) 1.9×105 ~4.2×105  (Borzacchiello et al. 
2007) 
            * See Table 3-2 and Figure 3-8 for details.  
 
The shear moduli of the hydrogels produced in this study are in the range of 104 and 
105Pa, depending on the HEMA concentrations and the nanoadditives in the 
hydrogels. One can see from Table 3-4 that the materials are very suitable for the 
applications as nerve and muscle tissues. In addition, the values in the PHEMA 
composite hydrogels are very close to the shear modulus of articular cartilage 
reported by the reference (Moutos, Freed, and Guilak 2007). The phase angle of 
PHEMA hydrogels was about 0.10-0.22, which covers the reported phase angle 
value for articular cartilage (~0.17) (Zhu et al. 1993).  
 
The shear moduli of a few commercial hydrogel polymers that are commonly used in 
engineering these tissues are also summarized in Table 3.4. HYAFF®11 is a linear 
derivative of hyaluronic acid obtained by total esterification of carboxyl groups with 
benzyl alcohol and has been investigated for adipose tissue engineering applications. 
The elastic moduli of HYAFF®11 sponges are between 1.9×105 Pa (200-315 µm) 
and 4.2×105 Pa (400-500 µm), depending on the pore sizes (Borzacchiello et al. 
2007).  
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Table 3-5 shows the tensile properties from current study (Figure 3-5), peer reported 
hydrogel materials for soft tissue regeneration and the values of a series of soft 
tissues. In comparison to PHEMA hydrogel fabricated via similar methods, Chirila et 
al. changed the polymerization procedure, resulting in an increase of tensile strength 
(Chirila et al. 1995). Also Liu et al. suggested having NaCl in the polymerization 
media, aiming for a multi-phase separation during the polymerization process. 
Significantly improved tensile modulus also has been seen for the produced PHEMA 
hydrogel (Liu et al. 2000). When photo-polymerization (5 min on each side of the 
mold at 365 nm and an intensity of 4 mW/cm2) was applied to produce porous 
PHEMA hydrogel using poly (methyl methacrylate) (PMMA) microspheres, 
different pore size hydrogel structures with a range of mechanical properties can be 
formed (LaNasa, Hoffecker, and Bryant 2011). Similar range of tensile strength was 
seen comparing to the results from current study. However, significant increased 
tensile modulus was seen, which could stem from their low water contents. 
Comparing with the values of soft tissues, the tensile strength of PHEMA covers 
partial range of arterial tissue and the tensile modulus covers the value for skin tissue. 
It should be noted that the elongation of PHEMA hydrogel produced in current study 
is significantly higher than the reported hydrogel systems, which could be a huge 
advantage in the applicable area. In comparison to hydrogel materials which have 
been popularly applied for the application of soft tissue regeneration, PHEMA 
hydrogel exhibits much high tensile properties (Wang et al. 2011; Temenoff et al. 
2002; Adekogbe and Ghanem 2005). The tensile properties of PHEMA and other 
hydrogel systems in this discussion are all low in comparison to some tissues like 
cartilage.  
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Table 3-5 Comparison of the tensile properties of various PHEMA hydrolgels, soft tissues and other hydrogel systems for soft tissue regeneration 
 
*The valve shown here is aquasi-static modulus which was evaluated within the lowest 75% of the curve prior to reaching the elastic limit 
Polymer/soft 
tissue   
Procedure Specification 
(mm) 
Water 
content 
(%) 
Testing 
conditions 
Tensile 
strength 
(kPa) 
Elastic 
modulus 
(kPa) 
Elongation 
(%) 
Reference 
Photo-polymerized for 5min at 365nm 
and an intensity of mW/cm2 
- 37-46 - ~60-220 ~60-850* - (LaNasa, Hoffecker, and 
Bryant 2011) 
See Chapter 2, Section 2.2.2 for details Porous sponge 60-90 ATSM D2116 
(0.5mm/s) 
Up to 250 ~5-220 ~175-500 Present study           
(Figure 3-5) 
 (1) Three 10h steps heating at 30˚C, 
40˚C, 50˚C or (2) Two steps heating at 
30˚C (6h), followed by 50˚C (15h) 
10×1×1.5 
sponge (pore 
size>10 µm) 
70 Myograph 320 - - (Chirila et al. 1995) 
Porous PHEMA 
Polymerization in a 0.3–0.7 M  NaCl 
solution 
45×6×1.5 40-60 30 mm/min - ~125-250 - (Liu et al. 2000) 
Hydrogel 
systems      /soft 
tissue   
Target tissue 
applications 
Preparation conditions       
Crosslinked 
chitosan 
scaffolds 
Skin tissue 
regeneration 
Non or dimethyl 3-3, dithio bis’ 
propionimidate crosslined crosslinked  
- 6 mm/min <100 ~36-110 ~8-110 (Adekogbe and Ghanem 
2005) 
Collagen-
chitosan 
scaffolds 
- (1) Thermally triggered fabricated 
scaffold;                                                  (2) 
GA cross-linked Col–Chi scaffold 
- 10 mm/min ~85-361 - - (Wang et al. 2011) 
Oligo(poly(ethy
lene glycol) 
fumarate) 
Cartilage 
tissue  
regeneration 
Develoed from different molecular weight 
poly(ethylene glycol) 
- ASTM D638-
98 
(25mm/min) 
~10-25 ~20-90 ~36-80 (Temenoff et al. 2002) 
Arterial tissue - - - - ~100-1000  - 
Intraocular lens - - - - ~2,300 ~5,000 - 
Skin  tissue - - - - ~7600 ~100  
Cartilage tissue - - - - ~27,000 ~10,000 - 
 
(Ramakrishna et al. 
2001) 
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3.4. Conclusions 
Comprehensive evaluation of the tensile and viscoelastic properties on PHEMA and 
PHEMA-TiO2 composite hydrogels were carried out. It was found that tensile 
modulus and strength, and viscoelastic moduli were mainly dependent on 
HEMA:water concentrations in the polymerization mixtures. In general, a high 
HEMA:water ratio facilitated the production of high modulus hydrogels, but a less 
porous microstructure. A low HEMA:water ratio resulted in more porous structure 
that showed a greater range of linear viscoelasticity. All hydrogels exhibited a quick 
recovery, and the full recovery was dependent on stresses, loading modes, the 
addition of the nanoadditive and the porous structures of the hydrogels. Therefore, 
these porous hydrogels have a better adaptivity to a more complex mechanical 
environment. The results demonstrated that the porous PHEMA and PHEMA 
composite hydrogels can be tailor-made for engineering a range of soft tissues.   
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CHAPTER 4 DELIVERY OF BIOMOLECULES FROM 
POROUS HYDROGEL POLYMERS UNDER STATIC 
AND DYNAMIC CONDITIONS 
 
4.1. Introduction 
This chapter focuses on the studies of the biomolecule delivery properties of porous 
hydrogels under both static and dynamic conditions. From previous studies, it is 
understood that drug delivery from macroporous hydrogels in static conditions is 
largely dependent on the porous structure and the drug concentrations in the polymer 
matrices (Lou, Munro, and Wang 2004; Lou, Wang, and Tan 2007; Wang et al. 
2010). Since there are no significant variations in porosity between composite 
hydrogels and the blank PHEMA hydrogels, the latter were used in the current 
investigations. The work in this Chapter is divided into two stages. First, three 
hydrogels, including 20HEMA, 25HEMA and 30HEMA, were selected to deliver a 
model drug, methylene blue (MB), under rheological stimulations, which were 
applied under different shear strains and frequencies. Second, based on results from 
the previous stage, the delivery of three biomolecules, including prednisolone 21-
hemisuccinate sodium salt (PSS), caffeine (CAF) and bovine serum albumin (BSA) 
from 20HEMA hydrogel, was examined under static conditions. The delivery of a 
dual-drug system from 20HEMA and 30HEMA was also investigated. PSS and CAF 
were used for dual-drug delivery. In the end, the relationship between the drug 
release characteristics of PHEMA hydrogels and their compositions, structures and 
the stimulations is then discussed.     
 
Successful delivery of biomolecules is of importance in tissue engineering 
applications and a controlled delivery manner is essential because tissue regeneration 
normally occurs over long time frames (Biondi et al. 2008; Tayalia and Mooney 
2009). These biomolecules include various growth factors and antibiotics (Baldwin 
and Saltzman 1998; Boontheekul and Mooney 2003; Shi et al. 2009; Tessmar and 
Göpferich 2007). Delivery of these biomolecules in a single manner using various 
controlled release strategies within scaffolding materials has been extensively 
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reported. However, in certain circumstances, a single biomolecule is not sufficient in 
type and/or quantity in engineering different tissues, particular for repairing large 
size defects. Therefore, multiple drug delivery is essential and studies on delivery of 
dual-drug have been conducted in a few research groups (Lee et al. 2008; Mandal 
and Kundu 2009; Su et al. 2009).  
 
Static conditions are the most commonly employed means for operating the drug 
delivery investigations. However, a tissue regenerating scaffold needs to adapt to 
habitual physical demands from the tissues within the body (such as compression in 
bone and cartilage, tension in muscle and tendon, and shear force in blood vessels) 
after implantation (Butler, Goldstein, and Guilak 2000). Therefore, the release of the 
biomolecules via the scaffold will be under dynamic conditions instead of static 
conditions. The release profiles of the biomolecules from static and dynamic 
conditions are believed to be different, and this eventually will affect the ultimate 
outcome of the regeneration process. Therefore, a study of dynamic drug release 
under physiological conditions is essential to correlate with that from static 
conditions. The relationship between them enables a complete understanding of the 
difference and thus facilitates the design of an ideal controlled drug delivery system 
for tissue regeneration.  
 
Attention has been paid to the release of biomolecules in response to some 
physiological variables in either chemical (pH, proteins) or physical signals 
(temperature, ultrasound, magnetic field, mechanical) (Kost and Langer 2001). A 
compressive signal consisting of six cycles of compression for 2 min, followed by 
relaxation for 8 min was employed to investigate its influence on controlled drug 
delivery (Lee, Peters, and Mooney 2001; Lee et al. 2000). It was pointed out that the 
effect of mechanical stimuli on the controlled delivery was dependent on the 
interactions of the drug with the polymer scaffolds and the mechanical signals can 
actively trigger the release of interactive drugs. A contrary study investigated drug 
absorbance characteristics in skeletal muscle tissue under controlled dynamic loads, 
both static (0-20%) and cyclic (±2.5% strain, 0-20% mean, 1-3 Hz) (Wu, Minisini, 
and Edelman 2009; Wu and Edelman 2008). The study demonstrated that the 
permeability and drug transport in mechanically active tissues can be influenced by 
the interrelated effect of architectural configuration and functional dynamics.  
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Most tissues in the human body are subjected to various in vivo mechanical loadings 
with the influence of variable frequencies during normal daily activities, which make 
the microenvironment complicated. As a result, the release investigations from either 
static conditions or a simple mechanical stimulation can not represent the real drug 
delivery results occurring in human body once the tissue substitutes are implanted. 
As explained in Chapter 3, rheological testing can be performed in various modes 
and the stresses/strains from these dynamic forces can be used to mimic the 
microenvironment of the tissues in human body. Therefore, a dynamic release 
platform, as established in Chapter 3, can provide these kinds of mechanical 
stimulations and is very useful for studying the biomolecule delivery from tissue 
scaffolds.   
4.2. Experimental 
4.2.1. Drug Selections and Hydrogel Specimens 
Methylene blue (MB) from Unilab (Australia) was used as the model drug in stage I. 
Prednisolone 21-hemissucinate sodium salt (PSS) powder, a very commonly used 
anti-inflammatory drug, and bovine serum albumin (BSA), a biomolecule 
representing large molecular weight proteins, were used for single drug delivery 
studies and both were from Sigma & Aldrich. Caffeine (CAF) was used in 
conjunction with PSS for dual-drug delivery study and was purchased from Ajax 
Laboratory Chemicals (Australia). A bicinchoninic acid assay kit was purchased 
from Sigma & Aldrich for protein assay. The chemical structures and UV-VIS 
spectrum properties of the used drugs are listed in Table 4-1. The evaluation of MB, 
PSS, and CAF was determined by measuring the absorbance at 665 nm, 247 nm, and 
272 nm, respectively using UV-VIS spectrometry. These measured values are well 
consistent with references (Lin, Chiu, and Lee 2005; Chung and Rubner 2002; Lou, 
Wang, and Tan 2007). 20HEMA, 25HEMA, and 30HEMA were prepared according 
to the procedure explained in Chapter 2.  
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Table 4-1 Chemical structures and wavelengths for UV-VIS measurements  
 
Model drug Chemical structure 
Maximum 
wavelength (nm) 
MB 
(Mw= 373.90) 
 
665 
PSS 
(Mw= 482.50) 
 
 
247 
CAF 
(Mw= 194.19) 
 
 
272 
BSA 
(Mw=67000) 
- 
562 
(BCA kit used) 
 
4.2.2. Drug Loading and Drug Loading Level 
Two different concentrations of MB solutions (20 mg/ml and 5 mg/ml), three drug 
solutions including PSS (10 mg/ml), CAF (10 mg/ml), and BSA (10 mg/ml), and 
three dual-drug solutions including PSS(10 mg/ml)-CAF(10 mg/ml), PSS(10 
mg/ml)-CAF(10 mg/ml), and PSS(5 mg/ml)-CAF(5 mg/ml)  were used for different 
delivery systems. The drug loading was conducted using freeze-dried hydrogel 
samples. Each hydrogel specimen was placed into a vial containing 3~5 ml drug 
solution, which was sufficient to allow full hydration of the hydrogel sample. The 
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drug loading was conducted for a minimum of 3 days at ambient temperature, 
ensuring a complete equilibration of the hydrogels. The drug loading level in the 
hydrogel samples was presented using the amounts of the drugs in the loading 
solution taking away the residual amounts of drugs after the loading. The method to 
determine the amounts of drugs in a solution is described in 4.2.4. The drug loading 
levels were then normalized against the weights of freeze dried samples, providing 
comparable values (drug uptake per unit mass) across the variety of hydrogel 
formulations. It should be noted that both the drug loading and drug delivery 
experiment are based on single measurement. The repeatability has been 
demonstrated in previous report and confirmed during method validation stage (Lou, 
Munro, and Wang 2004).   
4.2.3. Drug Delivery Set-ups  
Static drug release  
Figure 4-1 illustrates the experimental set-up for static drug release. A drug loaded 
hydrogel specimen was placed in a container, after being blotted with a wet tissue to 
remove the excessive drug solution. A Teflon disc (Φ17.3×2.5 mm) was then put 
above the top surface of the hydrogel serving as an impermeable barrier. Thus drugs 
can only be released out of the hydrogel sample from the radical direction. Release 
media (11 ml) was poured into the container carefully. The release experiment was 
conducted in an orbital shaker (Chiltern Scientific) at a speed of 50 rpm at room 
temperature. Sampling (200 µl) was done at pre-designed time intervals, which were 
30, 60, 120, 240, 360, 480 min.   
 
 
 
 
Figure 4-1 A set-up for static molecule release study 
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Dynamic drug release  
Dynamic release experiments were conducted on a set-up schematically illustrated in 
Figure 4-2. The set-up was developed from a HAAKE MARS III Modular Advanced 
Rheometer System (Thermo Electron, Germany), from which the rheological 
stimulations were transmitted to the hydrogel specimen. The set-up consists of two 
parts, including a sample part and a circulated part. A parallel-plate geometry was 
employed in the sample part and the plate geometry was kept in a beaker (91 mm in 
diameter). The hydrogel sample was then loaded between the two plates and 50 ml of 
the release medium was added into the beaker. A measurement gap size (90% height 
of hydrogel sample thickness) was reached by lowing down the top plate. The 
circulated part was connected with an external magnetic stirring. The mixing process 
using a pump ensures the homogeneity of the solution in the test. The dynamic drug 
release started whist the rheological stimulation was applied. Sand paper on both 
plates was applied to prevent slipperiness. Sampling (200 µl) was taken every 30 min 
up to 420 min.  
 
 
Figure 4-2 Schematic illustration of the set-up for biomolecule delivery study under dynamic 
stimulations 
4.2.4. Drug Quantification 
A GBC 916 UV-Visible (UV-Vis) Spectroscopy was used to quantify the drugs in an 
unknown solution which can be a sample containing released drugs or a sample from 
a drug loading solution. A maximum wave length was first selected depending on the 
drugs involved in the experiment. A calibration curve was established based on a 
series of known concentration solutions and the UV absorbance at the maximum 
wavelength. The concentration of an unknown solution was then calculated based on 
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its absorbance using the calibration curve. Details of drug quantification on each of 
the single and dual drug systems are given below.   
 
Bovine serum albumin (BSA) 
A bicinchoninic acid protein assay kit (Sigma-Aldrich) was used to evaluate the BSA 
release at different time intervals. The procedure of using the assay kit was according 
to the manufacturer's instructions. Basically, 0.1 ml BSA containing samples were 
mixed with 2 ml of BCA working reagent, followed by thorough mixing. The mixed 
samples were then incubated at 60°C for 15 min. The absorbance of the solutions 
was measured at the maximum wavelength of 562 nm. A UV-VIS spectrum of a 
BSA solution at a concentration of 600 µg/ml pre-treated with the BCA kit is shown 
in Figure 4-3, showing the maximum absorbance of the samples. The amount of 
released BSA was then determined by comparison the absorbance obtained with the 
standard curve prepared using a series of BSA solutions. The standard curve is 
shown in Figure 4-4.  
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Figure 4-3 An UV-VIS spectrum of BSA solution at a concentration of 600 µg/ml pretreated 
with a BCA kit 
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Figure 4-4 A standard curve of BSA solution at a wavelength of 562 nm 
 
MB 
The maximum wavelength used for the UV-VIS measurement of MB is 665 nm 
(Figure 4-5). A standard curve was established using a series of MB solutions 
(Figure 4-6). The retrieved sample solutions at different time points were diluted to a 
proper concentration and then measured using a GBC 916 UV-VIS spectroscopy. 
The concentration of the solution was then determined using the established standard 
concentration–intensity calibration curve taking into consideration the dilution 
factors.  
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Figure 4-5 An UV-VIS spectrum of MB solution at a concentration of 5 µg/ml 
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Figure 4-6 A standard curve of MB at a wavelength of 665 nm 
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PSS, CAF, and the combined PSS-CAF 
 
The maximum wavelengths are 247 nm and 272 nm for PSS and CAF respectively. 
Standard curves were established using a series of known concentrations of PSS and 
CAF solutions respectively. Two standard curves at both 247 nm and 272 nm 
wavelengths were obtained for each drug (Figure 4-7 and Figure 4-8).  
 
For the single release of PSS or CAF, the retrieved sample solutions at different time 
points were diluted to a proper concentration and then measured using a GBC 916 
UV-VIS spectroscopy. The concentration of the solution was then determined using 
the established standard concentration–intensity standard curve taking into 
consideration the dilution factors. The standard curve from the maximum absorbance 
was used to determine the single release of PSS and CAF. 
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Figure 4-7 Standard curves of PSS at both 247 nm and 272 nm wavelengths 
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Figure 4-8  Standard curves of CAF at both 247 nm and 272 nm wavelengths 
Figure 4-9 shows spectra of three solutions, including A (PSS, 10 µg/ml), B (CAF, 
10 µg/ml), and a dual-drug solution C containing both PSS and CAF of the same 
concentration (10 µg/ml). D was an imaginative solution synergising A and B.  C and 
D were almost the same, indicating that there was no interference between CAF and 
PSS at the investigated concentration. 
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Figure 4-9 UV-VIS spectra for a dual-drug and two single drug solutions 
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More solutions were examined at 247 nm and 272 nm, respectively. The absorbance 
of the dual-drug and each of the single drug solutions are listed in Table 4-2. It can 
be seen clearly that the absorbance of the dual-drug solution was a simple synergic 
result of the absorbance of the two individual drug solutions at the same wavelength. 
No interference between the two drugs was observed. Therefore, the following 
equations can be established (Equation 4-1).   
 



+=
+=
CAF
272
PSS
272272
CAF
247
PSS
247247
  
  
AAA
AAA
Total
Total
                                        (4-1) 
From Figure 4-7, 
 0035.00306.0 PSS247 += PSSCA                               (4-2) 
0004.00162.0 PSS272 −= PSSCA                               (4-3) 
From Figure 4-8, 
0013.00142.0 CAF247 −= CAFCA                               (4-4) 
0029.00502.0 CAF272 += CAFCA                               (4-5) 
 
Where TotalA247  and 
TotalA272  represent the absorbance of a dual drug solution at 247 nm 
and 272 nm respectively; PSS247 A  and 
PSS
272 A  represent the contribution of PSS to the 
absorbance at the specified wavelength. Similarly, CAF247 A  and 
CAF
272 A  represent the 
contribution of CAF to the absorbance at the two maximum wavelengths.  
 
Substitute PSS247 A , 
PSS
272 A , 
CAF
247 A , and 
CAF
272 A in Equation 4-1 with equations (4-2) to (4-
5), Equation 4-6 is obtained, from which PPSC  and CAFC can be determined with the 
measured TotalA247 and 
TotalA272 . 
 



++=
++=
025.00502.00162.0
0012.00142.00306.0
272
247
CAFPSS
Total
CAFPSS
Total
CCA
CCA
                     (4-6) 
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Table 4-2 UV-Vis absorbance of PSS, CAF, and combined PSS and CAF solution, confirming no 
interference from each of biomolecule 
 
 
4.3. Results and Discussion 
4.3.1. Drug Loading Level 
Drug loading levels for PHEMA hydrogels are presented by the weights of drugs in 
the hydrogel samples and then these values were normalised against the weights of 
freeze dried hydrogels (Table 4-3). The influence of hydrogel formulations on the 
mass of drugs per unit mass of hydrogels was apparent. When a MB solution (20 
mg/ml) was used for drug loading, 20HEMA had the largest quantity of MB per unit 
mass (93~108 mg/g) and the lowest quantity of MB per unit mass of the hydrogel 
was found for 30HEMA (30~42 mg/g). The significant difference for two hydrogels 
was due to the various porous structures, which was demonstrated in Chapter 2 using 
SEM micrographs and polymer volume fractions (Figure 2-6, 2-7, and 2-8; Table 2-
3). The MB mass uptake per unit mass of the hydrogel can also be significantly 
affected by the concentrations of the drug loading solutions. When a MB solution (5 
mg/ml) was used for the drug loading, a drastic decrease in the MB mass uptake per 
unit mass of dry 20HEMA hydrogel was noticed (20 mg/g). Similar results were 
Solutions A247 A272 Solutions A247 A272 
A1(10 µl/ml PSS) 0.3148 0.1675 A2(20 µl/ml PSS) 0.6018 0.3222 
B1(10 µl/ml CAF) 0.1447 0.5169 B2(20 µl/ml CAF) 0.2829 1.0128 
C1( 10 µl/ml PSS,  
10 µl/ml CAF) 
0.4501 0.6758 
C2( 10 µl/ml PSS, 
10 µl/ml CAF) 
0.4483 0.6792 
 A247 A272  A247 A272 
A3(14 µl/ml PSS) 0.4215 0.2247 A4(6 µl/ml PSS) 0.1884 0.1010 
B3(6 µl/ml CAF) 0.0872 0.3123 A4(14 µl/ml CAF) 0.2005 0.7155 
C3 ( 14 µl/ml PSS , 
6 µl/ml CAF) 
0.5070 0.5364 
C4( 6 µl/ml PSS , 
14 µl/ml CAF) 
0.3831 0.8118 
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obtained when PSS and CAF were used in combination for drug loading. For 
example, when a dual-drug solution containing PSS (10 mg/ml) and CAF (10 mg/ml) 
was used, drug uptake levels (54 mg/g for both drugs) were achieved. The drug 
uptake level of CAF was decreased to 27 mg/g when the concentration of CAF in the 
solution was decreased to 5 mg/ml, whereas there was no change in the drug uptake 
level for PSS. The mass uptake of different drugs per unit mass of 20HEMA 
hydrogel, PSS (60 mg/g), CAF (53 mg/g), and BSA (49 mg/g) was attributed to the 
difference of their molecule weights.  
 
Therefore, the porous structure and the polymer volume fraction of the hydrogel 
determine the drug uptake levels of these hydrogel materials. On the other hand, the 
drug loading level can be adjusted to a high degree when a high concentration drug 
solution was used. Finally, different drug uptake levels can be obtained when 
different drugs were applied. 
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Table 4-3 Information for biomolecule loading and delivery study 
Mass of molecules per gram of hydrogel (mg/g) Hydrogel 
codes 
Stock  
solutions for 
loading 
Concentrations 
 In the stock solutions 
(mg/ml) MB  PSS  CAF BSA 
Experimental conditions for 
biomolecule delivery 
20HEMA 20 93 - - - f=0Hz; γ=0%, 
20HEMA 20 108 - - - f=1Hz; γ=5%,  
20HEMA 20 106    f=5Hz; γ=5%  
20HEMA 5 20 - - - f=1Hz; γ=5%  
25HEMA 20 76 - - - f=1Hz; γ=0.5%  
25HEMA 20 66 - - - f=1Hz; γ=5%  
25HEMA 20 69 - - - f=15Hz; γ=5%  
25HEMA 20 45 - - - f=0Hz; γ=0%, 
30HEMA 20 30 - - - f=0Hz; γ=0%, 
30HEMA 
MB  solutions 
20 42 - - - f=1Hz; γ=5% 
20HEMA CAF (10) - - 53 - Static 
20HEMA PSS (10)  - 60 - - Static 
20HEMA 
Single 
biomolecule 
solutions BSA (10)  - - - 49 Static 
20HEMA PSS (10)–CAF(10) - 54 54 - Static 
20HEMA PSS (10)–CAF(5) - 53 27 - Static 
30HEMA 
Dual 
biomolecule 
solutions PSS (5)–CAF(5) - 16 17 - Static 
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4.3.2. Dynamic MB Release 
Hydrogel Formulation Effect  
 
The relative MB release profiles from 20HEMA, 25HEMA, and 30HEMA hydrogels 
under a same rheological stimulation (f=0 Hz; γ=0%) are displayed in Figure 4-10. 
About 65% MB was released from 20HEMA within 420 min. In the same period of 
time, 43% was released from 25HEMA and only 28% released from 30HEMA 
hydrogel. The difference in relative release rate of these hydrogels is mainly due to 
variations in the pore size and polymer volume fraction of these materials, which has 
been reported by other researchers (Lee and Lin 2002). In addition, it has also been 
reported that increasing the pore size and its volume fraction of pores in the hydrogel 
can lead to a significant improvement of drug release (Tamagawa, Popovic, and Taya 
2000; Falk, Garramone, and Shivkumar 2004). According to the results discussed in 
Chapter 2 (Figures 2-6, 2-7, 2-8 and Table 2-3), 20HEMA is the most porous, 
followed by 25HEMA and 30HEMA among these three hydrogels. Therefore, the 
highest relative release was observed for 20HEMA hydrogel, and the lowest relative 
release was seen for 30HEMA hydrogel. 
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Figure 4-10 Relative MB release from PHEMA hydrogels at f=0 Hz; γ=0% 
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Figure 4-11 shows (a) the relative MB release and (b) the released amount of MB 
from three hydrogels, including 20HEMA, 25HEMA, and 30HEMA, under the same 
rheological stimulation (f=1 Hz; γ=5%). 20HEMA and 25HEMA hydrogels showed 
similar release profiles during the whole release procedure, and eventually about 
41% MB was released from both hydrogels. 30% relative release was observed for 
30HEMA hydrogel. The similar relative release of MB from 20HEMA and 
25HEMA hydrogels was attributed to the similar porous structure (Figure 2-6a and 
2-7 a). The dramatic decrease in pore size of 30HEMA hydrogel resulted in a slow 
relative release of MB via 30HEMA hydrogel.  In comparison to the release with no 
stimulation, the relative release of MB from 20HEMA under the rheological 
stimulation was dramatically reduced, while no significant change was observed for 
both 25HEMA and 30HEMA hydrogels. The reduced relative release in 20HEMA 
hydrogel was probably caused by reabsorption of MB into the porous structure under 
the stimulation.  
 
The released amounts of MB from three hydrogels are displayed in Figure 4-11 b. 
Large amounts of MB were released from 20HEMA and 25HEMA hydrogels in 
comparison to that of 30HEMA hydrogel, which showed the lowest released amount 
of MB. The amount from 20HEMA hydrogel was higher than that from 25HEMA. 
This difference was caused by the different relative release in addition to the loading 
level difference when a certain concentration of MB solution was selected.  
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Figure 4-11 Dynamic release of MB from PHEMA hydrogels at f=1 Hz; γ=5%.  The figures 
show (a) relative MB release and (b) released MB amount at various time points 
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Drug loading level effect 
 
Figure 4-12 shows (a) the relative MB release and (b) the released amount through 
20HEMA hydrogels under a rheological stimulation (f=1 Hz; γ=5%). 20HEMA 
hydrogels were previously loaded using 5 mg/ml and 20 mg/ml MB stock solutions, 
resulting in different MB uptake per unit mass of hydrogel (20 mg/g and 108 mg/g), 
respectively. Similar relative release profiles were observed for both hydrogels 
(Figure 4-12a). However, the released amounts of drugs from the two discs were 
dramatically different (Figure 4-12b). This indicates that the relative release system 
is independent of the amounts of the drugs in the hydrogels, which were obtained 
using different concentrations of MB stock solutions. A similar conclusion was also 
obtained for other hydrogel delivery systems (Gayet and Fortier 1996). In this case, 
the amounts of the drugs can be adjusted by the concentrations of the loading 
solutions to meet the requirements for different therapeutic purposes.  
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Figure 4-12 Dynamic release of MB from 20HEMA hydrogels at f=1 Hz; γ=5% loaded with 
different concentrations of MB solutions. The figures show (a) relative MB release and (b) 
released MB amount at various time points 
 
Effect of shear strain 
 
Figure 4-13 shows the relative MB release through 25HEMA hydrogel under two 
different shear strains, including 0.5% and 5%. The static release profile is included 
in the figure for comparison. The relative MB release consisted of an initial eluting 
release, followed by a slow release. Similar release behaviours were seen for both 
strains in the initial release within 150 min and then a higher relative MB release was 
observed under 5% stimulation. After 420 min, 35% MB was released from 
25HEMA hydrogel at 0.5% shear strain, which was increased to 42% at 5% shear 
strain. A higher relative release was found under the static condition than for those 
from dynamic conditions due to the reabsorption of MB into the hydrogel. However, 
the release profile became very similar to that of the static condition when the 
dynamic conditions became vigorous.  
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Figure 4-13 Dynamic MB release from 25HEMA hydrogel at f=1 Hz under different shear 
strains. The static release profile was used for comparison     
 
Effect of frequency 
 
The influence of frequencies on the relative release of MB from 25HEMA (1, 15 Hz) 
and 20HEMA (1, 5 Hz) hydrogel at a shear strain of 5% is displayed in Figure 4-14 
and 4-15. Higher relative release was noticed under the higher frequency for both 
hydrogels. However, the impact of the frequency change on the relative release was 
greater to 20HEMA than to 25HEMA. Again reabsorption of MB into the hydrogel 
resulted in lower relative release of MB from the hydrogel under a mild dynamic 
condition. The relative release was increased as the dynamic condition became 
vigorous. The reabsorption was quicker for 20HEMA hydrogel due to its more 
porous structure. Thus, the relative release for 20HEMA under both dynamic 
conditions was much lower than that of static conditions.  
 
 116 
0 100 200 300 400 500
0
10
20
30
40
50
 
 
 Static release (45 mg/g) 
 1 Hz (66 mg/g)
 15 Hz (69 mg/g)R
e
la
tiv
e
 
re
le
a
se
 
(%
)
Time (min)
 
Figure 4-14 Dynamic MB relative from 25HEMA hydrogels at γ=5% under different 
frequencies. The static release profile was used for comparison    
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Figure 4-15 Dynamic MB relative from 20HEMA hydrogels at γ=5% under different 
frequencies. The static release profile was included for comparison    
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4.3.3. Release Profiles of Various Biomolecules 
When various biomolecules were used, the release profile changed significantly 
depending on molecule weights of the biomolecules and the drug type. Figure 4-16 
shows the relative release of PSS, CAF, and BSA from 20HEMA hydrogel under 
static release conditions. At 480 min, the released biomolecules are 63%, 56% and 
41%, respectively, although the drug uptake levels are similar for all of them. The 
drug uptake levels were 60 mg/g (PSS), 53 mg/g (CAF), and 49 mg/g (BSA).  
 
The release of the drugs through 20HEMA hydrogel is diffusion-controlled, and 
therefore the concentration gradient is the driving force for the release of the three 
drugs (Wang et al. 2010). A few factors, including pore volume fraction, pore size of 
the hydrogel, molecule weight of the biomolecules, and the type and strength of 
interactions of the drug with the polymer chains that make up the hydrogel network, 
are generally believed to influence the release of a biomolecule from a hydrogel 
sample (Fu and Kao 2010; Brazel and Peppas 1999). Since the hydrogel matrix is the 
same for all the biomolecules, the release rates of these molecules are largely 
determined by the molecular size, drug types, and the interactions between drug and 
the hydrogel matrix. From the perspective view of molecule size, the slowest release 
rate is found for BSA (Mw=67,000), followed by PSS (Mw=482.50) and then CAF 
(Mw=194.19). Given the similar molecular size of PSS and CAF, higher release 
level found in CAF could be due to the hydrophobic character of CAF and less 
solubilisation within the hydrophilic PHEMA gel matrix, which has been also been 
found in delivery of different drugs using PHEMA hydrogel (Hong et al. 2010; Ei-
Arini and Leuenberger 1995; Lee and Lin 2002). In addition, larger interaction 
between PSS with PHEMA hydrogel chains than that between the CAF and PHEMA 
chains can result in difference in the relative release (Lee and Lin 2002).  
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Figure 4-16 Relative release of PSS, CAF, and BSA from 20HEMA hydrogels under static 
conditions  
A dual drug system containing PSS (54 mg/g) and CAF (54 mg/g) was investigated 
using 20HEMA hydrogel. The release profile of each compound is shown in Figure 
4-17. The relative release of each compound was 61% for CAF and 57% for PSS 
after 480 min and there was small range of difference in the relative release 
percentages as compared with those from single drug delivery systems (Figure 4-16). 
This lack of difference in the relative release of PSS and CAF in the dual-drug 
delivery system is due to the macroporous structure of 20HEMA hydrogel. In 
addition, lack of intermolecular interactions between the two drugs also led to the 
appearance of this release characteristic. A similar measurement was conducted 
using 20HEMA hydrogel loaded with PSS (53 mg/g) and CAF (27 mg/g). Similar 
relative release profiles for both drugs were observed in this case (data not shown); 
whilst the released amounts of two single drugs at different time points were 
significantly different due to low loading level of CAF in the hydrogel (Figure 4-18). 
7.2 mg PSS and 4 mg CAF were released from 20HEMA hydrogel after 480 min. 
Therefore, the amounts of drugs released at a particular time can be properly 
controlled by the amount of drugs loaded in the matrix. This is particularly useful in 
a delivery system where various therapeutic levels are required for different drugs.   
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Figure 4-17 Relative releases of PSS and CAF from 20HEMA hydrogel in a dual biomolecule 
system under static conditions  
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Figure 4-18 Released amounts of PSS and CAF from 20HEMA hydrogel in a dual biomolecule 
system under static conditions  
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It has been demonstrated that the relative release of PSS and CAF from a 
macroporous structure hydrogel (20HEMA) did not show significant difference in 
their single and dual-drug release systems. 30HEMA, a much less porous hydrogel, 
was then used to investigate the release of the same two drugs. 30HEMA hydrogel 
was loaded with PSS (16 mg/g) and CAF (17 mg/g) and the relative release of the 
drugs is presented (Figure 4-19). It was found that the relative release CAF was 
much higher than that of PSS during the whole release period, which can be 
attributed the small size of CAF, its hydrophobic and less solubilisation 
characteristics, and its week interaction between PHEMA hydrogel (Lee and Lin 
2002). As such, a high amount of CAF was released from the hydrogel during the 
period due to its high transportable capability and high loading level (Figure 4-20).  
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Figure 4-19 Relative release of PSS and CAF from 30HEMA hydrogel in a dual biomolecule 
system under static conditions 
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Figure 4-20 Released amounts of PSS and CAF from 30HEMA hydrogel in a dual biomolecule 
system under static conditions 
 
4.3.4. Release mechanism studies 
In order to understand the release mechanism of different PHEMA hydrogels, power 
law, developed by Ritger and Peppas et al. (Equation 4-7) is used to analyse the 
results from current study (Siepmann and Peppas 2001; Peppas et al. 2000 ; Ritger 
and Peppas 1987). It is reported that the molecular diffusion in a matrix can be 
significant influenced by a mechanical force and its impact on transport kinetics 
could be much beyond molecular diffusion alone (McCarthy, Soong, and Edelman 
1984). Thus, this data analysis is carried out on the static release experiments from 
the current work (Section 4.3.3. in Chapter 4). The principle has been extensively 
used by other researchers for such a purpose and the materials include PHEMA 
hydrogel and other macroporous hydrogel materials (De La Torre, Torrado, and 
Torrado 2003; Lu and Anseth 1999). 
nt ktM
M
=
∞
                                                       (4-7) 
Here, Mt and M∞ are the absolute cumulative amount (%) of the drug release at 
time t (min) and at infinite time. n is a diffusional exponent, indicating the 
mechanism of the hydrogels. k is the apparent release rate (%/min) and it is a 
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constant incorporating structural and geometric characteristics of the delivery 
devices. For a cylinder geometry sample, when the exponent n=0.89 in Equation 4-
7, the drug release rate is independent of time. This corresponds to zero-order 
release. When the exponent n=0.45 in Equation 4-7, it corresponds to Fickian 
diffusion release. The n values between 0.45 and 0.89 indicate non-Fickian 
diffusion. This equation is applicable for 
∞
M
M t <0.6. 
 
Figure 4-21 shows the plots of ln(Mt/M∞) against lnt for different drugs release 
from 20HEMA hydrogel. This data analysis were done based on the data shown in 
Figure 4-16.  It can be seen that a good linearity is shown for each release, 
indicating that the power law equation is applicable to current release systems.  As 
can be seen, the diffusional exponents (n), shown in Table 4-4 for all the molecules 
delivery were greater 0.45, indicating the release of these three molecules from 
20HEMA followed non-Fickian behavior. In addition, the diffusional exponent 
shows an increasing trend as the molecule size increases, showing a consistent 
result from other report (Brazel and Peppas 1999). The diffusional exponent 
increased from 0.52 (CAF: Mw=194.19) to 0.86 (BSA: Mw=67000). No significant 
difference of diffusional exponent between small molecules (CAF and PSS) and 
large molecule (BSA) can be attributed to solute convection during the diffusional 
release process from macroporous 20HEMA hydrogel (Peppas and Lustig 1986; 
Lou, Munro, and Wang 2004).  The power law has also been applied for dual-drug 
delivery systems (Ma, Tu, and Zhang 2010; Wei et al. 2009). Thus, the dual-drug 
delivery results of release exponent (n), rate constant (k), and correlation coefficient 
(R2) following linear regression from Figure 4-17, Figure 18 (Only released 
amounts results are reported in the thesis)  and Figure 4-19 were evaluated using the 
equation and the results also are displayed in Table 4-4. When 20HEMA hydrogel 
was used for the dual-drug delivery, the diffusional exponents for both drugs were 
greater than 0.45, indicating non-Fickian behavior. In addition, as the drug loading 
level was reduced (PSS (53 mg/g) and CAF (27 mg/g)), the PSS release rate was 
decreased from 1.83 to 0.75 (PSS) and CAF release rate was decreased from 2.16 to 
1.1. This deduction in the release rates indicates a less control of the release kinetics 
from drug diffusion for 20HEMA hydrogel. It has been observed previously (Kim 
1998). However, as the pore size dramatically decreased seen for 30HEMA 
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hydrogel, the diffusional exponents for both drug were 0.46 and 0.47 respectively, 
indicating a non-Fickian diffusion release. But the values were close to the 0.45, 
which corresponds to Fickian diffusion. In comparison of the release rate constant, 
k for different conditions, it is noticed that CAF experienced a much higher release 
rate than that of PSS and BSA, which can be attributed to hydrophobic, weak 
interactions with PHEMA hydrogel and less solubilisation characteristics of CAF as 
discussed before (Hong et al. 2010).  
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        Figure 4-21 Plots of ln(Mt/M∞) against lnt for different drugs release from 20HEMA 
hydrogel 
 124 
Table 4-4 Release exponent (n), rate constant (k), and correlation coefficient (R2) following 
linear regression for static drug delivery experiments 
Release 
type 
Hydrogel 
code 
Drug 
Drug uptake 
level (mg/g) 
Release 
exponent, n 
Rate 
constant, 
k  
Correlation 
coefficient (R2) 
20HEMA BSA 49 0.86 0.24 0.97 
20HEMA PSS 60 0.75 0.62 0.97 
Single 
drug 
release 
20HEMA CAF 53 0.52 2.71 0.98 
PSS 54 0.56 1.83 0.97 
20HEMA 
CAF 54 0.54 2.16 0.98 
PSS 53 0.71 0.75 0.98 
20HEMA 
CAF 27 0.66 1.1 0.98 
PSS 16 0.47 1.67 0.99 
Dual-
drug 
release 
30HEMA 
CAF 17 0.46 2.53 1.00 
 
4.4. Conclusions 
The delivery of a model biomolecule, MB, and three different biomolecules, 
including PSS, CAF, and BSA, from porous hydrogels was investigated under static 
and dynamic conditions. Delivery of single and dual biomolecule was investigated.  
 
In the single biomolecule release, increasing the frequency and the shear strain of the 
stimulations enhanced the relative release of the biomolecule. However, the relative 
release of the biomolecule was slowed by the application of mechanical stimulations 
due to the reabsorption of the biomolecule into the hydrogel matrix in comparison to 
that seen for static conditions. The release profiles of the biomolecule were 
significantly affected by the porous structure of the hydrogels, molecule weights of 
the biomolecules, and the character of the biomolecule. In general, a more porous 
hydrogel demonstrated a higher relative release profile than that seen for a less 
porous hydrogel. A higher relative release was found for biomolecules with smaller 
molecule weights. A quicker release of CAF in comparison to PSS was attributed to 
its hydrophobic and less solubilisation characteristics. Analysis of the data obtained 
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from static conditions showed that the release the various biomolecules from 
20HEMA follows non-Fickian diffusion.     
 
PSS and CAF were used for a dual biomolecule delivery system. It was found that 
the delivery profiles of each of the biomolecules were the same as the single 
biomolecule delivery profile. No significant difference was found in the relative 
release profiles of PSS and CAF from macroporous 20HEMA hydrogels containing 
different loading levels of each component. However, the released amounts of the 
each component (PSS or CAF) were significantly dependent on its loading level. For 
example, the relative release of PSS and CAF was observed similar for two different 
loading levels-(PSS: 54 mg/g; CAF: 54 mg/g) and (PSS: 53 mg/g; CAF: 27 mg/g), 
while the released amount of CAF in the latter drug loading level was significantly 
deducted from 8.7 mg to 4 mg. The relative release of an individual biomolecule 
from a dual biomolecule delivery system was also affected by the pore structures of 
the hydrogels, the molecule weights of the biomolecules, and the interactions 
between the molecule and hydrogel. Analysis of the data obtained from dual 
biomolecule release showed that the drug release from 20HEMA behaviours non-
Fickian, and that from less porous 30HEMA is close to Fickian diffusion. It should 
be noted that the loading level of each biomolecule can be adjusted simply by 
changing the concentration of the component in the solutions. Therefore, adjusting 
the concentrations of each biomolecule can be used to administer proper amounts in 
order to reach clinical levels for the regeneration of tissues.   
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CHAPTER 5 CELL ACTIVITIES IN PHEMA AND 
PHEMA-TiO2 COMPOSITE HYDROGEL SCAFFOLDS 
 
5.1. Introduction 
The focus of this chapter is to investigate the cell activities in PHEMA and PHEMA-
TiO2 composite hydrogels after the hydrogels were modified using an 
OVICOLL®CLEAR collagen solution. From the cell viability assay results in 
Chapter 2, we know that: (1) both PHEMA and PHEMA-TiO2 composite hydrogels 
are not toxic to the mouse 3T3 fibroblast cells; (2) the cell growth on hydrogels 
containing more porous structures, such as 10HEMA and 20HEMA, is more rapid 
than less porous structures; and (3) the addition of nanoadditives to the porous 
PHEMA hydrogels has little influence on the cell adhesion or growth. However, in 
comparison to the cell growth on the tissue culture plates (TPP, Trasadingen, 
Switzerland), the cell growth on both PHEMA and PHEMA composite hydrogels is 
relatively slow (Figure 2-19 & Figure 2-20). For tissue engineering applications, 
improvement of cell activities is essential for these materials. Therefore, collagen 
was used to modify the existing hydrogels in order to increase the bioactivity of the 
hydrogels. The modification was completed by immersing the hydrogels in the 
OVICOLL®CLEAR collagen solution, followed by a crosslinking process using a 
glutaraldehyde solution. The hydrogels selected for this study included 10HEMA, 
10HEMA-7.5TiO2, 20HEMA, and 20HEMA-7.5TiO2. The presence of collagen in 
the hydrogels was examined using SEM, UV-VIS, and a FTIR. The cell activities in 
these scaffolds were investigated using three different cell types: green fluorescent 
protein (GFP)-transfected Swiss 3T3 mouse cells (GFP-3T3), green fluorescent 
protein (GFP)-transfected 253 human melanoma cells (GFP-MM253), and human 
mesenchymal stem cells (hMSCs). A laser scanning confocal microscope (LSCM) 
and a fluorescent microscope were used to monitor the cell adhesion and growth. In 
addition, a MTT assay was used to study quantitatively the proliferation of hSMCs 
on 20HEMA and Col20HEMA hydrogels. The influence of hydrogel composition, 
pore structure, and the presence of collagen in the hydrogels to the cell growth and 
proliferation is discussed.  
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Collagen is a major protein comprising the native extracellular matrix (ECM), which 
provides both the physical support for cells, as well as functions for cell adhesion and 
regulates cellular growth in human body (Järveläinen et al. 2009; Lutolf and Hubbell 
2005). Collagen has been extensively used to improve the bioactivities and cellular 
functions of synthetic and/or hydrogel scaffolds that are typically bioinert and lack 
the binding sides or functions that an ECM can provide (Heinemann et al. 2008; Ma 
et al. 2002; Brynda et al. 2009). Collagen molecules can be incorporated into tissue 
scaffolds by physical entrapment and blending methods (Lee et al. 2006), 
dipping/crosslinking methods (Heinemann et al. 2008), or covalent attachment (Bax 
et al. 2010). Modification from a contacting solution, followed by a further treatment 
(crosslinking or drying), is a convenient and quick route. In addition, this method has 
less influence on the porous structures and mechanical properties of the scaffolds 
(Heinemann et al. 2008; Ragetly, Griffon, and Chung 2010; Shi et al. 2010). Apart 
from collagen, other biomolecules, such as gelatin, heparin, hyaluronic acid, short 
peptide sequences originating from cell adhesive proteins such as the Arg-Gly-Asp 
(RGD) or Tyr-Ile-Gly-Ser-Arg (YIGSR), can also be used to modify tissue scaffolds 
(Chung and Park 2007; Hersel, Dahmen, and Kessler 2003; Järveläinen et al. 2009; 
Lutolf and Hubbell 2005). 
 
PHEMA hydrogels are synthetic polymers that do not process supporting lignands 
for cellular recognition.  Researchers have attempted to modify PHEMA hydrogels 
for better cellular responses (Zainuddin et al. 2008). Studies have been carried out to 
improve the bioactivities on both non-porous and porous bulk PHEMA-based 
hydrogels using various biomolecules. In one study, type I collagen has been 
deposited on non porous poly(2-hydroxyethyl methacralate-co-methacrylic acid) 
(p(HEMA/MA)) hydrogels. The resultant hydrogels showed improved mesenchymal 
stromal cell adhesion and growth (Brynda et al. 2009). In other studies, osteopontin, 
an ECM protein for regulating inflammatory responses, was immobilized onto non-
porous PHEMA hydrogels through an iodine monochloride immobilisation method 
(Martin et al. 2003). The presence of osteopontin on the surface of PHEMA 
hydrogels enhanced the adhesion of endothelial cells. Moreover, laminin, another 
ECM protein, and fibronectin/laminin (1:1) were tethered onto the surface of 
poly(methacryethyl mechacrylate-co-methacrylic acid) (p(HEMA-MMA)). The 
results indicated that the tethered surface enhanced the corneal epithelial cell 
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adhesion and growth in comparison to that seen from fibronectin or laminin-coated 
or plain p(HEMA-MMA) hydrogel surfaces (Jacob et al. 2005). In a different study, 
RGD was covalently coupled to the surface of PHEMA hydrogels through tresyl 
chloride immobilization method, which relies on the hydroxyethyl groups on the 
surface of PHEMA hydrogels. The modified PHEMA hydrogels showed an increase 
of 3T3 fibroblast cells adhesion by three orders of magnitude (Massia and Hubbell 
1990).  
 
For porous PHEMA hydrogels, the modification of hydrogels using collagen type I 
with the immobilization method was reported. The resultant hydrogels have shown 
significantly improved C2C12 skeletal myoblast cell spreading (Bryant et al. 2007). 
YIGSR and Ser-Ile-Lys-Val-Ala-Val (SIKVAV), two laminin-derived oligopeptides, 
have been covalently coupled to p(2-hydroxylethyl methacrylate-co-2-aminoethyl 
methacrylate) (p(HEMA-co-AEMA)) hydrogels. The resultant hydrogels promoted 
cell adhesion and neurite outgrowth (Yu and Shoichet 2005). The efforts of 
modification of porous PHEMA-based hydrogels have been demonstrated by another 
group (Kubinová et al. 2010; Kubinová, Horák, and Syková 2009). This research 
group has reported the cell activities on porous poly(2-hydroxyethyl methacrylate-
co-cholesterol methacrylate), PHEMA-CHLMA, when the laminin was used to 
modify the hydrogels. Desirable cell adhesion, spreading and proliferation are 
achieved on both unmodified and laminin-modified porous p(HEMA-CHLMA) 
(Kubinová, Horák, and Syková 2009). In a latest study, SIKVAV was immobilized 
on porous poly(2-hydroxyethyl methacrylate-co-2-aminoethyl methacrylate), 
p(HEMA-AEMA), hydrogels. The results demonstrated that the presence of the 
peptide sequence on porous p(HEMA-AEMA) hydrogels significantly increased 
numbers of rat mesenchymal stem cells adhesion and their growth area in the 
absence of serum in the culture medium. Also, it was found that the immobilized 
peptides supported human fetal neural stem cell attachment, proliferation and 
differentiation (Kubinová et al. 2010).  
 
In the present study, a mixture of collagen type I and III (OVICOLL®CLEAR 
collagen, 10 mg/ml) was used to modify PHEMA and PHEMA-7.5TiO2 hydrogels 
via a dipping method, followed by the crosslinking of collagen using a 
glutaraldehyde solution (0.25%). Cell activities (adhesion, spreading, and 
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proliferation) on these modified hydrogel were evaluated using three different cell 
lines, including GFP-3T3, GFP-MM253, and hMSCs. The purpose of using different 
cell lines is for a board screening.  
5.2. Experimental 
5.2.1. Chemicals  
Cell culture medium, Dulbecco's Modified Eagle's Medium (DMEM) high glucose 
without phenol red, for GFP-3T3 cells and GFP-MM253 cells was from Logan (Utah, 
USA). Mesenchymal stem cell growth medium (MSCGM) was from Lonza, USA. 
Fetal bovine serum (FBS) was from HyClone. L-glutamine, HEPES, sodium 
pyruvate and 0.05trypsin-EDTA were obtained from Invitrogen (Carlsbad, California, 
USA). RPMI-1640 medium was obtained from Signa-Aldrich (St Louis, Missouri, 
USA). 3-[4,5-dimethylthiazolyl-2]-2,5-diphenyl tetrazolium bromide (MTT), 
dimethyl sulfoxide (DMSO), Calcein AM, ethidium homodimer-1 and 
glutaraldehyde (50% in H2O) were purchased from Sigma-Aldrich. An 
OVICOLL®CLEAR collagen solution (10 mg/ml) was received from CollTech 
Australia Ltd, Australia. The OVICOLL®CLEAR collagen was a type I and III 
collagen combination and the ratio is approximately 80:20 (type I: type III). All other 
chemicals were of analytical grade, and used as-received. 
 
5.2.2. Modification of Hydrogels with Collagen  
Freeze dried hydrogels were first gently polished using a sand paper in order to allow 
the opening of the surface pores that might have been closed in the manufacture 
process due to the skin effect (Lou et al. 2005). The hydrogel samples were then 
placed in 2.5 ml centrifugation tubes separately, and 100 µl OVICOLL®CLEAR 
collagen solution (10 mg/ml) was added into each tube. The incubation was carried 
out in an orbital shaker (50 rpm) for 24 hours, followed by removing the collagen 
residual solution from each tube. 100 µl glutaraldehyde solutions (0.25 wt.%) were 
added into each tube for crosslinking and the samples were treated at 60ºC for 10 
minutes. The crosslinking process was further conducted at 5ºC for overnight. After 
the crosslinking process, they were treated at 60ºC for 10 minutes again. All 
hydrogel samples were removed from the container and put into Milli-Q water after 
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keeping them at room temperature for 2 hours. The residual chemicals including 
unattached collagen were extracted by water exchange twice per day for over 7 days.  
5.2.3. Characterization of the Modified Hydrogels 
Morphological analysis was conducted using SEM (Philips XL30 and Zeiss, NEON 
40EsB, Germany). The same procedure was used to prepare SEM samples (Chapter 
2.2.4).  
 
A PerkinElmer FTIR spectrometer (PerkinElmer, Spectrum 100 Series, USA) was 
used to verify the presence of OVICOLL®CLEAR collagen in PHEMA hydrogel. 
The test was conducted from 4000 to 1000 cm-1 using a resolution of 2 cm-1. Twenty 
measurements were repeated for each test.  
 
A GBC 916 UV-Vis spectrometer (GBC Scientific Equipment, Australia) also was 
used to verify the presence of collagen in PHEMA hydrogel (Alina 2001). A piece of 
Col20HEMA was cut into small pieces, followed by heating up to 60°C in 0.5 ml 
water. The clear solution was measured using the UV-VIS.  Control 20HEMA and an 
OVICOLL®CLEAR collagen solution (20 µg/ml) also were evaluated with UV-
VIS using the same procedure.  
 
5.2.4. Cellular Activities 
(1) Human mesenchymal stem cells (hMSCs) 
hMSCs were cultured in mesenchymal stem cell growth medium (MSCGM) (Lonza, 
U.S.A.) and incubated at 37°C in a humidified 5% CO2 incubator. The medium was 
refreshed every three days. The cells were harvested with PBS containing 0.025 % 
trypsin and 0.01% EDTA, followed by centrifuged and subcultured to passage 4 in 
the MSCGM medium. 30 µl of hMSCs suspension (1×105 cells/ml) were added on 
the top of PHEMA hydrogels (surface area: 0.2 cm2), which were placed in a 96-well 
culture plate. Three samples were used for each hydrogel formulation. At the desired 
time intervals (Day 1, 3, 6 or 7), 150 µl fresh MTT solution (5mg/ml in PBS) were 
added to each well and the culture plates were incubated for 4 hours. The formed 
purple formazan was dissolved with 200 µl DMSO. 100 µl of DMSO solution were 
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transferred to a fresh 96-well plate and measured with a spectrophotometer at 550 nm 
with background subtraction at 690 nm. In addition, the imaging was conducted at 
the designated time intervals. 
 
(2) Green fluorescent protein (GFP)-transfected Swiss 3T3 mouse cells 
(GFP-3T3)  
Green fluorescent protein (GFP)-transfected Swiss 3T3 mouse (GFP-3T3) cells were 
cultured in a phenol red free Dulbecco's Modified Eagle's Medium (DMEM) 
supplemented with 2 mM L-glutamine, 10mM HEPES, 1mM sodium pyruvate and 
10% fetal bovine serum (FCS) at 37°C in a humidified 5% CO2 incubator. Hydrogel 
disks (surface area: 0.33cm2) were sterilized (autoclave: 121°C, 15 min) prior to the 
pre-culture with DMEM media in 24-well cell culture plates for 2 hours. 5 µl of cell 
suspension with a density of 3.3×105 cells/ml were added to each of the hydrogels 
after the pre-culture media was aspirated. After 5 min, 5 µl of the same cell 
suspension were added again. 400 µl of fresh media were carefully added after 40 
min. The hydrogels were continuous cultured at 37°C in a humidified 5% CO2 
incubator until they were processed at time intervals (Day 3). The culture medium 
was refreshed every other day. 
 
(3) (GFP)-transfected MM253 human melanoma cells (GFP-MM253)  
Same culture protocol for GFP-3T3 mouse cells was used for GFP-MM253. The cell 
density in the cell suspension solution was 5×105 cells/ml. The hydrogels were 
continuous cultured at 37°C in a humidified 5% CO2 incubator until they were 
processed at time intervals (Day 1 and Day 4). The culture medium was refreshed 
every other day.  
 
The growth of the hMSCs was monitored and photographed using a confocal laser 
scanning microscope (CLSM; Olympus FV300, Japan). Live/dead staining assay was 
used for CLSM imaging. Briefly, cells cultured on the surfaces of hydrogels in 
chambered coverglass (NUNC, Denmark) were washed with PBS and incubated in 
0.5 ml of PBS containing calcein AM (2 µM; labelling live cells) and ethidium 
homodimer-1 (2 µM; labelling dead cells) for 30 min, and then visualized by CLSM 
at excitation wavelengths of 488 nm and 532 nm. The growth of GFP-3T3 and GFP-
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MM253 cells was monitored using a fluorescent microscope (Carl Zeiss). After the 
culture time has been reached, the hydrogel was placed on a glass slide and coved 
using a coverslip. The hydrogel was viewed under the fluorescent microscope and a 
Spot PursuitTM 4MP digital camera was used to take images. Mean ± standard 
deviation and the P value were calculated using one-way ANOVA with OriginPro 
(Version 7.5) software and Turkey test. P values <0.05 were considered statistically 
significant.  
5.3. Results and Discussion 
5.3.1. Confirmation of Collagen in Hydrogels 
Figure 5-1 shows the FTIR spectra of Col20HEMA and 20HEMA hydrogel and the 
FTIR spectrum from as-received OVICOLL®CLEAR collagen. Typical peaks 
including ~3380 cm-1 (O-H stretching vibrations), 1720 cm-1 (C=O stretching 
vibrations), 1650 cm-1 (H-O-H bending vibrations), and 1079 cm-1 (C-O-C bending 
vibrations), were attributed to wet 20HEMA hydrogel, and all these typical peaks 
were found in the spectrum of Col20HEMA hydrogel (Perova, Vij, and Xu 1997). A 
peak from the spectrum of Col20HEMA was seen at 1544 cm-1 after the hydrogel 
was modified using OVICOLL®CLEAR collagen. This peak was attributed to 
amide II group for amide N-H bending vibrations coupled with C-N stretching in 
collagen. In addition, the relative intensity of 1656 cm-1 was also found enhanced.  
This is due to the presence of the Amide I: C=O stretching vibrations, coupled with 
O-H in collagen. These findings indicate the presence of collagen in Col20HEMA 
hydrogel. Other typical peaks, including 3310 cm-1 (Amide A: N-H stretching 
vibrations coupled with O-H, and 1243 cm-1 (Amide III: N-H bending vibrations), 
were found for collagen.  
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Figure 5-1 FTIR spectra of collagen, 20HEMA, and Col20HEMA 
 
UV-VIS spectra from extracted solutions of Col20HEMA and 20HEMA, and an 
OVICOLL®CLEAR collagen solution (20 µg/ml), are displayed in Figure 5-2. 
Absorbance ranging from 250 nm to 280 nm was observed from the solution of 
Col20HEMA hydrogel and this absorbance range was in accordance with that from 
the OVICOLL®CLEAR collagen solution. In this range, there was no absorbance 
from the solution of 20HEMA hydrogel. Therefore, the presence of collagen in 
Col20HEMA hydrogel was verified again.   
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Figure 5-2 UV-VIS spectra of the aqueous extracts from Col20HEMA and 20HEMA hydrogels; 
Spectrum from an OVICOLL®CLEAR collagen solution (20 µg/ml) was used for comparison 
 
5.3.2. Morphological Analysis 
Figure 5-3 shows the morphology of the hydrogels including 10HEMA, 10HEMA-
7.5TiO2, 20HEMA, and 20HEMA-7.5TiO2 before and after the modification using 
OVICOLL®CLEAR collagen. There was a change in morphology between the 
treated and untreated 10HEMA and 10HEMA-TiO2 hydrogels which was probably 
due to the freeze drying process applied to the samples prior to the SEM examination. 
There was no apparent changes in the treated for 20HEMA and 20HEMA-7.5TiO2 
hydrogels. This is understandable as 20HEMA hydrogels are generally harder and 
have less water content than 10HEMA and 10HEMA-TiO2, therefore, the effect of 
freeze drying on these two hydrogels was less effective. Fibrous networks were 
found on the surface of the hydrogels of Col10HEMA, Col10HEMA-7.5TiO2, 
Col20HEMA, and Col20HEMA-7.5TiO2 (Figure 5-3 b, d, f, and h). These structures 
were very apparent on the surface of Col10HEMA and Col20HEMA hydrogels. A 
high magnification of SEM was taken from Col10HEMA (Figure 5-4 a) which 
displays a reassembling of collagen structure that has been shown by other 
researchers (Han 2006) (Figure 5-4 b).  
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Figure 5-3 SEM micrographs of hydrogels (a) 10HEMA, (b)Col10HEMA, (c) 10HEMA-7.5TiO2, 
(d) Col10HEMA-7.5TiO2, (e) 20HEMA, (f) Col20HEMA, (g) 20HEMA-7.5TiO2, and (h) 
Col20HEMA-7.5TiO2 
a b 
c d 
e f 
g h 
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Figure 5-4 (a) SEM micrograph of Col10HEMA hydrogel, and (b) collagen fibrils making up the 
rat cornea (Han 2006) 
 
5.3.3. Cell Activities in the Porous Hydrogel Surfaces 
Figure 5-5 shows the growth of GFP-3T3 cells on (a) 20HEMA, (b) Col20HEMA 
and (c) Col20HEMA-7.5TiO2. Cellular adhesion was observed for all hydrogels. 
However, significantly high GFP-3T3 cell densities were found on Col20HEMA and 
Col20HEMA-7.5TiO2 hydrogels compared to that on 20HEMA after Day 3. This 
finding suggests that the presence of OVICOLL®CLEAR collagen on the hydrogels 
a 
b 
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enhanced the cell adhesion after seeding and their growth. In addition, GFP-3T3 cells 
were not well spread on the 20HEMA hydrogel and they were mainly aggregated 
instead of adhering onto the surface of 20HEMA hydrogel. The GFP-3T3 cells were 
adhered, well spreaded and proliferated on hydrogels after modification using 
OVICOLL®CLEAR collagen, which confirmed the presence of collagen was also 
able to enhance GFP-3T3 cell spreading and stimulate GFP-3T3 cell growth. A 
higher magnification of GFP-3T3 cells on Col20HEMA hydrogel is inserted in 
Figure 5-5 (b). No significant influence from TiO2 addition on the cell growth was 
observed after a comparison that between Col20HEMA and Col20HEMA-7.5TiO2 
hydrogels (Figure 5-5 b and c).  
 
The growth of GFP-MM253 cells was also studied after Day 1 and 4 and the results 
are displayed in Figure 5-6. After Day 1, GFP-MM253 cells can be found on 
Col10HEMA and Col20HEMA hydrogels and there were no apparent cells on 2-
HEMA hydrogel. GFP-MM253 cells on Col10HEMA and Col20HEMA hydrogels 
were significantly increased after Day 3. The number of cells on 20HEMA after Day 
3 was still significantly low. This finding again suggests that the presence of collagen 
fibres on the hydrogel improved the cell adhesion and the following proliferation of 
GFP-MM253 cells. No significant difference in cell responses was found between 
Col10HEMA and Col20HEMA hydrogels (Figure 5-6 b and d). In comparison to 
cellular activities seen for GFP-3T3, it was observed that GFP-MM253 cells had less 
capability of spreading on the modified hydrogels.  
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Figure 5-5 Fluorescent micrographs showing the growth of GFP-3T3 cells on the surface of (a) 
20HEMA, (b) Col20HEMA and (c) Col20HEMA-7.5TiO2 hydrogels after Day 3  
 
 
 
a b 
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Figure 5-6 Fluorescent micrographs showing the growth of GFP-MM253 cells on the surface of (a, d) 20HEMA, (b, e) Col20HEMA, and (c, f) 
Col10HEMA hydrogels after Day 1 and Day 4 
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Figure 5-7 shows of the growth of hMSCs on 20HEMA and Col20HEMA after Day 
1, 3, and Day 7. Similar results of the cell activities were observed. Very limited 
numbers of hMSCs were seen on the surface of control 20HEMA hydrogel, while the 
numbers of hMSCs on Col20HEMA were increased greatly, attributed to the 
presence of collagen in the hydrogel. In addition, when the cell culture incubation 
was increased until Day 7, the cells on Col20HEMA showed good spreading and 
signs of apparent proliferation. However, the cells on 20HEMA hydrogel did not 
show a good spreading and no apparent sign for cell proliferation was seen. This 
further demonstrates that not only cell attachment but also cell growth capability 
were enhanced after the modification using OVICOLL®CLEAR collagen. 
Furthermore, a cross-sectional image for investigating the growth of hMSCs within 
Col20HEMA after Day 7 is shown in Figure 5-8, from which hMSCs were observed. 
It indicates that hMSCs were capable of growing into Col20HEMA hydrogel. This 
in-growth characteristic can be beneficial greatly for regenerating tissues. From the 
top surface of the hydrogel indicated by an arrow in the image, hMSCs have, overall, 
penetrated downwards the macroporous structure about 0.6 mm. It was seen that 
aggregates of the hMSCs were located separately within the hydrogel. This 
distribution probably was attributed to the pore structure and the amounts of the 
collagen in the places where cells were found.  
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Figure 5-7 LSCM micrographs showing the growth of hMSCs on the surface of (a, c, and e) 
20HEMA and (b, d, and f) Col20HEMA after Day 1, 3, and 7  
a b 
c d 
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Day 7 
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20HEMA                          Col20HEMA 
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Figure 5-8 Cross-section analysis of hMSC in Col20HEMA after Day 7 using a LSCM (arrow 
shows the top surface of the hydrogel) 
 
Figure 5-9 shows the optical density, which is proportional to the cell density of 
hMSCs, of 20HEMA and Col20HEMA hydrogels. Overall, increased viable hMSCs 
on both hydrogels was seen as the incubation time was increased. The relatively low 
absorbance at Day 1 was attributed to the recovery of the cells from the culture 
conditions. Increased cell growth was noticed at Day 3 and Day 7. At Day 7, 
significant increase of cell numbers were found in Col20HEMA hydrogels, 
indicating that the modified hydrogels were more preferable for cell adhesion and 
cell growth. This finding indicates that the treatment of the hydrogels with 
OVICOLL®CLEAR collagen had a positive impact on the cell proliferation. 
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Figure 5-9 The hMSCs growth measured by the MTT assay. The optical density values are 
proportional to the numbers of the living hMSCs. (*) indicates the significant different in optical 
density in comparison to that from Day 1 Day 3 for Col20HEMA 
5.4. Conclusions 
Four hydrogels, including 10HEMA, 20HEMA, 10HEMA-7.5TiO2, and 20HEMA-
7.5TiO2, were successfully modified with OVICOLL®CLEAR collagen. The 
presence of collagen in the hydrogels was confirmed using FTIR, UV-VIS and 
morphological analysis. Fibrous networks of collagen were found on the cross-
section of the modified hydrogels. The presence of collagen in hydrogels enhanced 
significantly the cellular adhesion and spreading for three cell lines, including GFP-
3T3 cells, GFP-MM253 cells, and hMSCs. Accelerated proliferation of GFP-MM253 
cells and hMSCs was also observed for hydrogels modified with collagen along the 
incubation time.  
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CHAPTER 6 CONCLUSIONS  
 
Eighteen porous PHEMA composite hydrogels containing TiO2, multi-walled CNTs 
and SiO2, and five plain PHEMA hydrogels were successfully synthesized and 
evaluated for applications as soft tissue regeneration scaffolds. Four of these 
hydrogels were further modified with an OVICOLL®CLEAR collagen, a mixture 
of type I and type III collagen, for the improvement of cell activities.  
 
Both PHEMA and PHEMA composite hydrogels appeared opaque and exhibited 
macroporous structures. The porous structures were largely dependent on the 
HEMA:water concentrations in the polymerization mixtures. In general, a lower 
HEMA:water concentration ratio resulted in a more porous structure, whist a higher 
HEMA:water ratio facilitated the production of a less porous structure hydrogel. The 
addition of the nanoadditives showed some minor impact on the porous structures of 
the less porous hydrogels, i.e., the hydrogels contained high HEMA concentrations. 
This finding is very useful for the production of tissue scaffolds with incorporation of 
essential biomolecules for the regeneration of specific tissues without varying the 
pore structures of the scaffold.    
 
The porous structure in hydrogel polymers had significant impacts on their 
mechanical properties. In general, higher tensile and elastic moduli were seen for 
hydrogels with less porous structures. Conversely, lower tensile and elastic moduli 
were seen for more porous structured hydrogels. The addition of TiO2 particulates 
did not show significant influence on tensile and elastic moduli. However, the 
addition of CNTs increased the viscoelastic moduli of PHEMA hydrogels, attributed 
to their fibre characteristics. Both PHEMA and PHEMA-TiO2 composite hydrogels 
showed a moderate shear elastic modulus in the range of 104~105 Pa, which is 
comparable for the liver, muscle, and nucleus pulpous tissues. The value was also 
within the range for native cartilaginous tissue (0.7×103-1×106 Pa) (Söntjens et al. 
2005; Vanderhooft et al. 2009). In comparison with another hydrogel, poly (ethylene 
glycol) diacrylate, that have been evaluated for human adipose tissue regeneration 
(Patel, Smith, and Patrick 2005), PHEMA and PHEMA-TiO2 hydrogels produced in 
this study have showed a greater range of linear viscoelasticity (2~25%), dependent 
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on the macroporous structures and the presence of the TiO2 nanoadditives. In 
addition, the tensile properties of the investigated hydrogels are within the range of a 
few soft tissues. Moreover, PHEMA and PHEMA-TiO2 composite hydroegls 
demonstrate excellent elongation properties, which is truly an advantage when this 
property becomes a factor for tissue regeneration. These indicate that macroporous 
PHEMA and its composite hydrogels have a better adaptivity and can be tuned to 
accommodate more complex mechanical environments, which enable them to 
become a potential scaffolding materials for engineering such tissues as nerves, 
muscles, and cartilaginous tissues such as articular cartilage.  
 
The delivery of biomolecules from the selected PHEMA hydrogels was also 
investigated. Four different biomolecules were investigated using both single and 
dual molecule modes at both static and dynamic conditions. For the dynamic delivery, 
increasing the frequencies and the shear strains of the rheological stimulations 
accelerated the relative release of these biomolecules from PHEMA hydrogels. In 
comparison with results from the release without stimulation, significant difference 
in the relative release was found only when the frequency and strain of the 
rheological stimulations were relative low. When these parameters were increased, 
the delivery properties became similar to those in the static conditions. This finding 
can assist the researches to consider the dosing amount of different biomolecules in 
such a dynamic release circumstance. The relative release of the biomolecules was 
affected by the concentration and molecular weights of the biomolecules, the 
biomolecule type, the interaction between the biomolecule and the hydrogel, as well 
as the porous structure of the hydrogels. In general, a more porous PHEMA hydrogel 
showed a higher relative release under both static and dynamic conditions. A quicker 
relative release was seen for the biomolecules with a smaller molecule weight or a 
higher concentration. When dual biomolecules were used in the system, the delivery 
profiles of each of the biomolecules were the same as the single biomolecule delivery 
profile. The relative release was dependent on the molecule weights and the porous 
structures. It should be noted that loading level of each biomolecule could be easily 
adjusted by using various concentrations of the biomolecule, resulting in different 
released amounts of the biomolecule (Lou, Munro, and Wang 2004; Wang et al. 
2010). Therefore, it becomes possible to regulate accurately the amount and time 
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period of biomolecule release for regenerative processes. This is a great benefit for 
the tissue engineering scaffolds.  
 
Finally, bioactivity of the PHEMA and PHEMA composite hydrogels were evaluated 
though a calcification study and cell activities study. At low HEMA concentrations, 
the composite hydrogels contain more pores and more suitable surface properties and 
are favourable to the formation and infiltration of CaP. The addition of TiO2 
nanoparticles can significantly enhance the formation of CaP in hydrogel polymers. 
However, no significant effect can be seen from composite hydrogels containing 
SiO2 and CNTs. For the cell activity studies, no significant impact has been seen 
from the incorporation of nanoadditives in this study. However, when small amounts 
of collagen molecules were added into the hydrogels, the cell activities were 
significantly enhanced. This is true for both PHEMA and PHEMA-TiO2 composite 
hydrogels.  
   
Overall, the macroporous structures, the mechanical properties, and biomolecule 
transportation and delivery properties of PHEMA and PHEMA-composite hydrogel 
polymers can be tailor-made to meet specifications required by various applications. 
Moreover, the cellular responses of PHEMA and PHEMA-TiO2 hydrogels can be 
further improved using collagen, an ECM protein. Therefore, these preliminary 
investigations of PHEMA and PHEMA composite hydrogel have demonstrated their 
great potential for such applications as liver, muscle, nucleus pulpous, and articular 
cartilage.  
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